Modified Oligonucleotides : Investigations and Applications of the Diels-Alderase Ribozyme by Wahl, Florentine
  
Dissertation 
submitted to the 
Combined Faculties for the Natural Sciences and for Mathematics 
of the Ruperto-Carola University of Heidelberg, Germany 
for the degree of 
Doctor of Natural Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
presented by 
 
Diplom-Chemikerin Florentine Wahl 
born in Freiburg i. Br., Germany 
oral-examination: March 3rd 2011 
 
 
 

  
 
 
Modified Oligonucleotides: 
Investigations and Applications of the 
Diels-Alderase Ribozyme 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Referees: Prof. Dr. Andres Jäschke 
   Prof. Dr. Stefan Wölfl 
 

Acknowledgements 
 
First and foremost I want to thank my supervisor Prof. Andres Jäschke, for giving me the 
opportunity to work in his research group, as well as for his constant support, encouragement 
and guidance during my thesis. 
 
I am thankful to Professor Wölfl for accepting to review and co-examine this thesis. Furthermore 
I want to thank Prof. Fricker and Prof. Haefeli to who agreed to take part in my oral exam. 
 
I owe sincere and earnest thankfulness to Dr. Roberto Fiammengo for mentoring me and for 
his support and friendship throughout all these years. 
 
My thanks also go to Viola Funk and Karin Weiß, who supported me in any possible way. 
The personal of the IPMB, Heiko Rudy for everything he ever did help me with, Tobias 
Timmermann for acquiring NMR spectra and his support with computer problems, Besarta 
Ljaic and Sandra Suhm for their synthetic expertise, Steffi Dräger for her help. 
Big thanks also go to my interns Michael Wrede, Helen Hagen, Michael Morgen and 
Michaela Stach for their excellent work. 
 
Special thanks to Benjamin Strauss, Marie Winz, Dr. Roberto Fiammengo, Anna Wiesmayer, 
Dr. Alexander Niert and André Krause for proof-reading the manuscript. 
Furthermore I want to thank my friends Dr. Bernd Sterling, Dr. Dave Smith and Martina 
Mechler for their invaluable support and especially Dr. Thomas Schultz for believing in me 
and make me believe in myself. 
 
I am obliged to many of my colleagues - the present and past members of the Jäschke lab as 
well as the Helm group, who all helped me, contributed to this thesis and always created a 
good working atmosphere. Anna, for her help in the lab, as well with my terrace and the 
breaks spent together. Benjamin, for invaluable help during the last couple of months. Marie, 
for her advice. Sandeep, for great discussions and his support with my project. Armine and 
Martin, for introducing me into the word of biology. Matthias for his support. Ayan, for the 
good discussions. Juliane, André, Alex, Steffi K., Ankita, Surjendu, Hana, Steffi P., Marco, 
Salifu, Markus P., Felix, Madeleine, Michaela, Markus H., Mihaela … 
I am truly indebted and thankful to all my friends, who supported me during these years and 
helped me to get through the ups and downs of this thesis. Terje for the good times spent 
together. 
 
My parents and my sister have always provided strong and consistent support. Without them I 
wouldn’t be where I am now and I will forever be grateful for that. 
  
 
 
 
 
 
 
For my family 

Abstract          Florentine Wahl, Diplom-Chemikerin 
 
Modified Oligonucleotides: Investigations and Applications of the Diels-Alderase 
Ribozyme. 
 
1st Referee: Prof. Dr. Andres Jäschke 
2nd Referee: Prof. Dr. Stefan Wölfl 
 
The hypothesis of the origin of life was fundamentally changed by the discovery of catalytic 
RNA. The fascinating fact that RNA can function as a catalyst in the formation of carbon-
carbon bonds, thereby creating enantiomeric centers and thus potential building blocks for 
life-sustaining structures, is of great importance to those who wish to understand biocatalytic 
processes. Ribozymes are generally identified by in vitro selection. Such an artificial 
ribozyme was utilized for the work presented in this dissertation; specifically, the Diels-
Alderase ribozyme was the focus of the investigation. This ribozyme catalyzes a Diels-Alder 
reaction between anthracene and maleimide. The work presented herein revolved around 
modifications of oligonucleotides on different levels. Modification of RNA with organic 
moieties is indispensable for effective in vitro selection of such ribozymes.  
This thesis consists of three parts. In the first, new pathways were established for the synthesis 
of modified guanosine monophosphates (GMPs). The ability of the enzyme T7 RNA 
polymerase to incorporate these modified GMPs during transcription priming coined the term 
initiator nucleotides. The syntheses of a substituted anthracene and aldehyde-modified 
initiator nucleotides connected with a flexible polyethylene glycol linker were realized in just 
three synthetic steps. The incorporation of the initiator nucleotides into short RNA transcripts 
was investigated, as well as their incorporation into an RNA library with a randomized region 
eligible for in vitro selection. Excellent incorporation rates up to 77% were obtained for the 
transcription into the RNA library. The reactivity of thereby modified RNA molecules was 
subsequently studied in chemical reactions. Whereas the anthracene derivative could be 
reacted in a Diels-Alder reaction, the aldehyde led to full conversion in the reaction with 
hydrazides. 
In the second part of this thesis, the effect of divalent metal ions on the folding and stability of 
the Diels-Alderase ribozyme was studied in UV thermal denaturation experiments. Low 
concentrations of Mg2+ cations led to secondary structure stabilization of up to 85°C. Thermal 
denaturation studies of the wild-type ribozyme and comparison to mutants complement other 
ongoing investigations of the complex interplay of non-standard base pairs and triples in the 
ribozyme structure. While the wild-type ribozyme exhibited a significant stabilization in the 
presence of Mg2+ cations, a comparable stabilization of the mutants could not be observed. In 
accordance with the findings in other studies, the best interpretation of this effect on stability 
was that the mutants, despite their ability to form a pseudoknot structure, could not undergo 
further compaction. 
In the third part of this thesis, the Diels-Alderase ribozyme, which causes a remarkable 
acceleration of the Diels-Alder reaction rate, was successfully used as a catalyst for 
fluorescently labeling oligonucleotides in cis and in trans. Investigations of the substrate 
specificity of the ribozyme revealed that only fluorescent maleimide dyes with five carbon 
atoms next to the dye were accepted as substrates. This distinct feature was utilized as a 
bioorthogonal labeling strategy for the Diels-Alder bioconjugation of anthracene-modified 
oligonucleotides with equimolar proportions of fluorescent dyes. A new dual orthogonal 
labeling strategy was achieved by using an iodoacetamide dye for the thiol modification and a 
maleimide dye for the anthracene modification within the same DNA strand. For the 
anthracene modification, the Diels-Alderase ribozyme was employed as a catalyst. 
 
Zusammenfassung                    Florentine Wahl, Diplom-Chemikerin 
 
Modifizierung von Oligonukleotiden: Untersuchungen und Anwendungen des Diels-
Alderase Ribozyms. 
 
1. Gutachter: Prof. Dr. Andres Jäschke 
2. Gutachter: Prof. Dr. Stefan Wölfl 
 
Die Entdeckung, dass RNA katalytische Eigenschaften aufweist, beeinflusste die Hypothese 
über den Ursprung des Lebens fundamental.  Für das Verständnis biokatalytischer Prozesse ist 
die faszinierende Tatsache, dass RNA die Bildung neuer Kohlenstoff-Kohlenstoff Bindungen 
katalysieren und dabei Stereozentren generieren kann von entscheidender Bedeutung. Die 
vorliegende Arbeit basiert auf der Erforschung und Anwendung eines solchen Ribozyms - des 
Diels-Alderase Ribozyms. Dieses Ribozym katalysiert die Diels-Alder Reaktion zwischen 
Anthracen und Maleimid. Ribozyme werden grundsätzlich durch in vitro Selektion 
identifiziert. Ein wichtiges, zentrales Thema dieser Arbeit ist die Modifikation und 
Funktionalisierung von Oligonukleotiden. Die Modifikation von RNA durch funktionelle 
Gruppen ist für die in vitro Selektion derartiger Ribozyme unverzichtbar. 
Im ersten Teil der Arbeit wurden neue Synthesewege chemisch modifizierter 
Guanosinmonophosphate (GMP) untersucht. Die Fähigkeit des Enzyms T7 RNA-Polymerase 
während der Transkription GMP spezifisch als erste Base einzubauen, prägte dabei den 
Namen Initiatornukleotid. Die Darstellung eines Anthracen-Derivates und eines Aldehyds mit 
einem flexiblen Polyethylenglykol-Linker konnte in nur drei Syntheseschritten erreicht 
werden. Der Einbau der Initiatornukleotide in kurze RNA-Transkripte wurde ebenso wie der 
Einbau in eine für die in vitro Selektion geeignete RNA-Bibliothek mit randomisiertem 
Bereich untersucht und optimiert. Dabei konnten Inkorporationsraten bis zu 77% für den 
Einbau in die RNA Bibliothek erzielt werden. Anschließend wurde die Reaktivität der dabei 
modifizierten RNA Moleküle untersucht. Das Anthracen-Derivat konnte in einer Diels-Alder 
Reaktion umgesetzt werden, während der Aldehyd vollständig mit Hydraziden reagierte. 
Im zweiten Teil wurde der Einfluss zweiwertiger Metallionen auf die Faltung und Stabilität 
des Diels-Alderase Riboyzms in UV-Denaturierungsexperimenten untersucht. Dabei konnte 
gezeigt werden, dass bereits geringe Konzentrationen von Mg2+-Kationen in der Lage sind, 
die Sekundärstruktur bis 85°C zu stabilisieren. Studien zur thermischen Denaturierung des 
Wildtyps sowie Mutanten ergänzen andere laufende Studien zur Erforschung des komplexen 
Zusammenspiels ungewöhnlicher Basenpaarungen und Basentripel in der Ribozymstruktur. 
Obwohl beim Wildtyp eine signifikante Stabilisierung durch Mg2+ festgestellt wurde, konnte 
eine ebensolche Stabilisierung der Mutanten nicht nachgewiesen werden. In 
Übereinstimmung mit anderen Studien kann dies so interpretiert werden, dass die Mutanten, 
trotz ihrer Fähigkeit einen Pseudoknoten zu bilden, keine weiter Kompaktierung erfahren. 
Im dritten Teil der Arbeit wurde das Diels-Alderase Ribozym, welches eine bemerkenswerte 
Reaktionsbeschleunigung hervorruft, erfolgreich als Katalysator für die Markierung von 
Oligonukleotiden mit Fluoreszenzfarbstoffen sowohl in cis als auch in trans, eingesetzt. 
Untersuchungen zur Substratspezifität haben gezeigt, dass nur Maleimide-Derivate mit fünf 
Kohlenstoffatomen zwischen Maleimid und Fluoreszenzfarbstoff als Substrat erkannt werden 
konnten. Dieses distinktive Merkmal konnte genutzt werden, um eine neue bioortogonale 
Markierungsmethode für Anthracen-modifizierte Oligonukleotiden mit equimolaren Mengen 
an Fluoreszenzfarbstoffen zu schaffen. Eine neue zweifach orthogonale Markierungsmethode 
von Modifikationen im gleichen DNA-Strang konnte erzielt werden, indem für Thiol-
Modifikationen Iodoacetamid- und für die Anthracen-Modifikation Maleimid-
Fluoreszenzfarbstoffe verwendet wurden. Dabei wurde das Anthracen in einer Ribozym-
katalysierten Diels-Alder Reaktion umgesetzt. 
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1 Introduction 
 
1.1 The RNA world and ribozymes 
 
The question of the origin of life is one of the oldest questions of mankind and one of the 
most difficult to address in biology. The term “RNA World” was first used by Gilbert in 
1986,[1] even though the idea of an RNA based world as a hypothetical origin in the evolution 
had been suggested long before by Sir Francis Crick. [2] When Gilbert established the term 
RNA word solely cleavage and ligation of phosphodiester bonds by RNA were known, but 
his hypothesis inspired and is still inspiring scientists all over the world to seek proof of an 
RNA world. 
In 1982 Cech et al.[3, 4] discovered RNA sequences that were able to cleave and rejoin the 
phosphate esters between their own nucleotides. This self-splicing RNA provided the first 
example of a catalytically active site formed by a ribonucleic acid.[5] Independently, Altmann 
and co-workers[6] found that RNase P is an RNA, processing endonuclease cleaving 
precursors of tRNA and releasing 5′-precursor sequences and mature tRNA.[7, 8] Since then a 
number of other natural ribozymes have been discovered. The most prominent ribozymes are 
group I and II self splicing introns,[9] encompassing the Tetrahymena ribozyme that was 
originally discovered by Cech, the hammerhead ribozymes,[10] the hairpin ribozyme,[11] the 
small self-cleaving Varkud satellite (VS)[12] or the hepatitis delta virus ribozyme (HDV).[13] 
Ribozymes can either catalyze a reaction in cis, meaning the ribozyme modifies itself, or in 
trans non-selfmodifying. These ribozymes, mostly discovered by the in vitro selection 
methodology, could turn out to be the missing link between a formerly RNA dominated world 
to todays protein-dominated world. 
In 1993 Crick wrote “It may turn out that we will eventually be able to see how this RNA 
world got started. At present, the gap from the primal 'soup' to the first RNA system capable 
of natural selection looks forbiddingly wide.”[14] Even though some years have passed and the 
discovery of new natural and artificial ribozymes has lead to a further understanding of this 
hypothesis, more fundamental research into the function and application of ribozymes may 
eventually lead to hints that may further support the hypothesis of an RNA world. 
Introduction 
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1.2 In vitro Selection 
 
The progress in the discovery of new ribozymes is mainly due to the technique of in vitro 
selection, independently developed by Joyce, Szostak and Gold in 1990. This technique 
enables to screen libraries of up to 1015 different nucleic acid molecules for a distinct 
functionality.[15] This method is known as in vitro selection,[16] in vitro evolution[17] or 
SELEX, an acronym standing for Systematic Evolution of Ligands by EXponential 
enrichment.[18] With this technique large libraries of randomized nucleic acids have been 
screened successfully for catalytic activity [19-26] and screened for binding to small molecules 
or proteins.[27-33] RNA and DNA molecules that can bind small molecules are called aptamers. 
After two decades of in vitro selection ribozymes have proven that they are indeed potent 
catalysts. Ribozymes are capable of catalyzing a broad spectrum of chemical reactions with 
good catalytic rate enhancement. An overview over some in vitro selected ribozymes are 
given in table 1. 
 
Table 1: Examples for artificial ribozymes obtained by in vitro selection. 
Reaction Reference  Reaction Reference 
RNA cleavage [34]  Aminoacylation [35, 36] 
RNA ligation [20, 37]  Aldol-reaction [38] 
Phosphoester cleavage [39, 40]  Diels-Alder reaction [41, 42] 
Phosphoester transfer [43, 44]  Michael addition [45] 
Phosphorylation [46]  Formation of an amide bond [47]a 
Peptide bond formation [26, 48]  Cleavage of an amide bond [49] 
Self-capping [50]  Formation of an urea bond [51] 
RNA polymerization [52]  Nitrogen alkylation [53] 
Aldehyde reduction [54]  Sulfur alkylation [55] 
Alcohol dehydrogenation [56]  Porphyrin metalation [57] 
Acyl transfer [58, 59]  Claisen condensation [60] 
a Contains 5´-substituted uridine analogs that are essential for catalysis. 
 
The general procedure of the in vitro selection methodology starts with a chemically 
synthesized DNA pool with a randomized region, flanked by two constant regions consistent 
of the primer binding sites and a T7 RNA polymerase promoter (figure 1). This DNA pool is 
to be amplified in a preparative scale PCR to gain several copies of each sequence. After T7 
RNA polymerase transcription the obtained RNA pool is employed in the reaction it should 
catalyze, or exposed to the molecule it should bind. Subsequently active or binding sequences 
Introduction 
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are separated by affinity chromatography. The obtained RNA sequences are reverse 
transcribed into DNA, amplified by PCR and again transcribed into RNA to re-enter the 
selection cycle. Generally 5 to 10 rounds of selection should suffice to enrich the reactive 
sequences.[15, 61] 
 
 
Figure 1: General selection scheme for the in vitro selection of reactive RNA sequences. 
 
1.3 The Diels-Alder reaction 
 
 
Scheme 1: The Diels-Alder reaction. 
 
The Diels-Alder reaction is one of the most important reactions in organic chemistry. It was 
named after Otto Diels and Kurt Alder, who first described the reaction in 1928[62] and were 
awarded the Nobel Prize in 1950 for their research on [4 + 2] cycloadditions. In one step two 
new carbon-carbon bonds are formed in a chemoselective manner and a six-membered ring is 
created (scheme 1). This cycloaddition between the diene and the dienophile is concerted, 
requiring the arrangement of the frontier orbitals.[63, 64] 
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The reactivity of the Diels-Alder reaction depends on the energy difference between the 
HOMO (highest occupied molecular orbital) and LUMO (lowest occupied molecular orbital). 
The lower the energy difference between the two molecular orbitals the lower is the energy of 
the transition state of the Diels-Alder reaction (figure 2). 
 
 
Figure 2: The Diels-Alder reaction. The dienophile reacts with a diene to form a six-membered cyclohexene. 
Three π-bonds in the substrates are converted into two σ-bonds and a new π-bond in the product. Molecular 
orbitals (S = symmetrical, A = asymmetrical) are shown according to the Woodward-Hoffmann rules. For clarity 
only the HOMO π-electrons are shown. Adapted from Tarasow et al..[65] 
 
Since the discovery of the Diels-Alder reaction studies using water as a solvent have been 
undergoing.[66] Woodward and co-workers reported a change in the endo-exo selectivity for 
the Diels-Alder reaction between furan and maleic acid in water.[67] Eggelte et al. reported the 
first reaction rate acceleration for Diels-Alder reactions in aqueous media.[68] However, it was 
not until the landmark paper by Breslow et al. in 1980[69] that the acceleration of the Diels-
Alder reaction in water had been recognized in the scientific society. Breslow and Rideout 
attributed the acceleration to an entropy-driven hydrophobic effect (scheme 2). [69] 
 
 
Scheme 2: Illustration of the hydrophobic hydration shells around the diene, dienophile and the Diels-Alder 
product. The red hydration shells are released into the solution during the reaction. Adopted from Otto et al.. [70] 
Introduction 
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1.4 Diels-Alder reactions in biocatalysis 
 
Following the fundamental principles of Pauling,[71] Jencks proposed in 1969 that 
complementarity between the active site and the transition state of an enzyme contributes 
significantly to enzymatic catalysis; therefore, the construction of an antibody to a hapten, 
resembling the transition state of a reaction should lead to such an enzyme. A transition state 
analogue provided by the antibody should stabilize the transition state and therefore cause an 
acceleration of the reaction.[72] The first proof of this principle was provided by Schulz and 
Lerner[73-75] studying esterase antibodies. The first catalytic Diels-Alder reaction had been 
demonstrated in 1989 by Hilvert et al. with the antibody 1E9.[76, 77] 
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Scheme 3: Antibody 1E9 catalyzes the Diels-Alder reaction between tetrachlorothiophen dioxide 1 and N-
ethylmaleimide 2. The reaction proceeds in two steps: the intermediate 3, which eliminates sulphur dioxide to 
give the product 4, undergoing air oxidation to form N-ethyl tetrachlorophthalimide 5. The Antibody 1E9 was 
raised against the hexachloronorbornene derivative 6 as structural analogue of the transition state.[78] 
 
The chemical structure of many natural products suggests an involvement of a Diels-Alder 
reaction, but so far in most of these pathways a Diels-Alderase was illusive. For a long time 
three enzymes were believed to act as Diels-Alderases.[79, 80] The solanapyrone synthase,[81] 
the lovastatin nonaketide synthase (LNKS), and the macrophomate synthase.[82] Studies of the 
macrophomat synthase suggested the involvement of a Diels-Alder reaction, but in fact the 
reaction seems to proceed via a sequential Michael-aldol pathway.[83-85] 
Computational studies have led to designed enzymes catalyzing a Diels-Alder reaction.[86, 87] 
Recently Baker and co-workers have indeed selected an enzyme catalyzing an intermolecular 
Diels-Alder reaction of the diene 4-carboxybenzyl trans-1,3-butadiene-1-carbamate and the 
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dienophile N,N-diemthylacrylamide (figure 3).[88] Employing an algorithm of the modelling 
program RosettaMatch[89] the transition state and its stabilization in the catalytic pocket was 
simulated and subsequently libraries of protein scaffolds were scanned to find applicable 
candidates. An initial scan of 1019 protein scaffolds identified about 106 possible active sites 
in proteins. By further optimizing this modelling approach the proteins were limited to a 
manageable number of 84 proteins. These 84 proteins were then expressed within E. coli. 
After engineering, 50 stable proteins remained and were then tested for catalytic activity in 
the Diels-Alder reaction. Only two of these enzymes actually showed catalytic activity. 
Further modified, these enzymes show strong selectivity for the substrates and compared with 
the metal catalyzed reaction the novel enzymes are only one magnitude slower. In principle, 8 
different isomers could result in this Diels-Alder reaction, out of which four are produced 
during the uncatalyzed reaction. Remarkably, the engineered enzyme only catalyzes the 
reaction of one specific isomer. 
 
 
Figure 3: The Diels-Alder reaction - diene and dienophile undergo a pericyclic [4 + 2] cycloaddition to form a 
chiral cyclohexene ring. The image also shows the designed target active site, with hydrogen bond acceptors and 
donors activating the diene and dienophile and a complementary binding pocket holding the two substrates in an 
orientation optimal for catalysis. Adapted from Siegel et al..[88] 
 
Not only antibodies and proteins are able to catalyze Diels-Alder reactions. Nucleic acids are 
also capable of accelerating Diels-Alder reactions. The first artificial ribozyme was published 
by Tarasow and Eaton, this ribozyme however is dependent on the presence of pyridine and 
copper ions.[42] This ribozyme was only active if covalently attached to one of the reactants 
and therefore is not really a true catalyst. The first true Diels-Alder ribozyme was selected by 
Jäschke and co-workers. This Diels-Alder ribozyme provides the basis for the present work 
and shall be elaborated further in the next chapter. 
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Not only ribozymes for the catalysis of Diels-Alder reactions have been selected, Silverman 
and co-workers reported a deoxyribozyme that can catalyze the Diels Alder reaction as 
efficiently as the reported ribozymes.[22, 90] 
 
1.5 The Diels-Alderase Ribozyme 
 
Seelig and Jäschke selected a Diels-Alderase ribozyme, catalyzing the carbon-carbon bond 
formation between an anthracene derivative and a maleimide.[91] This ribozyme is able to 
catalyze a multiple turnover reaction, with an acceleration of up to 20 000 fold with high 
enantio-selectivity. It is the first true Diels-Alderase ribozyme and capable of performing the 
Diels-Alder reaction between the free reactants (scheme 4). 
 
N
O
O
OH
N
O
O
OH
Diels-Alderase
ribozyme
 
Scheme 4: Diels-Alderase ribozyme catalyzed reaction between 9-hyroxymethyl anthracene and N-
pentylmaleimide. 
 
Rational design and ribozyme engineering lead to the identification of a minimal motif 
consisting of 49 nucleotides.[41] The secondary structure motif consists of 3 helices (helix I-
III), and an asymmetric internal loop, composed of a pentanucleotide UGCCA, and a 
hexanucleotide AAUACU, and a formally single stranded 5´-end (figure 4). Mutation analysis 
identified highly conserved structural elements to be part of the formally single stranded 
regions. The nucleotides G1, G2, A3, G4, U8, U10, C11 and U20 are highly conserved while the 
sequence of the helices I and III are variable as long as the strands are complementary to each 
other. A strong conservation was found for helix II, both in length and purine/pyrimidine 
pattern. Mismatches in this region lead to a total loss of catalytic activity. [92] 
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Figure 4: a: Secondary structure of the Diels-Alderase ribozyme minimal motif. b: X-ray structure of the Diels-
Alder ribozyme with co-crystallized reaction product (blue) in the catalytic pocket. 
 
The complex three-dimensional structure of the Diels-Alderase ribozyme had been predicted 
by mutational analysis[92] and was later confirmed by crystal structures of the ribozyme.[93] 
The ribozyme adopts a λ-shaped fold of its three helices in which stems II and III stack 
coaxially, with stem I abutting the active site.[94] The 5′ end of the RNA bridges helical stems 
III and I, generating a complex nested pseudoknot topology. The pseudoknot architecture 
presents a preformed hydrophobic pocket, precisely complementary to the reaction 
product.[93] 
The minimal motif of the ribozyme could be converted into a two- and three-stranded system 
by formally cleaving the two tetraloops. The bipartite system consists of an unmodified 38mer 
and an anthracene-tethered 11mer, while the tripartite version consists of a 24mer an 18mer 
and the thethered 11mer.[92, 95] Both constructs show a similar catalytic activity to the 49mer 
minimal motif. All versions of the Diels-Alder ribozyme can catalyze the reaction in cis and 
in trans between the free ligands. The benefit of a reaction catalyzed in trans is that a huge 
variety of different substrates could be investigated as potential substrates. Stuhlmann et al. 
showed that the ribozyme tolerates several substitutions on both substrates, except in the 2- 
and 3-position of anthracene.[96] The significance of the above mentioned results will be 
explicitly discussed in chapter three and four. 
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2 Synthesis and applications of novel initiator nucleotides 
 
2.1 Scientific background 
 
2.1.1 Incorporation of initiator nucleotides with T7RNA polymerase 
 
The structural and mechanistic studies of RNA biochemistry greatly depend on the 
incorporation of modified nucleotides. Nucleotides that bear a modification at the phosphate 
backbone or at a base can either be introduced randomly or at a specific site. If the desired 
RNA sequence is short enough (max. 40 nt), chemical synthesis is the simplest solution. For 
long RNA sequences a combination of chemical synthesis and RNA ligation has to be 
employed.[97] 
An efficient possibility for site-specific 5´-modification of RNA is transcription initiation 
priming. Nucleotides lacking a 5´-triphosphate are unavailable for incorporation during 
elongation of the RNA molecule. Due to their ability to initiate transcription reactions they 
are named initiator nucleotides.[98] RNA polymerase binds specifically at the promoter 
sequence of the double stranded DNA and starts the transcription with the nucleoside 
triphosphates present in the reaction mixture. As the modified nucleoside monophosphate can 
only be incorporated at the 5´-end, each transcribed RNA sequence can only carry a single 
modification. Transcription priming naturally leads to mixed populations of modified and 
unmodified RNA sequences, because not every RNA strand is primed with a GMP. To 
produce as much modified RNA as possible the concentration of the modified nucleotide has 
to be high as compared to the unmodified nucleotide, albeit this usually has the effect of 
lower transcription efficiencies. Therefore the concentration of 5´-modified nucleotide over 
unmodified nucleoside triphosphate has to be optimized carefully. 
Modified nucleotides have been used as initiators to prime in vitro RNA transcription for 
quite a while.[99] Initiator nucleotides can be divided in dinucleotides and guanosine 
monophosphate (GMP) derivatives modified with an organic moiety. The transcription 
initiation with commercially available guanosine derivatives like adenylyl-(3'-5')-guanosine 
(ApG) and cytidylyl-(3'-5')-guanosine (CpG) has been utilized to create a free 5´-hydroxyl 
group, which is then available for subsequent RNA radioactive end-labeling with [γ-32P] ATP 
using T4 RNA polymerase or polynucleotide kinase.[100] Fluorescein, 
carboxytetramethylrhodamine (TAMRA) or biotin ApG are nowadays common modifications 
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in chemical oligonucleotide synthesis. Guanosine-5´-O-(1-thiomonophosphate) (GMPαS) is 
commercially available, and can e.g., be derivatized with photochemical groups such as p-
azidophenacyl bromide[101] and has been used to select ribozymes by Famulok or Suga and 
co-workers.[54, 59] 
Except of the above-mentioned, the variety of chemically modified initiator nucleotides that 
have been described in literature is limited. For the synthesis of 5´-amino and 5´-thiol 
modified initiator nucleotides a series of synthetic routes have been published earlier.[102-104]  
5´-Thiol modified RNA can be used for the selection of ribozymes catalyzing e.g. a Michael 
addition, while 5´-amino modified RNA may be used for the selection of an amide 
synthase.[102] Recently, Pfander and Jäschke developed an initiator nucleotide with an 
aldehyde modification which was then amino- or hydrazine-derivatized.[105] Furthermore, 
Famulok and co-workers introduced a photocleavable initiator nucleotide with a ketone 
functionality[106] and fumaramide-derivatized guanosines as Michael acceptors.[45] Tri-Link 
recently brought 5´-biotin and 5´-amino-GMP respectively AMP to the market.[107] All 
initiator nucleotides mentioned above have been synthesized by the modification of guanosine 
monophosphate. A slightly different approach has been pursued by Huang and co-workers 
who introduced modified adenosine monophosphates but the scope of modified AMPs for 
transcription priming is still less common, because it requires a different T7 promoter.[108-110] 
The research group of Prof. Jäschke has a long-standing interest in the in vitro selection of 
novel catalytic RNA sequences. For that purpose, initiator nucleotides with polydisperse 
polyethylene glycol linkers have been synthesized for the selection of a Diels-Alder 
ribozyme.[111] The anthracene tethered initiator nucleotide described by Seelig et al. is the 
only published example of a modified GMP with a polydisperse linker. Polydisperse linkers, 
in this context, have the advantage over monodisperse polyethylene glycol linkers that the 
same modification is at disposal with many different linker lengths creating a library of RNA 
molecules. This diversity increases the chances to successfully select a catalytically active 
sequence. Notwithstanding the fact, that due to their molecular-weight non-homogeneity, the 
synthesis of polydisperse initiator nucleotides is by far more demanding than the synthesis of 
monodisperse compounds. 
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2.1.2 Anthracene derivatives 
 
The usefulness of site-specific modifications with anthracene for oligonucleotide synthesis 
will elaborately be illustrated in chapter four. 
The main purpose of anthracene-modified initiator nucleotides has so far been the in vitro 
selection of Diels-Alderase ribozymes[41] or studies of folding, the reaction mode or allosteric 
activation of the same.[112]  
 
2.1.3 Aldehydes in bioconjugation reactions 
 
Aldehydes are highly reactive and therefore periodate oxidation has found widespread 
application, especially in carbohydrate and protein biochemistry. For RNA, this technique is 
less common,[113] but can be used in the same manner for cross-linking,[114] fluorescent 
labeling [115] and biotinylation.[116] In their native state, proteins, peptides and nucleic acids 
contain no naturally occurring aldehyde residues. On the other hand, aldehydes are one of the 
most reactive and most versatile functional groups known to chemists. Therefore establishing 
new and straightforward strategies to introduce aldehydes into oligonucleotides is of utmost 
interest. 
The most common method for introducing aldehydes and ketones into polysaccharides and 
glycoproteins is the oxidation of vicinal diols by periodate.[117] The vicinal diols of ribose in 
RNA nucleotides can also be cleaved with periodate,[118] allowing the addition of a 3′-end 
label to RNA.[119] DNA lacking a 2´-diol can not be oxidized with periodate (scheme 5). DNA 
however, can be partially depurinated to form aldehydes for further labeling or cross-
linking.[120] Silverman and co-workers identified a deoxyribozym, which can depurinate its 
5´-terminal guanosine nucleotide using periodate as a cofactor.[121] 
 
N
NH2
ON
O
OHOH
OPO
O-
O
N
NH2
ON
O
OO
OPO
O-
O
RNA RNA
NaIO4
 
Scheme 5: Periodate oxidation of a 3´-cytidine. 
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Back in 2003 Glen Research launched the first aldehyde modifier as a phosphoramidite for 
the 5´-end modification of DNA in automated oligonucleotide synthesis, but is yet far from 
being a standard modification in custom oligonucleotide synthesis. Three synthetic 
procedures for the synthesis of aldehyde-modified phosphoramidites for the 5´-end 
modification of DNA have been published so far.[122] The introduction of an aldehyde moiety 
by T7 RNA transcription and subsequent conjugation reactions have been described by 
Pfander et al..[105] 
Scheme 6 illustrates reactions that are possible with aldehydes in aqueous solution. An 
uncountable number of other reactions are possible with aldehydes and presumably many will 
sooner or later find their way into bioconjugation, protein and nucleic acid chemistry. 
 
 
Scheme 6: Reaction products of aldehydes that have been demonstrated in water with DNA, RNA, PNA or 
peptides. 
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2.1.4 Classic bioconjugation reactions 
 
The most important bioconjugation of aldehydes is the reaction with primary and secondary 
amines to form Schiff bases. The Schiff base formation is relatively labile, because it is a 
reversible reaction and can be hydrolyzed easily. Therefore a subsequent reduction stabilizes 
the conjugation product (scheme 7). This technique has recently been employed extensively 
in the pioneering work on DNA-templated organic synthesis and DNA-templated peptide 
nucleic acids (PNA) oligomerization by Liu and co-workers.[123-125] 
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Scheme 7: The aldehyde can be aminated with ammonia (a) or a diamine (b) to form a Schiff base in the 
presence of sodium cyanoborohydride as a reducing agent, to produce an amine modification. 
 
The second most important reaction is the modification of aldehydes with hydrazide or bis-
hydrazide compounds. Aldehydes spontaneously react with hydrazides to form a hydrazone 
linkage (scheme 8). The hydrazone bond is a type of Schiff base, but the linkage between a 
hydrazide and an aldehyde is more stable than the linkage between an aldehyde and an amine. 
Further stabilization can be achieved under reductive conditions. 
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Scheme 8: Aldehydes and hydrazides form a hydrazone linkage. 
 
The hydrazone linkage formed from a hydrazine and an aldehyde is much more stable than 
the bond formed between a hydrazide and an aldehyde.[126] Furthermore, the reactivity of 
hydrazines exceeds the reactivity of hydrazides by far, but up to today most commercially 
available tags and cross-linking reagents are only available as hydrazides. The selection of 
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commercially available hydrazides ranges from immobilization tags like biotin hydrazide, 
hydrazide activated streptavidin or hydrazide-terminated magnetic beads, to fluorescent dyes, 
and proteins. Containing a hydrazide group at both ends homo-bifunctional hydrazides can be 
used as cross-linking reagents (scheme 9). 
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Scheme 9: Bis-hydrazides can be used to transform an aldehyde into a terminal hydrazide group. 
 
Further reactions for bioconjugation with aldehydes are the formation of acetals, hydrazone 
formation with semicarbazides and thiosemicarbazides, thiazolindine or oxime linkage. 
 
2.1.5 Classic organic reactions 
 
Initiator nucleotides provide excellent tools for the in vitro selection of ribozymes. In the last 
couple of years many organic reactions have found their way into protein and nucleic acid 
chemistry. Herein, a short summary over a selection of possible organic reactions with 
aldehydes in biomolecules will be given. 
The aldol reaction has found widespread application in DNA-templated synthesis[127, 128] and 
Famulok and co-workers have reported the in vitro selection of an aldolase ribozyme. In their 
case the aldehyde moiety was the substrate while the RNA was modified by a photocleavable 
ketone initiator nucleotide.[106] Fan et al. reported that double-stranded DNA can be used as a 
catalyst to facilitate the Henry reaction (nitro-aldol reaction) of several different 
substrates.[129] 
The Wittig reaction is possibly the most popular method to create carbon–carbon double 
bonds. Recently it was found that the Wittig reaction is accelerated in water and that ylides 
and aldehydes can be stabilized in water. Water was found to enhance the reactivity in Wittig 
reactions due to its ability to stabilize the polar transition state, a phenomenon that a nonpolar 
medium is less capable of.[130] Liu and co-workers have implemented a DNA-templated 
Wittig reaction with excellent yields and short reaction times.[131] McKee et al. recently 
reported three sequential DNA-templated Wittig reactions.[132] 
Two multi-component reactions of which one of the components is an aldehyde have to be 
mentioned in this context. The Ugi condensation, also known as the Ugi four-component 
reaction, usually refers to the reaction between a carbonyl compound, an amine, an 
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isocyanide, and a carboxylic acid.[133, 134] The Ugi reaction is like the Wittig reaction 
accelerated in water[135] and has been applied in peptide synthesis[136] and labeling of PNA 
monomers.[137] 
The Mannich reaction, well known to organic chemists, is the condensation of an iminium 
ion, formed in situ from an aldehyde with an amine and an enolizable carbonyl. Almost one 
century after its discovery Francis and co-workers described the first bioconjugation 
application.[138] 
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2.2 Objectives 
 
From previous studies by Stuhlmann et al.[96] it is known that the Diels-Alder ribozyme 
selected for anthracene and maleimide has strict limitations to its tolerated substrates. We 
envisioned it should be possible to select a different ribozyme motif, able to form a bigger 
binding pocket and thus able to catalyze the Diels-Alder reaction between 2,3-
dimethylanthracene and maleimide derivatives. The original Diels-Alderase ribozyme does 
not tolerate any substituents in the 2 and 3 position of anthracene (scheme 10) 
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Scheme 10: IUPAC nomenclature for anthracene. 
 
The aim was to develop a synthetic approach for the synthesis of novel initiator nucleotides 
and implement it for the synthesis of 2,-3 dimethylanthracene, as well as for non-substituted 
anthracene, to make it easily accessible for studies of the existing Diels-Alderase ribozyme. 
Furthermore, the incorporation into RNA during T7 RNA polymerase transcription was to be 
studied with a short DNA template and a DNA pool with a randomized region to study the 
availability for a possible in vitro selection. 
 
Anthracene is mainly employed in Diels-Alder reactions. Aldehydes on the other hand are 
extremely reactive and versatile molecules that can be used for a countless number of organic 
reactions, respectively bioconjugations and therefore are extremely useful for the introduction 
of many functionalities into nucleic acids. In cases where the distance is critical polydisperse 
polyethylene glycol linkers are highly advantageous. Therefore, aldehyde modified initiator 
nucleotides with different linker lengths are attractive compounds. The synthesis of initiator 
nucleotides with aldehyde functionalities will be designed, realized and subsequently the 
incorporation into RNA will be studied. After incorporation studies the reactivity of the 
resulting modified RNA has to be determined. 
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2.3 Results and Discussion 
 
2.3.1 Synthesis of novel initiator nucleotides 
 
The initiator nucleotides 7a-d (scheme 11) were synthesized establishing new synthetic 
procedures. 
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Scheme 11: Initiator nucleotides 7 a-d. 
 
Even though the polydisperse polyethylene glycol compounds are here linguistically 
described as a single compound it has to be pointed out that each PEG compound consists of 
several compounds, identical in their functional groups or modifications, but different in the 
number of ethylene glycol units. 
 
2.3.1.1 Synthetic procedures to anthracenyl initiator nucleotides 
 
For the synthesis of the 9-(chloromethyl)-2,3-dimethyl anthracene bearing initiator 
nucleotides 7a-b a synthetic procedure to 9-(chloromethyl)-2,3-dimethyl anthracene had to be 
established 12 (scheme 12). 
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Scheme 12: Preparation of 9-(chloromethyl)-2,3-dimethyl anthracene. 
 
The synthesis of 9-(chloromethyl)-2,3-diemethylanthracene 12b starts from the commercially 
available 2,3-dimethylanthraquinone 8. 2,3-Dimethylanthraquinone was reduced with 
granular zinc and aqueous ammonia in an autoclave and later treated with hydrochloric acid. 
Purification turned out to be rather difficult and after flash chromatography on silica and 
displacement only 28% 2,3-dimethylanthracene 9 could be obtained. In a Vilsmeier-Haak 
reaction anthracene could exclusively be formylated at the 9-position with a yield of 95%, 
similar to a procedure described for non substituted anthracene.[139] 2,3-dimethylanthracene-9-
carbaldehyde 10 was reduced with sodium borohydrate to yield 92% of the corresponding 
alcohol 11 and was further reacted with thionyl chloride and without further purification 94% 
of 9-(chloromethyl)-2,3-dimethyl anthracene 12b was obtained. 
Synthesis and applications of novel initiator nucleotides 
 23
DMTCl, TEA, DMAPHO
O
OH DMTO
O
DMTO
O
Cl
NaH, ACN
HO
O
R
R
R
RR
R
H
n n
nn
12 a  R = H
     b  R = CH3
15 a  R = H
     b  R = CH3
16 a  R = H
     b  R = CH3
13 14
CCl3COOH
 
Scheme 13: Synthesis of (anthracen- 9-yl-methoxy)-polyethylen glycol 16a and 2- ((2,3-dimethylanthracen- 9-
yl)- methoxy)-polyethylene glycol 16b. 
 
PEG 600 was selectively mono-protected with 4,4´-dimethoxytrityl (DMT) according to the 
procedure published by Fiammengo et al. for hexaethylene glycol.[140] PEG 600 was dissolved 
in acid free dichloromethane with 4-dimethylaminopyridin (DMAP) as activator and 
triethylamine to deprotonate the hydroxyl group. In a dichloromethane solution DMT-Cl was 
added very slowly during several hours via a syringe pump. An excess of PEG and the slow 
addition of DMT-Cl prevent a di-protection. Traces of di-protected product could be 
eliminated by purification over silica. Mono-protected PEG 600 14 was obtained in a yield of 
75%. In an SN2-reaction the free hydroxyl group of the DMT-protected polyethylene glycol 
was deprotonated with sodium hydride and either reacted with 9-(chloromethyl)anthracene to 
form the bifunctional PEG with DMT and anthracene 12a or reacted with 9-(chloromethyl)-
2,3-dimethylanthracene 12b to form the corresponding derivative. For anthracene a yield of 
46% was achieved while for 2,3-dimethylanthracene 75% of the pure product was obtained 
after flash chromatography. The DMT protecting group was removed by exposure to 3% 
trichloro acetic acid in DCM for five minutes. After purification over silica 82% of 
(anthracen-9-yl-methoxy)-polyethylene glycol 16a and 84% of 2-((2,3-dimethylanthracen-9-
yl)-methoxy)-polyethylene glycol 16b were obtained. 
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Scheme 14: Synthesis of initiator nucleotides 7a and b. 
 
2′,3′-bis TBDMS-protected guanosine was synthesized from unprotected guanosine according 
to literature.[141] The corresponding 5′-O-phosphoramidite was prepared in 88% yield using 2-
cyanoethyl-N,N-diisopropylchlorophosphoramidite for phosphitylation. This synthesis can be 
achieved without protection of the nucleobase.[142] As reported in literature no N-
phosphitylation during phosphoramidite coupling with imidazolium activators was 
observed.[143] The initiator nucleotides 7a and 7b were synthesized the anthracene modified 
polyethylene glycol compounds 16a and 16a and 2,3-bis-(t-butyldimethylsilyl) guanosin-5-O-
(β-cyanoethyl-N,N-diisopropylphosphor-amidite) 17 in the presence of 4,5-dicyanoimidazole 
(DCI). After 1 h the reaction was quenched by the addition of t-butylhydroperoxide. The 
solvent was removed and the guanosine intermediate directly deprotected from the TBDMS 
protection groups on the 2´-and 3´-hydroxyl and the β-cyanoethyl by the addition of tetra-n-
butylammonium fluoride (TBAF). Purification was carried out via reverse phase column 
chromatography, followed by ion exchange and a second reverse phase column 
chromatography. 
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2.3.1.2 Novel aldehyde containing initiator nucleotides 
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Scheme 15: Protection of 4-hydroxybenzaldehyde. 
 
Commercially available 4-hydroxybenzaldehyde 18 was protected as an acetal in a p-
toluenesulfonic acid catalyzed reaction. General organic synthetic procedures for the acetal 
protection of aldehydes require the removal of the formed water to push the equilibrium to 
form more acetal. The azeotropic distillation with a water trap did not shift the equilibrium 
towards the desired product. When performed with one equivalent potassium carbonate the 
conversion observed by TLC was only 50%. In another approach, two equivalents of dry 
magnesium sulfate lead to a similar conversion. Notably, the performance of the reaction 
without any auxiliary agents made the workup easiest and after purification on silica 62% of 
the protected aldehyde 19 was obtained. 
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Scheme 16: First synthetic strategy to polyethylene glycol-p-toluolsulfonat. 
 
All compounds represented in scheme 16 were purified on silica by flash chromatography. 
Reaction conditions for tosylation are not compatible with DMT as a protecting group. DMT 
would be cleaved off during the tosylation and bis-tosylated PEG compounds would be the 
consequence. For that reason it was decided to use TBDMS as a protection group instead. To 
ensure that only mono-protected PEG was available for subsequent reactions, DMT-protected 
PEG was prepared as described earlier. 
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The remaining free hydroxyl group was then protected with TBDMS-Cl under standard 
conditions. After purification bis-protected PEG 600 21c was obtained with a yield of 76%, 
while the yield for PEG 1500 21d was 70%. The deprotection of DMT resulted in the mono 
TBDMS protected PEG compounds in a moderate yield of 50% for PEG 600 22c and 78% for 
PEG 1500 22d. Subsequent tosylation with p-toluenesulfonyl chloride in the presence of TEA 
as a base and 4-dimethylaminopyridine (DMAP) as a catalyst was successfully carried out to 
yield 87% clean product for PEG 600 23c and 75% for PEG 1500 23d. Nucleophilic 
substitution by the protected aldehyde 19 yielded 60% for PEG 600 24c and 99% for PEG 
1500 24d. 
Surprisingly, deprotection from the TMDMS protection group failed. Neither TBAF, nor 
hydrogen fluoride in triethylamine lead to the liberation of the aldehyde modified 
polyethylene glycol. An acid catalyzed deprotection was not possible because the acetal 
protected aldehyde is acid labile and the latter is only deprotected after incorporation into 
RNA via T7 transcription. This synthetic route was not persevered any further; however it 
could be useful for non acid labile modifications. 
Having experienced the above mentioned problems with protecting groups not being 
removable after a multistep synthesis, we were curious if we could accomplish a direct 
activation by mono-tosylation of the polydisperse polyethylene glycol substrates, PEG 600 
and PEG 1500. 
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Scheme 17: Second synthetic strategy to polyethylene glycol p-toluenesulfonate and subsequent substitution. 
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Mono-functionalization of symmetrical diols has been of high interest in organic synthesis, 
but the scope of selective reactions is still very limited. Mono-tosylation of polyethylene 
glycols is the key step to all kinds of hetero-bifunctional PEG derivatives. Synthetic 
procedures for the mono-tosylation of short monodisperse polyethylene glycol have been 
reported, but many of the approaches are rather exotic, like the montmorillonite catalyzed,[144] 
or silver (I) mediated combined with potassium iodine catalyzed mono-tosylation.[145-149] A 
more simple approach had been reported for di-, tetra- and hexaethylene glycol.[103, 150, 151] p-
Toluensulfonyl chloride was added to the polyethylene glycol with pyridine as base, the 
product had to be purified by column chromatography, in some cases even twice on normal 
silica and RP-C18 silica. 
The mono-tosylation was achieved by a slow addition of p-toluenesulfonyl chloride in DCM 
in the presence of the catalyst 4-dimethylaminopyridine and TEA. PEG is commercially 
available and relatively inexpensive and was therefore used in ten-fold excess over the p-
toluenesulfonyl chloride. After tosylation the mono-tosylated product was separated from the 
excess PEG simply by extraction. While PEG alone is extracted into the aqueous phase, the 
mono-tosylated PEG remains in the organic dichloromethane phase. Mono-tosylated PEG 600 
26c was obtained in a yield of 74% and PEG 1500 26d in a yield of 96%. The absence of bis-
tosylated or non-tosylated PEG could unambiguously be ensured by MALDI-TOF MS 
analysis. Commonly, the tosyl function is easily hydrolyzed in the presence of water. 
However, the tosylated polyethylene glycol could be stabilized over a long period of time if 
the residual water was removed directly after the synthesis by coevaporation with toluene. 
The activation of polyethylene glycol by tosylation allows their modification with basically 
all hard nucleophiles in an SN2 reaction. 
The aldehyde-functionalized PEGs were obtained from 4-(5,5-diethyl-1,3-dioxan-2-yl) phenol 
19, which was first deprotonated with sodium hydroxide in ACN and refluxed with the mono-
tosylated PEG for two days. After silica purification 47% of aldehyde mono-functionalized 
PEG 600 25c and 80% and of PEG 1500 25d were available for subsequent synthesis of the 
initiator nucleotide. 
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Scheme 18: Synthesis of initiator nucleotides 7c and d. 
 
The initiator nucleotides 7c and d were synthesized from the aldehyde mono-functionalized 
polyethylene glycols and 2,3-bis-(t-butyldimethylsilyl)guanosin-5-O-(β-cyanoethyl-N,N-
diisopropylphosphoramidite) 17 in the presence of DCI. After the addition of t-butyl 
hydroperoxide the solvent was removed and the guanosine intermediate directly deprotected. 
While for the anthracene derivative initiator nucleotides a relatively small excess of TBAF 
was sufficient to deprotect the guanosine, for the aldehyde initiator nucleotides six 
equivalents TBAF and prolonged reaction times were necessary. Purification of the initiator 
nucleotides was carried out by reverse phase column chromatography, ion exchange and a 
second reverse phase column chromatography. 
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2.3.1.3 Analytics of polydisperse polyethylene glycols 
 
The easiest way to analyze polydisperse polyethylene glycols is MALDI-TOF MS analysis.  
In all cases, a Gaussian set of highly resolved peaks representing the distribution of PEG 
molar masses was produced. For PEG 600 chain lengths from 7 to 19 PEG units were 
observed and the highest intensity was assigned to n = 13, while for PEG 1500 the chain 
lengths varied from 17 to 40 with 27 giving the most intense signal. 
It is also generally known that the quantitativeness of MALDI-TOF MS strongly depends on 
the process of ionization.[152] However, the purity of the synthesized compound and the 
absence of side products can absolutely be proven, as no other masses have been observed. 
Synthetic polymers usually contain alkali metal cations as impurities from chemicals, solvents 
or glassware. Even during MS analysis alkali cation, impurities still remaining in the mass 
spectrometer, form adducts and the attachment of these cations, with Na+ being the most 
common one, are observed.[153] Modeling studies showed that alkali cations are coordinated to 
available oxygen sites along the backbone.[154] 
In the present work for polyethylene glycols with higher masses in MALDI-TOF MS analysis 
the main signal observed is not only just the adduct of one alkali cation, but combinations of 
either two alkali cations or mixtures of two different alkali cations. Shimada et al. had shown 
that additions of alkali cations mainly take place for the cation with the smallest ionic radius. 
During synthesis Li+ was never present in any of the reactions, but residual Li+ in the 
spectrometer from preceding samples was coordinated by the PEG compounds.[155] Alkali 
cation adducts were observed with a increasing length of the polyethylene glycol, especially 
for PEG 1500 adducts of different cation combinations were measured. To prove that indeed 
the described product had been obtained the initiator nucleotides were later analyzed by high 
resolution ESI mass spectrometry. The integrity of the product was evidenced with absolute 
accuracy. 
 
2.3.2 Towards the in vitro selection of a novel Diels-Alder ribozyme 
 
The so called direct in vitro selection of a Diels-Alderase ribozyme, was first described by 
Seelig and Jäschke.[41] For the selection of a true catalyst the substrate has to be tethered to the 
RNA library. The polymer linker attaches the anthracene substrate to the RNA, but after a 
Diels-Alder reaction with a maleimide derivative the RNA itself remains unaltered. After 
incubation, the RNA library is covalently attached to anthracene and therefore an anchoring 
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functionality has to be introduced during this reaction to allow for separation of the reactive 
from the uncreative species. Biotin maleimide is commercially available and thus the reactive 
species can easily be separated via biotin - streptavidin interaction on a solid support. 
 
DNApool RNA
N
O
O
RNA
N
O
O
RNA
RNA
N
O
O
RNA
biotin  maleimide
streptavidin agarose  
Scheme 19: Selection scheme for the in vitro selection of a Diels-Alderase ribozyme catalyzing a Diels-Alder 
reaction between 2,3-dimethylanthracene and biotin maleimide. 
 
The selection scheme for a possible in vitro selection of a Diels-Alderase ribozyme (scheme 
19) proceeds from the RNA library, created by T7 RNA polymerase (RNAP) transcription 
starting from a DNA pool. During the transcription 2,3-dimethylanthracene is incorporated 
into the RNA library by the enzyme T7 RNAP. The subsequent Diels-Alder reaction between 
2,3-dimethylanthracene and biotin maleimide creates two species. The desired sequences, 
which catalyze the Diels-Alder reaction and the ones where no reaction has taken place. The 
two species are partitioned on streptavidin agarose, while the RNA where no Diels-Alder 
reaction has taken place passes through the streptavidin agarose columns, the species now 
carrying biotin remain on the column. The retained RNA is eluted, reverse transcribed, 
amplified by PCR and again transcribed into RNA in the presence of an initiator nucleotide 
and re-introduced into the selection cycle. Noteworthy, other options than streptavidin for the 
separation of reacted and unreacted species e.g., separation on bead are available. 
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2.3.2.1 T7 RNA polymerase transcription 
 
During transcription initiation the 5´-modified guanosine monophosphate is selectively 
incorporated at the 5´-end of the transcript (scheme 20). 
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Scheme 20: 5´-Modification of RNA with 2,3-dimethylanthracene via initiator nucleotide priming during T7 
RNAP transcription. 
 
For the initial experiments on the incorporation and reactivity of the initiator nucleotide a 
dsDNA template was used that transcribes into a 25 nt long RNA. Polydisperse polyethylene 
glycol based initiator nucleotides consist of many compounds with a molecular weight 
difference of 44.03 g mol-1. This is naturally the case for the transcribed RNA, several 
different RNA molecules originate from one sequence, all set apart by the difference of one 
polyethylene glycol unit. These differences in molecular weight exceed the resolution of 
PAGE analysis and therefore the modified transcribed RNA does not appear like a sharp band 
but rather like a smear. For the 25mer the resolution was still acceptable if analysis was 
performed by 20% denaturing PAGE (figure 5).  
 
The reaction was carried out using 0.2 µM template, 4 mM ATP, CTP and UTP, 0.35 mM 
GTP and 4 mM initiator nucleotide 7a. For better visualization the transcription was 
performed with [α-32P]-CTP. 
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Figure 5: Transcription initiation of a 25-mer DNA template with the 2,3-dimethylanthracene initiator 
nucleotide 7a. 20% PAGE gel, autoradiography. 
 
T7 RNA polymerase in general suffers from 3´-end heterogeneity of the RNA transcripts, 
meaning it has the tendency to append one or two and sometimes even more non-templated 
nucleotides.[156, 157] For the 25mer these elongated sequences were observed, which in some 
cases resulted in a slight superimposition of the observed bands of the conjugate. 
The incorporation rate was determined by HPLC and autoradiography to be 71% and the mass 
was confirmed by MALDI-TOF MS analysis (figure 6). 
 
 
Figure 6: a: HPLC diagram at 260 nm of the polydisperse 2,3-dimethylanthracene initiator nucleotide after 
incorporation into the 25mer RNA transcript. b: MALDI–TOF MS analysis: here the signal also shows that the 
polydisperse initiator nucleotide was incorporated. For n = 11 a mass of 8794 m/z was observed, which confirms 
the calculated mass of 8792 m/z for [M+H]+. 
Synthesis and applications of novel initiator nucleotides 
 34
2.3.2.2 Evaluation of the reaction conditions 
 
To evaluate the reaction conditions of the Diels-Alder reaction between RNA tethered 2,3-
dimethylanthracene and biotin maleimide (see scheme 19) the reaction was performed with 
the above described model-transcript. 
 
 
Figure 7: Diels-Alder reaction between RNA tethered 2,3-dimethylanthracene and biotin maleimide. While the 
transcript without initiator nucleotide showed no reactivity with biotin maleimide the transcript with 
incorporated 2,3-dimethylanthracene reacted with an 1000 fold excess of biotin maleimide. Analysis by 
autoradiography of a 20% PAGE.  
 
In the first cycles of an in vitro selection the biotin maleimide has to be present in excess to 
enrich all sequences, even those that show moderate or low catalytic activity. The 
determination of the background rate is important to distinguish catalysts with low to 
moderate efficiency from good catalysts. In an initial experiment the conversion of the 
transcript was compared to the conversion of the transcript with the incorporated 2,3-
dimethylanthracene initiator nucleotide. Only if incubated over night with a 1000 fold excess 
of biotin maleimide a reaction product could be observed. The unmodified transcript showed 
no reactivity with biotin maleimide even at a 1000 fold excess and incubation over night 
(figure 7). 
It was established that the new 2,3-dimethylanthracene initiator nucleotide can be 
incorporated into a short model transcript and subsequently reacted with biotin maleimide. As 
a next step the incorporation into an RNA library with a randomized region should be tested. 
To accomplish this task the library had to be generated as described in the following section. 
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2.3.2.3 Generation of an RNA library 
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Figure 8: Generation of an RNA library with randomized region. The promoter sequence is essential for the 
recognition of the DNA template by RNAP. A polymerase specific promoter sequence can be appended to the 
dsDNA template during PCR by application of a primer containing this sequence. The dsDNA template can then 
be transcribed into RNA. 
 
An RNA library was synthesized beginning from a DNA pool with a randomized region 
(figure 8). A DNA pool with a randomized region is the key feature to provide the huge 
complexity necessary to in vitro select catalytic species. Mathematically the limitation of this 
complexity is reached if the randomized region is only 25 base pairs long. If all four bases are 
randomly incorporated at all positions and every sequence is only represented once a 
complexity of 425 ~ 1015 would be reached.[15] 25 base pairs are too short to form the three-
dimensional structures that are necessary for binding or forming a catalytic pocket in an active 
RNA structure. Therefore longer randomized regions provide better exit criteria for a 
successful in vitro selection. A 70 nucleotide long randomized region was chosen, flanked by 
the conserved regions, thus the resulting ssDNA template was 109 nucleotides long. 
 
5'-GGA GCT CAG CCT TCA CTG C- N70-GGC ACC ACG GTC GGA TCC AC-3' 
 
From a 1 µmol scale DNA synthesis 16.70 nmol DNA were obtained, equating to a pool 
complexity of 1.01 x 1016. But even after purification not all templates can be amplified. To 
asses the complexity of the generated pool, primer extension with a radioactively labeled 
primer was performed. Only 24% of the pool could be amplified to full length product, 
resulting in an excellent pool complexity of 3.3 x 1015. 
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2.3.2.4 Optimization of the PCR reaction 
 
The two primers used for the PCR of this DNA pool are standard primers in our laboratory 
and have been named primer A and primer B. Primer A contains a promoter sequence which 
is added to the double stranded DNA during PCR (see figure 8). The addition of a promoter is 
indispensable for T7 polymerase recognition and thus transcription into RNA. In the case of 
the 109mer the addition of the promoter sequence leads to a 128 nucleotides long dsDNA 
template after PCR. For that reason primer A is 38 nt long while primer B only consists of 20 
nucleotides, resulting in different optima for hybridization during PCR. This problem could 
partially be overcome by the use of higher primer B concentrations during PCR. 
After several optimizations of the template concentration, annealing temperature, magnesium 
ion concentration and number of PCR cycles a preparative PCR was carried out with 
prolonged annealing and elongation steps in every cycle. In a pool with high complexity only 
one or very few copies of each sequence are represented and therefore long elongation steps 
are essential for the amplification of all sequences. Unspecific product formation could be 
avoided by performing only 6 PCR cycles. Repetitive cycles did not improve the product 
formation considerably, but two side product bands with a length of around 180 and 210 base 
pairs were formed. 
The optimal PCR conditions were determined to be a template concentration of 0.2 µM, 10 
µM primer A, 15 µM primer B, 0.2 mM concentration of all NTPs and the use of 4 mM 
magnesium chloride. For the preparative PCR a total volume of 55 mL was partitioned into 
several 96 well plates and after PCR combined again and purified by phenol extraction. 
 
2.3.2.5 Transcription initiation with the DNA library 
 
The transcription of the DNA library has first been studied without the initiator nucleotide. 
The highest yield in terms of oligonucleotide multiplication was obtained with 4 pmol dsDNA 
template. Several transcription buffer systems and MgCl2 concentrations were tested and 40 
mM Tris buffer at pH 8.1 containing 22 mM Mg2+, 0.1 mM spermidine and 0.01% Trition X-
100 were determined to be the best conditions for the transcription of the DNA pool. 
For the incorporation of the initiator nucleotide into the RNA library the concentration of the 
initiator nucleotide and of GTP was varied while the three other NTPs were kept constant at 4 
mM. The use of a high concentration of NTPs had been shown to yield the highest amount of 
RNA transcript.[158] 
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without
For the transcription of the DNA library with the 2,3-dimethylanthracene initiator nucleotide 
incorporation rates up to 77%, determined by HPLC (figure 9), could be achieved. 
Unfortunately the transcription was considerably inhibited by the initiator nucleotide. Low 
transcription yields were linked to the presence of the initiator nucleotide. The transcription 
was carried out with 0.35 mM GTP and 4 mM initiator nucleotide. In the reference reaction 
no initiator nucleotide was present. If the initiator nucleotide would not cause inhibition of the 
T7 RNAP similar yields for the transcription with and without initiator nucleotide would be 
the case. However a decupled RNA yield was observed in the absence of the initiator 
nucleotide (figure 9). 
 
 
Figure 9: Transcription initiation without and with 2,3-dimethylanthracene initiator nucleotide, using 0.35 mM 
GTP and 4 mM initiator nucleotide. Analysis by autoradiography of 12% denaturing PAGE and incorporation 
rate determination via HPLC detection of the 32P signal. 
 
The overall yield could be improved by inverting the ratio between GTP and initiator 
nucleotide, using 4 mM GTP and 1 mM initiator nucleotide. However, the incorporation rate 
dropped below 10%, which resulted in less conjugation product than using 0.35 mM GTP and 
4 mM initiator nucleotide. Furthermore this experiment (figure 10) again showed that the 2,3-
dimethylanthracene initiator nucleotide has an inhibiting effect on the T7 RNAP enzyme. 
 
 
Figure 10: Transcription initiation without and with 2,3-dimethylanthracene initiator nucleotide, using 4 mM 
GTP and 1 mM initiator nucleotide. Analysis by autoradiography of 8% PAGE. 
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Anthracene derivatives are known to readily react with oxygen upon exposure to light to form 
the corresponding epidioxyanthracenes, or sometimes described as photoperoxides.[159, 160] 
Therefore elevated temperatures and exposure to light have to be avoided, because loss of the 
aromaticity of the anthracene would make a Diels-Alder reaction impossible. 
The enzyme T7 RNAP is usually used at 37°C or higher temperatures. The stability of the 
initiator nucleotide and the anthracene derivative were investigated under conditions 
analogous to the conditions of the transcription. The initiator nucleotide was incubated in 
transcription buffer for four hours and the integrity of the initiator nucleotide was confirmed 
by HPLC analysis before incubation, after two and four hours at 37°C (figure 11). The 
initiator nucleotide remained unaltered and no epoxide formation was observed. Furthermore, 
this experiment allowed the conclusion that for the initiator nucleotide no decomposition 
accured over the period of four hours at a temperature of 37°C. Low incorporation yields can 
therefore not be linked to decomposition of the initiator nucleotide. 
 
 
Figure 11: HPLC at 260 nm at different time points after incubation of the initiator nucleotide in transcription 
buffer at 37°C. 
 
Further approaches to improve the yield of the conjugated RNA library were investigated. 
These approaches included elongated reaction times, the use of commercially available 
transcription kits or the addition of a so called booster mix, containing NTPs and additional 
Synthesis and applications of novel initiator nucleotides 
 39
initiator nucleotide in buffer supplemented with T7 RNAP, after two hours, followed by 
continuous transcription for another two hours. T7 RNAP has a DNase and RNase function, 
which can be inhibited by an excess of NTPs during the transcription, the addition of a 
booster mix thus does not only provide more material for the transcription, but also inhibits 
the nuclease function of the RNAP.[161] Commonly, residual salt from the preparation of the 
DNA template can be responsible for low transcription yields.[113] To eliminate this aspect the 
template was desalted before transcription and the initiator nucleotide was purified via a 
second ion exchange and a third reverse phase column chromatography. But the inhibition of 
the transcription of the DNA library in the presence of the initiator nucleotide bearing 2,3-
dimethylanthracene could not be overcome. 
However, the fact that an incorporation rate of 77% could be achieved during RNAP 
transcription with a DNA library with a 109 nucleotide long sequence is quite noteworthy. 
 
 
Figure 12: Enzymatic incorporation of the initiator nucleotide (1 mM) via T7 RNA polymerase transcription (2 
h reaction time) of the 109 nt dsDNA library, varying the GMP concentration. 
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2.3.3 Incorporation and application of aldehyde containing initiator nucleotides 
 
In section 2.3.1.4 a short and efficient synthetic approach to the synthesis of polydisperse 
aldehyde-modified initiator nucleotides was developed (scheme 21). The incorporation and 
reactivity of the aldehyde-modified initiator nucleotides will be tested and is described herein. 
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Scheme 21: Aldehyde modified initiator nucleotides. 
 
Initiator nucleotide 7c with nPEG varying from 7–19 was synthesized from PEG 600, while the 
initiator nucleotide with PEG 1500 7d resulted in a distribution of nPEG ~ 17–41 (figure 13). 
 
 
Figure 13: Illustration of the differences between the initiator nucleotide with PEG 600 7c and PEG 1500 7d. a: 
MALDI TOF MS of initiator nucleotide 7c; b: MALDI TOF MS of initiator nucleotide 7d; c: HPLC detection at 
260 nm of initiator nucleotide 7c; d: HPLC detection at 260 nm of initiator nucleotide 7d. 
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Incorporation of the aldehyde initiator nucleotides was tested by T7 RNAP transcription with 
the 25mer model-transcript. The transcription was carried out with the optimized protocol 
employing 4 mM of the initiator nucleotides over 0.35 mM GTP. Figure 14 shows an 
autoradiograph of the enzymatic incorporation of the initiator nucleotides 7c and 7d. For 
initiator nucleotide 7c an incorporation rate of 52% could be determined while for initiator 
nucleotide 7d no incorporation could be observed (figure 14). 
 
 
Figure 14: Left: transcript (25mer) with the PEG 600 linked aldehyde initiator nucleotide 7c; right: with the 
PEG 1500 linked aldehyde initiator nucleotide 7d. -: reference without initiator nucleotide, +: with initiator 
nucleotide. 20% PAGE, autoradiography scan. 
 
To confirm the presence and reactivity of the terminal aldehyde group at the 5´-end of the 
transcript by incorporation of the initiator nucleotide the conjugate was eluted and 
precipitated. As a model reaction the hydrazone bond formation between biotin-hydrazide and 
the deprotected aldehyde was chosen (scheme 22). 
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Scheme 22: Biotin-hydrazide was used to label the aldehyde, creating a hydrazone bond. 
 
The aldehyde initiator nucleotide could be deprotected by treatment with 2% trifluroacetic 
acid for 10 minutes and the reaction was quenched by the addition of sodium bicarbonate. 
Hydrazone bond formation is favored at a slightly acidic pH, therefore the pH was adjusted to 
5.5 and a 1000 fold excess of biotin hydrazide was added. After incubation for four hours at 
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room temperature the reaction was analyzed via PAGE and a gel shift for the biotinylated 
conjugate was observed. Notably, full conversion could be observed for the reaction between 
the aldehyde-modified initiator nucleotide and the hydrazide (figure 15). 
 
 
Figure 15: Lane 1: conjugate protected aldehyde. Lane 2: conjugate deprotected aldehyde. Lane 3: conjugate 
aldehyde deprotected and reacted with biotin hydrazide. 12% PAGE, autoradiography scan. 
 
 
2.4 Conclusion 
 
The 5´-end modification of RNA could be achieved co-transcriptionally by transcription 
priming using T7 RNAP and initiator nucleotides with either a benzaldehyde organic moiety 
or 2,3-dimethylanthracene. For the transcription of short oligonucleotides no inhibition of the 
enzyme T7 RNAP was observed. The initiator nucleotide bearing 2,3-dimethylanthracene 
could be incorporated into a 109 nucleotide long RNA library with a randomized region with 
an incorporation rate of 77% although diminished total yields were observed. For the 
aldehyde modified initiator nucleotide an incorporation rate of 52% could be observed. 
Hydrophilic moieties are known to result in lower incorporation efficiencies than hydrophobic 
moieties.[140] 
The reactivity of the incorporated initiator nucleotides was confirmed. After transcription the 
anthracene modified RNA was biotinylated in a Diels-Alder reaction with biotinmaleimide, 
while the aldehyde-modified RNA was biotinylated employing a biotin-hydrazide. Full 
conversion for the formation of the hydrazone was observed. 
 
The synthesis of polydisperse initiator nucleotides could considerably be improved. For the 
synthesis of polydisperse initiator nucleotides with an anthracene moiety a very clean and 
rather short synthetic route could be established. Originating from the anthracene derivative 
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and the TBDMS protected guanosine monophosphate the synthesis could be achieved in only 
five steps. Furthermore, a novel synthetic pathway, via a mono-tosylated polyethylene glycol 
compound, was established and demonstrated for the aldehyde modified initiator nucleotide 
presenting a superior synthetic strategy for the incorporation of many highly functional 
organic modifications into RNA. The mono-tosylated polyethylene glycol represents the key 
step to a vast variety of organic modifications in RNA. The tosyl-activated PEG can be 
reacted in an SN2 reaction with a multitude of nucleophiles. Furthermore, the synthesis of 
such initiator nucleotides can be achieved in only three synthetic steps. 
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3 Thermal denaturation studies of the Diels-Alderase ribozyme 
 
3.1 Scientific background 
 
3.1.1 Metal ions in ribozyme folding and catalysis 
 
The discovery that RNA molecules do not only carry genetic information, but can also have 
catalytic activity and thus require a defined structure, has lead to a new understanding of the 
structures and mechanisms of folding. Like proteins, RNA adopts complex three-dimensional 
structures for the precise presentation of chemical moieties that are essential for its function as 
biological catalyst, translator of genetic information and structural scaffold.[162] The most 
important parameter in folding and shape of single-stranded nucleic acids is complementary 
Watson-Crick base pairing via hydrogen bonding. Even though RNA molecules usually 
consist of single strands, RNA molecules contain linear runs that are complementary to other 
runs elsewhere in the molecule. This way RNA can form double-stranded regions. Further 
important nucleotide interactions as part of tertiary interactions are intra- or intermolecular 
interactions based on canonical and non-canonical base pairs, pseudoknots, water bridges, and 
interactions with metal ions.[113] 
The structure of oligonucleotides, either free or in complex with metal ions or specific 
ligands, can be analyzed using various experimental methods, like X-ray crystallography, 
cryo-electron microscopy, NMR, structure-specific probes, RNA engineering, mass 
spectrometry and thermal denaturation. A good explanation on structure, folding and function 
of an oligonucleotide is generally obtained from a combination of experimental setups. 
Using UV spectroscopy, thermal denaturation experiments can be utilized to determine the 
stability of RNA secondary and tertiary structures and are informative about the hierarchy and 
dynamics of RNA folding. Thermal denaturation of RNA complements other techniques, such 
as crystallography, NMR, CD spectroscopy or probing experiments.[163] 
Two distinct functions of metal ions are essential for ribozymes. Divalent cations provide 
stabilization for the structural folding of RNA and can be required for chemical reactions. 
Pyle described the RNA molecule as an extended polyanion that is not easily packed into its 
catalytically active form without substantial charge neutralization between the interacting 
strands.[164] Cations therefore neutralize the charge in folded RNA molecules. It was 
suggested that divalent cations bind to specific sites, and thus form a metal ion core in RNA 
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equivalent to the hydrophobic core in proteins. This way the core folds the secondary 
structure into the required tertiary structure.[165, 166] The tertiary structure is the three-
dimensional organization, which is relevant for the biological function of RNA molecules. 
RNA contains a number of ligands for metal coordination, mainly due to the phosphate 
oxygens, 2´-hydroxyls, base carbonyls and transition-state oxyanions, which preferentially 
coordinate hard alkaline earth metals ions such as Mg2+. Magnesium ions are generally hexa-
hydrated and are coordinated in an octahedral geometry, whereas coordination numbers 
greater than six are common for Ca2+. The Mg2+ cation has a low affinity to nitrogen ligands 
and basically now affinity for sulphur. Transition metals such as Mn2+ can be coordinated by 
ribonucleic oxygens as well as the nitrogens in the ring of the bases.[167] Other common 
transition metals like Zn2+ and Cd2+ exhibit a similar behaviour as Mn2+.[168] 
With one negative charge per nucleotide (located at every phosphate of the phosphodiester 
back bone) the negative charge density of RNA is extremely high. These negative charges 
would repel each other, but that repulsion is greatly diminished when each phosphate is 
surrounded by a cloud of small cations. Due to their high charge density and their negative 
electrostatic potential all nucleic acids accumulate concentrated cation atmospheres, which 
extend over a distance of several Ångström.[169] Simplified, the interaction of RNA with 
cations can be divided into two major categories. One interaction is diffuse, meaning that the 
ions remain entirely hydrated and are only affected by the electrostatic potential of the RNA. 
The other is chelating and characterized by direct contacts between the RNA and the metal 
ions.[170] Chelating metal ion binding sites have been identified for a number of RNA 
molecules in X-ray crystal structures. 
For a long time it was believed that ribozymes only fold and catalyze reactions in the presence 
of divalent metal ions. The hammerhead, the hairpin and the VS ribozyme were the first 
ribozymes reported to have catalytic activity in the absence of divalent metal ions.[171] 
However, monovalent metal ions have to be applied at molar concentrations (non-
physiological) for folding, activity, and stabilization of the structure. Nevertheless, they can 
not compete with the catalytic activity observed in the presence of divalent metal ions.[172] 
As for structural concerns, the pseudoknot RNA from Beet Western Yellow Virus (BWYV) is 
possibly the most prominent example of a pseudoknot structure stabilized by monovalent 
cations. The crystal structure revealed four putative coordination sites for alkali metal 
cations.[173] UV denaturation experiments showed that the RNA could entirely be stabilized 
up to high temperatures by sodium cations alone.[174] 
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3.1.2 The Diels-Alderase ribozyme 
 
Various analytical techniques have been employed to study the structural and mechanistic 
properties of the Diels-Alderase ribozyme.[92, 93, 175, 176] 
The Diels-Alderase ribozyme was found to require divalent metal ions such as Mg2+, Mn2+or 
Ca2+ for folding into its three-dimensional structure, but it has to be pointed out that, unlike 
many other ribozymes the Diels-Alder ribozyme does not involve metal ions in the catalytic 
process. 
 
Figure 16: Crystal structure of the Diels-Alderase ribozyme. Mg stands for magnesium ions indicated in green. 
Latin numbers indicate the helices I-III. Figure adapted from Berezniak et al.[177] 
 
The Diels-Alderase ribozyme is stabilized by eight Mg2+ cations (figure 16). Mg1 and Mg2 
contribute most to the structural scaffold of the catalytic pocket, while Mg3-Mg6 stabilize the 
λ-shaped RNA structure. Mg7 and Mg8 mediate contacts between RNA molecules in the 
crystal lattice, but these magnesium ions are not coordinated to the ribozyme in solution.[177] 
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Figure 17: Two and three dimensional structure of the Diels-Alderase ribozyme; the three bases involved in this 
triple are indicated. 
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In the following, light will be shed on a particular structural element of the Diels-Alderase 
ribozyme. A tertiary interaction of three bases in the heart of the binding pocket: the tertiary 
interaction of the U17 base with the pseudoknot base-pair C10-G2 was first identified in the 
X-ray crystallographic structure and has proven to be absolutely essential. These triple 
bridging bases facilitate the cross-strand junction of the pseudoknot, stacking interaction with 
the neighbouring bases and one magnesium ion number five (figure 17) which stabilizes this 
junction point. Furthermore these bases are part of the central H-bonding network forming the 
binding pocket of the ribozyme. 
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Scheme 23: a: the base triple G2 – C10 – U17 (wild-type) b and c: mutants (C10 – C17 and C10 – iC17). 
Hydrogen bonding disrupted. 
 
Atomic mutagenesis has been utilized to selectively perturb these bonds and illustrate the 
functional relevance of the interaction between U17-O2 and C10-HN4. To gain further insight 
into this triple base pair an U17C and an U17iC mutant (scheme 23) ribozyme have been 
compared to the wild type. 
A comparison in reactivity between the wild-type ribozyme and these mutants showed that 
both mutants fold into a pseudoknot structure, but can not undergo further compactation. 
While the U17C mutant shows a factor three decreased activity, the U17iC mutant is entirely 
inactive.[178] Furthermore the dienophile is activated by two weak H-bonds related to that 
triple (U17-2’OH and G9-HN2 vs. dienophile-O). This H-bonding network contributes to the 
stabilization of the transition state and is therefore crucial for the catalytic activity. Lead 
(Pb2+) probing also showed that the U17iC mutant has no affinity to the Diels-Alder 
product.[179]  
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3.1.3 UV melting curves 
 
The temperature induced transition between the native and denatured state of nucleic acids 
can conveniently be observed by UV absorbance. The absorbance versus the temperature 
profile is referred to as a UV absorbance melting curve and the midpoint of this transition is 
called the melting temperature (Tm) of the analyzed nucleic acid. Tm corresponds to the 
temperature at which half of the sample is folded and half is unfolded.[180] As the temperature 
increases the ratio of molecules in a denatured state increases. The native state and the 
denatured state of the nucleic acid exhibit different absorptivities,[181] enabling to monitor this 
chance in absorption as the process of melting and the disruption of the structural elements of 
the nucleic acid.[182] 
 
3.1.4 Practical considerations of determining UV denaturation 
 
The choice of buffer is an extremely important aspect when it comes to performing reliable 
UV thermal denaturation studies. Among the most important considerations are the pKa and 
its temperature dependency, the buffer capacity, and the compatibility with divalent 
metals.[183] Table 2 lists some of the most common buffers for UV denaturation experiments. 
 
Table 2: Buffers used for UV thermal denaturation studies. 
Buffer pKa (25°C, I = 0.1 M) ΔpKa/ΔT (°C-1) 
Compatible with 
divalent ions 
Reference 
Sodium cacodylate 6.27 -0.0015 Yes a 
Sodium phosphate 7.20 -0.0028 No a 
Tris.HCl 8.06 -0.0280 No a 
MOPS 7.20 -0.0150 Yes b, c 
HEPES 7.55 -0.0140 Yes a 
a [183], b [184], c [185] 
 
The optimized buffer for the Diels-Alderase ribozyme consists of 30 mM Tris.HCl (pH 7.4), 
300 mM NaCl and 80 mM MgCl2.[111] Unfortunately Tris.HCl buffer has a huge temperature 
dependency of the pKa. The most commonly used phosphate buffer, consists of a mixture of 
monobasic dihydrogen phosphate and dibasic monohydrogen phosphate,[186] but can not be 
used, because it sequesters divalent ions such as Mg2+, Mn2+, Cd2+ or Ca2+. The MOPS buffer 
is often used for thermal denaturation studies, even though its pKa is known to be temperature 
Thermal denaturation studies of the Diels-Alderase ribozyme 
 50
dependent.[182, 187] Initial experiments considering different buffers showed that MOPS has a 
high temperature dependency and pH changes from 7.0 to 6.2 if heated from 25°C to 80°C 
were observed. While sodium cacodylate showed best results and was therefore used 
throughout all melting experiments. One has to keep in mind that all buffers contain cations, 
e.g. a 25 mM sodium cacodylate buffer contains 25 mM Na+ cations, which naturally 
contribute to the stability of the RNA. 
 
 
3.2 UV denaturation of the Diels-Alderase ribozyme 
 
The aim was to study secondary and tertiary interactions of the Diels-Alderase ribozyme 
wild-type as well as the two mutants U17C and U17iC. In previous studies the mutant 17iC 
mutant, in which the H-bonding network is disrupted, was entirely inactive, while the C17 
mutant, that is still capable to form an H-bond, only showed a catalytic activity of 30% as 
compared to the wild-type.[178] The magnesium ion Mg5 is in close proximity to this base-
triple (figure 17) and therefore studies of the thermal stability in dependency on the Mg2+ ion 
concentration may lead to further insight on this interaction. 
 
A UV/Vis spectrophotometer equipped with a Peltier block temperature-controller was 
utilized to determine the melting curves at 260 nm. Heating and cooling cycles in the 
temperature range of 15-90°C were measured in 25 mM sodium cacodylate buffer with a 
temperature gradient of 0.5°C/min. The melting curves itself were obtained from plotting the 
normalized melting temperatures vs. the absorbance at 260 nm. The interesting structural 
information however, was extracted from a plot of the first derivative of the absorbance vs. 
the temperature. 
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Figure 18: Absorption of the wild-type at different MgCl2 concentrations in the presence of 300 mM NaCl. 
 
Figure 18 presents the melting curve of the wild-type ribozyme in the presence of 300 mM 
NaCl as present in the commonly used buffer for the Diels-Alderase ribozyme. A good 
stabilization of the structure can already be extracted from this plot. 
Looking at the first derivative of UV denaturation curves the first peak in the low temperature 
range can be attributed to the opening of the tertiary structure. For the opening of the 
secondary structure much higher temperatures are required (figure 19).[113] Each 
independently folding element therefore has its own Tm. Thermal denaturation studies of the 
Diels-Alderase ribozyme (wild-type) in the presence of 300 mM NaCl (99.999% pure NaCl) 
showed that the structure is entirely stabilized. The melting temperature of the Diels-Alderase 
ribozyme in the presence of high concentrations of Na+ was found to be at 86°C (± 0.2°C) and 
independent from the Mg2+ concentration. The opening of the tertiary structure was observed 
at 65°C (± 0.2°C). 
 
 
Figure 19: UV denaturation curves of the Diels-Alderase ribozyme in the presence of 300 mM NaCl. First 
derivative of the absorption plotted vs. the temperature. 
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In the presence of 300 mM NaCl (figure 19) the entire structure was stabilized and additional 
stabilization with divalent metal cations could not be monitored with thermal denaturation 
experiments. If further stabilization would be possible, e.g. with higher concentrations of 
monovalent or divalent metal cations it can not be monitored by thermal denaturation 
experiments. Therefore, further thermal denaturation experiments were carried out in the 
absence of Na+ cations to study denaturation behaviour in dependency on the presence of 
EDTA and divalent metal ions, respectively Mg2+ cations. 
 
 
Figure 20: Absorption of the wild-type at different MgCl2 concentrations respectively with EDTA. 
 
If EDTA was added to trap traces of divalent ions (figure 21), the structure of the Diels-
Alderase ribozyme was found to be destabilized and the melting temperature was shifted by 
26°C from 83°C (± 0.2°C) to 57°C (± 0.2°C). 
 
 
Figure 21: Absorption of the wild-type at different MgCl2 concentrations. Tm1 indicates the opening of the 
tertiary structure and Tm2 the opening of the secondary structure. 
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The addition of 5 mM MgCl2 was already sufficient to fully stabilize the Diels-Alderase 
ribozyme (figure 21). 
 
 
Figure 22: Absorption of the wild-type at different MgCl2 concentrations respectively with EDTA. 
 
In dependency of the EDTA concentration, the opening of the tertiary structure (Tm1) was 
observed at different temperatures, while the addition of Mg2+ significantly stabilized the 
tertiary structure (figure 22, table 3). Buffer solutions generally contain impurities of divalent 
metal ions, the difference in the melting temperature between 1.0 and 0.1 mM EDTA can be 
seen as a reflection of the divalent metal ions present in the buffer solution. 
 
Table 3: Tm values of the Diels-Alderase ribozyme in the presence of different MgCl2 and EDTA 
concentrations. Tm1 opening of the tertiary structure; Tm2 opening of the secondary structure. 
MgCl2 / EDTA Tm1 [°C] Tm2 [°C] 
1 mM EDTA 33 57 
0.1 mM EDTA 44 74 
0.5 mM MgCl2 - 80 
2 mM MgCl2 - 80 
5 mM MgCl2 - 83 
 
3.2.1 Comparison of the Diels-Alderase wild-type with two mutants: U17C and U17iC 
 
In a series of measurements the wild-type, the U17C mutant and the U17iC mutant have been 
compared at different magnesium chloride concentrations. 
Initial experiments showed that the opening of the secondary structure for the mutants occurs 
at similar temperatures of the wild-type. For further experiments the mutants were 
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investigated at temperatures up to 60°C. The interesting transition observed in UV 
denaturation experiments is Tm1, the opening of the tertiary structure and this transition occurs 
below 60°C. 
 
Mg2+ ion concentrations between 0.1 mM EDTA and 2 mM showed no considerable 
difference between the wild-type and the mutants. As an example the comparison between the 
wild-type and the mutants at 0.2 mM MgCl2 is shown (figure 23, for details see appendix). At 
an Mg2+ concentration of 5 mM a significant difference between the mutants was monitored, 
the stabilization of the wild-type lead to a lower absorption (figure 24 and 25). 
 
 
Figure 23: Comparison between the wild-type and the U17C and C17iC mutant at 0.2 mM MgCl2, plotted as a 
function of the normalized absorption vs. the temperature. 
 
 
Figure 24: Comparison between the wild-type and the U17C and C17iC mutant at 5 mM MgCl2, plotted as a 
function of the normalized absorption vs. the temperature. 
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Figure 25: Stabilization of the tertiary structure; Comparison between the wild-type and the U17C and C17iC 
mutant at 5 mM MgCl2; first derivative of the absorption vs. the temperature. 
 
 
3.3 Conclusion and Discussion 
 
In a single-molecule fluorescence resonance energy transfer study Kobitski et al. found three 
different states in the Mg2+ dependent folding of the (wild type) Diels-Alderase ribozyme. 
These states were assigned as the unfolded, the intermediate and the folded state. The 
intermediate state shows a very strong Mg2+ dependency on the compaction of the ribozyme 
structure. These single-molecule studies further showed that in the absence of MgCl2 the 
unfolded state has the highest population and with an increasing Mg2+ concentration the 
transition from the intermediate state to the folded state is clearly evident. The Mg2+ 
dependent midpoint transition to reach the fully folded structure occurs around 5 mM 
MgCl2.[175] 
These results are in accordance with our UV denaturation experiments. No significant 
difference could be observed between the wild-type and the two mutants U17C and U17iC at 
concentrations below 5 mM MgCl2. With increasing Mg2+ concentration an increase in 
stabilization of the ribozymes could be observed. Both the wild-type and the mutants were 
equally stabilized, while at an Mg2+ ion concentration of 5 mM a significant increase in 
stabilization of the wild-type could be observed, while the mutants were not further stabilized. 
Other experiments have shown that the mutants can form the pseudoknotted structure but can 
not undergo further compaction.[175] The missing H-bond provides a good explanation why 
the U17iC mutant can not undergo this compaction. The U17C mutant on the other hand can 
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participate in the H-bonding network. However, it is yet not entirely understood why this 
mutant only shows 30% catalytic activity.[178] The assumptionis that the U17C mutant can not 
bind the Mg2+ ion number five as tightly as the wild-type is substantiated by the finding in the 
here presented thermal denaturation experiments. The fact that mutant U17C, can form a 
pseudoknot, but can not be further compacted by the association of the magnesium ion 
number five would explain why it only shows a catalytic activity of 30%. 
 
The G-C rich structure of the helix I and III of the Diels-Alderase ribozyme suggested a high 
melting temperature. With these thermal denaturation studies it could be shown that it is 
indeed extremely stable at temperatures up to 85°C. The secondary structure is stabilized by 
the addition of relatively low amounts of divalent metal ions. The good stabilization observed 
for the Diels-Alderase ribozyme is in conformity with thermal data observed for other RNA 
molecules forming pseudoknot structures.[163, 188] 
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4 Bioorthogonal and orthogonal labeling of oligonucleotides 
 
4.1 Scientific background 
 
4.1.1 Bioorthogonal labeling 
 
The possibility to use covalent chemistry to label biomolecules has become an essential tool 
and has significantly contributed to a greater understanding of chemical and biological 
systems. These labels serve for visualization, for studying the nature, structure or behavior of 
the biomolecule, for diagnostic analytics, for identification or quantification, for purification 
or for conjugation of the biomolecule to a surface or other biomolecules. 
A bioorthogonal reaction can be defined as a chemical transformation between two functional 
groups that takes place selectively within complex biological samples.[189] Bioorthogonal 
functionalities are incorporated into biological molecules like proteins, amino acids, or 
nucleic acids. After the integration of these tags into a biomolecule the desired label or 
biophysical probe is attached in a bioorthogonal reaction. In contrast to the number of 
chemical modifications in biomolecules the scope of bioorthogonal labels is still limited, 
because not many chemical reactions fulfill the requirements of bioorthogonal strategies. 
Bertozzi et al. characterized the challenges an organic chemist has to face when designing a 
bioorthogonal labeling strategy. A bioorthogonal reaction can be identified from the repertoire 
of a chemical text book, by first removing all reactions that are sensitive to water; second, 
removing all the reactions that are redox sensitive; third, reactions that require temperatures 
above 37°C, pressure or high concentrations. Further limitations are functionalities that can be 
digested by cellular enzymes and all reagents that are cytotoxic. The remaining reactions are 
potential bioorthogonal reactions.[190] 
Bioorthogonal reactions for the modification of biomolecules with two different labels are of 
paramount interest. The applications mentioned above for labeled biomolecules can thereby 
be combined. In nucleic acid chemistry dual fluorescently labeled probes have found 
particular recognition. They provide access to diagnostic detection[191, 192] or structural 
investigations especially employing FRET (Förster resonance energy transfer) techniques.[193, 
194] 
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In an ideal case of bioorthogonal labeling of biomolecules the tags and the labels are so 
specific that the labeling can be performed in a “one-pot reaction” (scheme 24a). If the 
specifity and selectivity of either the tags or the labels is not high enough, the labeling has to 
be performed in two subsequent steps (scheme 24b). In this case the single-labeled 
biomolecule has to be purified after the first step to ensure selectivity for the second label. 
 
a b
 
Scheme 24: Cartoon representation of the technique of dual bioorthogonal labeling of oligonucleotides with 
fluorescent dyes, a: ideal scenario: a “one-pot-reaction” b: two step labeling reaction. 
 
 
4.1.2 Fluorescent labeling of oligonucleotides 
 
In the following, some important achievements in fluorescent labeling of oligonucleotides 
will be discussed, with focus on 5´-end modifications. 
While enzymatic DNA and RNA synthesis is carried out from the 5´- to the 3´-end, chemical 
synthesis of oligonucleotides follows the 3´- to 5´-direction. Therefore, modification of 
chemically synthesized oligonucleotides at the 5´-end is accomplished making use of 
chemically modified phosphoramidites. However, modification at the 5´-end is in general 
limited to the selection of available phosphoramidites. Some fluorescent dyes are 
commercially available as phosphoramidites for automated DNA synthesis, but these dyes are 
basically limited to fluorescein derivatives. Fluorescein was the first fluorescent dye 
discovered,[195] and is therefore well studied and many derivatives are known, but fluorescein 
dyes also suffer from the effect of photo-bleaching.[196] Recently, phosphoramidites with 
rhodamine, Cy3 and Cy5 dyes, as well as phosphoramidites with Cy-dye-like structures have 
become commercially available, but many of these dyes are sensitive to the conditions 
required for the removal of the base protecting groups during chemical oligonucleotide 
synthesis. To combine high yield automated synthesis and fluorescent labeling for many dyes 
special base-labile phosphoramidite monomers are required.[197] Even though this method is 
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the easiest way to large amounts of fluorescently labeled oligonucleotides the limitations in 
the use of fluorescent dye phosphoramidites are obvious and undeniable. When it comes to 
chemical synthesis of modified RNA molecules the limitations are even considerably 
larger.[198] A post-synthetic approach can overcome most of these limitations. Small reactive 
groups are introduced into DNA or RNA during oligonucleotide synthesis, which can then be 
conjugated to the desired functional molecule in a bioorthogonal manner after oligonucleotide 
synthesis and deprotection.[199] These chemical modifications are introduced into the desired 
oligonucleotide in the form of phosphoramidites, but in general these molecules are small and 
much more stable as compared to the direct introduction of fluorescent dyes. Furthermore, 
these small molecules are non reactive with nucleic acids but are highly reactive organic 
molecules. The beauty of this approach is that, depending on the modification, several 
different types of functional tags can be conjugated to the oligonucleotide. Table 4 provides 
an overview over common post-synthetic modifications of oligonucleotides.[113, 200] 
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Table 4: Common post-synthetic labeling reactions. 
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4.1.3 Thiol modification 
 
The variety of natural thiol-containing biomolecules ranges from cysteine, gluthathione, to 
coenzyme A to peptides, enzymes, and membranes. Therefore, thiol-modifications have a 
longstanding history in biochemistry.[201] An SH functional group is generally referred to as 
either a thiol group or a sulfhydryl group. 
Aliphatic thiols are easy to alkylate and are the most active group found in cells. This is 
caused by the large dipole moment, nucleophilicity, and the vacancy in the d orbital of the 
thiol group.[202] Because of this reactivity thiol-containing phosphoramidites, for 
oligonucleotide synthesis (so called thiol-modifiers) are commercially available and have 
found widespread application.[203, 204] Consequently, a large number of reagents are available 
for the bioconjugation to sulfhydryl groups, of which the most common ones are maleimides, 
haloacetyl and halide derivatives, aziridines, acryloyl derivatives, thiol-disulfide exchange 
reagents, and dative bond-formation reagents with metal surfaces. For this thesis, only 
maleimides and α-haloacetamides are of greater importance and shall be discussed in detail in 
chapter 4.1.5 and 4.1.6. 
 
4.1.4 Disulfide reducing reagents 
 
Thiol modified oligonucleotides can form inter- or intramolecular disulfide bonds and are 
often still protected by disulfide bonds after synthesis. Therefore, prior to any site-specific 
reaction the disulfides need to be reduced. For this purpose commonly used reductants are β-
mercaptoethanol (ME), dithiothreitol (DTT), and tris(2-carboxyethyl)phosphine (TCEP). ME 
cleaves disulfides in a reaction that proceeds via a mixed disulfide, meaning that two 
molecules of reducing reagent are necessary to reduce one disulfide bond. DTT itself has two 
free thiol groups and forms a very stable cyclic disulfide as oxidation product and therefore 
can be used in lower concentrations. 
TCEP was first synthesized by Levinson et al. in 1969[205] and employed for the reduction of 
disulfide bonds in proteins by Rüegg et al. in 1977.[206] As compared to other phosphines 
TCEP is resistant to oxidation, non-volatile, odorless, and exhibits a much higher reactivity 
and stability than DTT or ME. Despite these seemingly excellent properties this phosphine 
fell into oblivion until 1991 when Burns et al.[207] found a way to synthesize large quantities 
of TCEP. Only after that Pierce Chemical Co started to market the product in 1992.[208] The 
reduction of a disulfide bond with TCEP is shown in scheme 25.  
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Scheme 25: Reduction of a disulfide bond with TCEP. 
 
TCEP has an outstanding stability in water and shows no reactivity towards other functional 
groups present in proteins or nucleic acids. The advantage of TCEP over DTT is clearly that 
excess TCEP does not have to be removed by dialysis prior to the actual reaction. Standard 
labeling protocols do not include the removal of excess TCEP before the reaction. However, a 
few publications report that TECP does, against common belief, react with molecules used for 
bioconjugation.[209-211] 
 
4.1.5 Maleimides 
 
Maleimides are derivatives of the maleic anhydride and an amine derivative. The double bond 
of the maleimide undergoes alkylation with thiol groups to form stable thioether bonds 
(scheme 26) or can serve as a dienophile in the Diels-Alder reaction. The Diels-Alder reaction 
will be further discussed in chapter 4.1.7. 
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Scheme 26: Reaction of a sulfhydryl compound with a maleimide. 
 
Maleimides are widely used in bioconjugation especially in the bioconjugation of proteins. 
Therefore, almost any desirable label is available as maleimide. The scope of commercially 
available maleimides ranges from fluorescent dyes, to proteins, and antibodies to hetero-
bifunctional cross-linkers. 
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4.1.6 α-Haloacetamides 
 
α-Haloacetamides are reactive towards several functional groups present in biomolecules, 
amine groups being the least, and thiols the most reactive. α-Haloacetamides are known for all 
halogens. Iodine presents the most reactive α-haloacetamide, followed by bromine, chlorine, 
and fluorine, which is almost unreactive towards all functional groups. Iodoacetamides are 
typically used as blocking reagents for thiol groups in protein chemistry.[126] Commercially 
available dyes are almost exclusively synthesized as the iodoacetamide. For that the term 
iodoacetamide will be used equivalent with the term α-haloacetamide. The reaction between 
an iodoacetamide and a thiol group forms a stable thioether bond (scheme 27). 
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Scheme 27: Reaction of a sulfhydryl compound with iodoacetamide. 
 
4.1.7 Diels-Alder reaction as tool for bioconjugation 
 
The Diels-Alder reaction between a diene and a dienophile reacting in a [4+2] cycloaddition 
is a powerful tool for post-synthetic bioconjugation. The fact that the Diels-Alder reaction is 
accelerated in water makes the Diels-Alder reaction a perfect fit for bioconjugation.[212-214] 
Maleimides are widely used in many types of bioconjugation reactions and therefore are the 
most popular dienophiles for Diels-Alder reactions. A huge variety of maleimide derivatives 
is commercially available: virtually any fluorescent dye, biotin maleimides, antibody 
maleimide conjugates, surface immobilized maleimides, proteins e.g. maleimide-HRP 
(horseradish peroxidase), or maleimide-alkaline phosphatase. 
 
The first bioconjugation via Diels-Alder reaction had been described by Seelig and Jäschke, 
who selected a ribozyme for the Diels-Alder cycloaddition between anthracene and a 
maleimide.[41] 
A number of Diels-Alder reactions for the modification of proteins and peptides[215, 216] have 
been reported in the recent years among others e.g., conjugations of oligonucleotides to 
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peptides[217-219] or the ligation of oligonucleotides via Diels-Alder reaction.[220] A rather 
limited number of oligonucleotide modifications with small tags have been reported so 
far.[221] Up to today fluorescent labeling of oligonucleotides via Diels-Alder reaction has so 
far only been reported by very few authors. Hill et al. reported the 5´-end modification of 
oligonucleotides with cyclic and acyclic hexadienes and the subsequent Diels-Alder reaction 
with maleimides.[221] While most maleimides used by Hill et al. reacted easily with the diene 
within 30 min, and not more than two equivalents of functionalized maleimide were required, 
the modification with fluorescent dyes appeared much more demanding. After 20 h reaction 
time and by the use of twelve equivalents of fluorescein maleimide a labeled product could be 
detected. Graham et al. reported the labeling reaction of an internally diene modified 20mer 
with fluorescent dyes. Apart from difficulties in distinguishing the products from each other, 
their approach seems to be more efficient than the above mentioned, but still requires 30% v/v 
acetonitrile and elevated temperatures for four hours.[222] The use of organic solvents and 
elevated temperatures during labeling reaction prevents the use of this strategy for sensitive 
biomolecules. 
In summary, a number of examples for the Diels-Alder reaction mediated bioconjugation 
have been reported in the last couple of years. However, so far only very few authors have 
described an efficient Diels-Alder bioconjugation of fluorescent dyes to oligonucleotides. The 
general picture that can be drawn from these reports shows that labeling of oligonucleotides 
by Diels-Alder reaction can be very efficient, but is extremely dependent on the type of label. 
Dyes seem to be the least efficient labels. The Diels-Alder reaction is a promising tool for 
bioconjugation of small molecules to nucleic acids and the addition of a suitable catalyst 
could be a way to overcome the abovementioned problems.[200] 
 
4.1.8 The Diels-Alderase ribozyme 
 
A ribozyme that catalyzes the Diels-Alder reaction between tethered anthracene and biotin 
maleimide was selected by Jäschke and co-workers.[41] In the selection the anthracene-
modified RNA acted as a ribozyme and substrate at the same time, thus modifying itself in a 
reaction catalyzed in cis. Furthermore, this ribozyme was also found to accelerate the Diels-
Alder reaction of the free reactants in a true catalytic manner in trans (scheme 28). 
 
Bioorthogonal and orthogonal labeling of oligonucleotides 
 65
N
O
O
OH
N
O
O
OH
Diels-Alderase
ribozyme
 
Scheme 28: Ribozyme-catalyzed reaction between 9-hyroxymethyl anthracene and N-pentylmaleimide. 
 
4.1.9 Anthracene as substrate 
 
In the landmark paper by Sauer et al. the reactivity of dienes towards maleic anhydride in 
Diels-Alder reactions was investigated and two major findings support the choice of 
anthracene as a diene.[223] 
I. The reactivities of cyclic and quasi-cyclic dienes considerably exceed the reactivities of 
acyclic dienes. Electron-donating substituents on the diene usually accelerate the 
reaction. 
II. The k2 values of anthracene derivatives are influenced to a high degree by substituents 
in the 9- and 10 position. 
Even though these experiments were carried out in dioxane the results are comparable to 
water as solvent, as the influence of the substituents on the energetic properties of the π-
system is independent from the solvent. 
 
However, previously published results on modification of biomolecules via Diels-Alder 
reaction have, with two exceptions have not employed anthracene as a diene. So far the first 
and only successful description of a Diels-Alder bioconjugation with anthracene as a substrate 
was described be Seelig and Jäschke in 1999.[41] 
Recently, Overkleeft and co-workers reported the labeling of endogenously expressed 
enzymes based on the Diels-Alder ligation and reported that among the investigated dienes 
the anthracenyl modified biomolecule was unable to undergo Diels-Alder ligation.[189] 
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4.2 Objectives 
 
The ever-expanding demand for new and better fluorescent labeling techniques for 
biomolecules, and the broad but still limited scope of labeling methods for oligonucleotides, 
has prompted an interest in an investigation into the Diels-Alder bioconjugation of 
oligonucleotides. Knowing that the Diels-Alderase ribozyme is able to accelerate the 
cycloaddition between an anthracene and maleimide in a true biomolecular fashion the aim 
was to investigate whether the Diels-Alderase ribozyme could be utilized as “machinery” for 
fluorescent labeling reactions of oligonucleotides. 
 
Investigating the following steps one after another the idea was to find a bioorthogonal 
method to fluorescently label oligonucleotides with the Diels-Alderase ribozyme. Since dual 
labeled fluorescent probes are of paramount interest it will also be investigated if a dual 
orthogonal labeling strategy can be developed. 
 
The objectives for this investigation are: 
 
I. Can the Diels-Alderase ribozyme catalyze the fluorescent labeling of oligonucleotides 
in cis? 
II. Can the Diels-Alderase ribozyme catalyze the post-synthetic fluorescent labeling of a 
functionalized DNA in trans? 
III. Is it possible to develop a bioorthogonal labeling strategy exploiting the substrate 
specificity that has been reported for the Diels-Alderase ribozyme earlier? 
IV. How can a dual orthogonal labeling strategy employing the Diels-Alderase ribozyme 
be developed and implemented? 
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4.3 Results and Discussion 
 
4.3.1 Synthesis of anthracene modified oligonucleotides 
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Scheme 29: 9-Anthracenylmethyl tetraethylene glycol (ATEG) phosphoramidite 27a and 9-anthracenylmethyl 
hexaethylene glycol (AHEG) phosphoramidite 27b. 
 
An efficient way to synthesize short oligonucleotides bearing an anthracene modification is 
the coupling of 2-(anthracen-9-ylmethoxy)ethyl 2-cyanoethyl diisopropylphosphoramidite 
(scheme 29) with different PEG linkers at the 5´-end, as a last coupling step in automated 
oligonucleotide synthesis. For this purpose two of these molecules 27a and b have been 
synthesized, differing in the length of the glycol linker, according to published procedures.[95] 
This approach has been utilized to synthesize oligonucleotides ORN1, ODN2, ODN5, ODN6 
and ODN8. The oligonucleotides were purified by preparative HPLC and integrity was 
determined by mass spectrometry (table 4). 
 
Table 4: Oligonucleotides, HPLC and mass analysis. 
ODN Type Sequence  
tR 
[min] 
[M+H] 
calculated 
[M+H] 
observed 
ORN1 RNA 5´- AHEG GGA GCU CGC CC - 3’ 23.4 c 4019.59 4018.5 b 
ODN2 DNA 5´ - AHEG GGA GCT CAG CCT TCA CTG C-3’ 37.7 6300.27 6300.4 a 
ODN3 DNA 5´ - GTA CAG TCT GAA GTG - 3’ 18.8 4630.81 4630.5 a 
ODN4 DNA 5´ - CAC TTC AGA CTG TAC - 3’ 19.1 4511.96 4511.8 b 
ODN5 DNA 5´ - ATEG GTA CAG TCT GAA GTG - 3’ 36.3 5079.46 5079.7 a 
ODN6 DNA 5´ - AHEG GTA CAG TCT GAA GTG - 3’ 37.3 5165.02 5166.1207 b 
ODN7 DNA 5´ - SH C6 GTA CAG TCT GAA GTG - 3’ 24.0 4830.09 4832.0 a 
ODN8 DNA 5´ - AHEG GTA CAG TCT GAA GTG C3 SH -3’ 37.3 5335.14 5336.0263 b 
a MALDI-TOF MS – measured in the positive mode, b high resolution ESI MS – measured in the negative mode. 
Unless indicated otherwise HPLC gradient O1 was used; c gradient O2 (chapter 6.1.12). 
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4.3.2 Dipartite Diels-Alder ribozyme assay 
 
The dipartite Diels-Alderase ribozyme construct consists of two hybridized RNA strands. A 
38mer forming the catalytic pocket and an 11mer (figure 26). The 11mer can be modified 
with anthracene polyethylene glycol and serves as substrate. In this case the catalytic reaction 
will proceed in cis. 
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Figure 26: Dipartite Diels-Alderase ribozyme assay; b: Diels-Alder reaction catalyzed by the dipartite Diels-
Alderase ribozyme. 
 
The Diels-Alderase ribozyme has rather strict requirements regarding the structure of the 
diene and the dienophile. The main restriction of the Diels-Alderase ribozyme is that it only 
catalyzes the Diels-Alder reaction between the original substrates it was selected with: 
anthracene and maleimide derivatives. During the selection of the Diels-Alderase ribozyme 
biotin maleimide 28 (scheme 30) has been used and indeed maleimidocaproic acid and N-
pentylmaleimide are among the best substrates for the ribozyme.[41, 96] 
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Scheme 30: Chemical structure of biotin maleimide; in blue maleimidocaproic acid hydrazide. 
 
Now, the challenge was to find out if these restrictions in substrate specificity could be 
extended to fluorescent maleimide dyes. It was expected that the Diels-Alderase ribozyme 
would catalyze the reaction with maleimides connected with five carbon atoms long linkers, 
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while maleimides with shorter linkers should be less efficient substrates for the Diels-
Alderase ribozyme. 
Most commercially available fluorescent maleimides have a linker length of two carbon 
atoms (C2-maleimide) next to the amide bond connecting the dye to the maleimide. Very few 
maleimide dyes with a linker of five carbon atoms (C5-maleimide) are available. Scheme 31 
gives a schematic overview of all the dyes, which were used for this work. Detailed 
information and chemical structures of the dyes are given in the experimental section. 
N
H
N
O
O
O
DY 547
H
N
O
Atto 532N
O
O
N
H
O
N
O
O
BODIPY
H
N
N
H
N
O
O
DY 649
H
N
O
N
O
O
DY 649
N
H
O
N
O
O
Alexa 532
O
O
C5 -maleimide
C2 -maleimide
C5 -maleimide hydrazide
A
B
C
D
E
F
 
Scheme 31: Maleimide dyes with C2- and C5-linkers. All maleimides with five carbon atoms next to the amide 
bond are subsumed as C5-maleimides (A-C). The linkers of the commercially available C5-maleimides Alexa 
Fluor 532 (A) and BODIPY (B) are different from the self synthesized hydrazide C5-maleimide (C), which will 
be introduced in chapter 4.3.3. All C2-maleimides (D-F) are commercially available. 
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For the catalyzed Diels-Alder reaction in cis, the 38mer and the 11mer RNA anthracene-
conjugate (ORN1) were hybridized in a ratio of 1:2. The 11mer-AHEG (ORN1) was doped 
with [32P]-pCp labeled 11mer-AHEG to visualize the difference between modified and 
unmodified 11mer in a gel shift assay. 
The ribozyme clearly showed the expected selectivity towards the C5-maleimide. For the C2-
maleimide dyes, no conversion was observed (figure 27). However, the reactivity of the C5-
maleimide dye is also dependent on the nature of the dye. For the C5-maleimide Alexa Fluor 
532 dye 20% product formation was observed, while only 12% Diels-Alder product was 
formed with the C5-maleimide BODIPY dye. This is possibly due to its chemical structure 
and solubility. The Alexa Fluor 532 dye bears two sulfonate groups and has a good solubility 
in water, whereas the BODIPY dye is poorly soluble in water. 
 
 
Figure 27: Comparison of C2- and C5-maleimide. Conjugation of ORN1 in the dipartite Diels-Alderase 
ribozyme assay. Reaction time 30 min. 38mer (0.2 µM) and ORN1 (0.1 µM), doped with α32-pCp labeled 
ODN2, all dyes 50µM. The gel shift assay with autoradiography showed that for C5-maleimide dyes (a) a 
labeling reaction took place, while with C2-maleimide dyes (b) no Diels-Alder product formation was observed. 
For each dye the controls were performed without dye (middle) and without 38mer = uncatalyzed (right). 
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With this experiment it was demonstrated that the Diels-Alderase ribozyme only tolerates C5-
maleimide as substrates. No conversion was observed for maleimides with a C2-linker. 
Against the backdrop of the results by Stuhlmann et al.[96] and the selectivity observed in the 
dipartite Diels-Alder assay (figure 27) a fluorescent dye with a C5-maleimidocaproic acid 
hydrazide was synthesized. 
 
4.3.3 Synthesis of DY 649 C5-maleimidocaproic acid hydrazide 
 
29
O
O
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H2N
HMDS, ZnBr2
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R R
30 a  R = COOH
     b  R = CH3
31 a  R = COOH
     b  R = CH3  
Scheme 32: Synthesis strategy for maleimide derivatives. 
 
The general way how maleimide derivatives are obtained is the simple addition of the desired 
amine to maleic anhydride in acetonitrile. An attempt to synthesize maleimidocaproic acid via 
this route failed, because too many side products were formed. Based on the initial work of 
Vorbrueggen[224] the use of hexamethyldisilazane (HMDS) and zinc bromide as Lewis acid 
(scheme 32) to initiate the reaction provides a superior route to synthesize maleimide 
derivatives in good yield and purity.[225] Maleimidocaproic acid 31a was obtained from 
maleic anhydride 29 and 6-aminocaproic acid 30a by initiation of the reaction with HMDS/ 
ZnBr2 under reflux for three hours and subsequent stirring over night.[226] The product could 
be purified by column chromatography to result in a clean product in 74% yield. 
N-Pentylmaleimide 31b is used in all kinds of Diels-Alderase ribozyme assays, thus the above 
described synthetic procedure was extended to the synthesis of N-pentylmaleimide. The 
synthesis and quality of the product could be improved significantly as compared to common 
procedures. For reaching a purity that is compatible with biological assays purification by 
flash chromatography was carried out and yellow crystals (82%) were obtained. For 
biological assays the purity is extremely important. HPLC analysis confirmed a purity of 
99.8%. 
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Scheme 33: Synthesis of 6-maleimidocaproic acid hydrazide. 
 
6-Maleimidocaproic acid 31a was stirred with tert-butyl carbazate in the presence of N-ethyl-
N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl) in acetonitrile at room 
temperature for 17 h. The product was further purified by silica chromatography and pure 
Boc-protected 6-maleimidocaproic acid hydrazide 32 was obtained in a yield of 61%. 
Deprotection was carried out with 10% trifluoroacetic acid (TFA) in dichloromethane, to 
yield 93% 6-maleimidocaproic acid hydrazide 33. DY 649 NHS ester was purchased from 
Dyomics and incubated with 6-maleimidocaproic acid hydrazide 33 in DMF in the presence 
of Hünig's base (N,N-diisopropylethylamine (DIPEA)) as a proton scavenger for 36 hours at 
25°C. DY 649 C5-maleimidocaproic acid hydrazide 34 was obtained in good yield and was 
purified by semi-preparative HPLC. 
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Scheme 34: Synthesis of DY 649 C5-maleimidocaproic acid hydrazide. 
 
The use of DY 649 C5-maleimidocaproic acid hydrazide for labeling of oligonucleotides will 
be introduced in chapter 4.3.4.1. 
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4.3.4 Diels-Alderase ribozyme-catalyzed labeling in trans 
 
In contrast to the Diels-Alderase ribozyme catalyzed reaction in cis that has been discussed so 
far, the aim of this thesis was to employ the Diels-Alderase ribozyme as a catalyst for post-
synthetic modification of various oligonucleotides. For the reaction in trans, the reaction 
partners are free in the solution. The maleimide is connected to the fluorescent dye and the 
anthracene is tethered to the target oligonucleotide. Figure 28 explains how the 
functionalization of oligonucleotides is accomplished catalyzed by the Diels-Alder ribozyme. 
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Figure 28: Schematic model of a Diels-Alder reaction between anthracene and maleimide catalyzed by the 
Diels-Alderase ribozyme in trans in the catalytic pocket of the 49 nucleotide long minimal motive of the Diels-
Alder ribozyme. 
 
For fluorescently labeling oligonucleotides in trans with the Diels-Alderase ribozyme DNA 
sequences were synthesized as introduced in chapter 4.3.1. An important technique for the 
introduction of small molecules into DNA, which has not been mentioned yet, is the extension 
of modified primers. This technique facilitates the chemical synthesis of long modified DNA 
strands. For that reason a DNA 19mer-AHEG sequence was synthesized, which had earlier 
been utilized to serve as a forward primer in PCR, where it is extended to yield long DNA 
products. The first seven bases of this DNA 19mer-AHEG (ODN2) can be aligned with the 
first seven bases of the Diels-Alder ribozyme. 
Notably, the radioactive 3´-end labeling of DNA (ODN2) with [32P]-pCp could be 
accomplished with T4 RNA ligase. 
For the reaction with Alexa Fluor 532 no gel shift could be observed. It was therefore 
concluded that the labeling reaction was not successful (figure 29). The reason is probably 
that interactions like base pairing of ODN2 with the Diels-Alderase ribozyme prevent the 
anthracene from entering the catalytic pocket. 
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Figure 29: Labeling reaction of ODN2 (AHEG 19mer) with Alexa Fluor 532 C5-maleimide. Conjugation of 
ODN2 in trans Diels-Alder assay. Reaction time 30 min, autoradiograph. Lane 1: ODN2 reaction with Alexa 
Fluor 532 C5-maleimide catalyzed by the 49mer Diels-Alderase ribozyme. Lane 2: ODN2 without Alexa Fluor 
532 C5-maleimide. Lane 3: uncatalyzed background reaction of ODN2 with Alexa Fluor 532 C5-maleimide. 
 
Consequentially, an oligonucleotide that cannot hybridize with the Diels-Alderase ribozyme 
in any way and could not form any hairpins was designed. Oligonucleotides ODN8 and 
ODN9 were synthesized. Both share the same sequence but differ in the number of ethylene 
glycol units in the spacer between the anthracene and the 5´-end of the oligonucleotide. 
ODN5 was modified with anthracene tetraethylene glycol (ATEG), while ODN6 was 
modified with anthracene hexaethylene glycol (AHEG). 
It was also decided to desist from further labeling the oligonucleotides with [32P]-pCp, 
because the 3´-labeling reaction with [32P]-pCp is not very efficient, neither for RNA nor 
DNA. Therefore, only doping of the oligonucleotides during the reaction is possible and not 
very practical, because the radioactively labeled oligonucleotide and the non-radioactive 
oligonucleotide have a different mobility in PAGE. For further experiments, visualization by 
fluorescent imaging and SYBR Gold staining was considered sufficient, as the amount of 
DNA in the assays was high enough for detection by staining. 
 
ODN5 and the Alexa Fluor 532 C5-maleimide were mixed in a 1:1 ratio and the Diels-
Alderase ribozyme added as a catalyst. Even though the reaction was performed at high 
concentrations no significant labeling was observed even after reaction times up to two hours 
(figure 30). Thermal denaturation studies (appendix) showed that ODN5 and ODN6 have 
exactly the same melting temperature. The best interpretation of this effect is that the short 
linker hinders the anthracene to enter the catalytic pocket. 
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Figure 30: Labeling reaction of ODN5 (ATEG 15mer (tetraethylene glycol)) with Alexa Fluor 532 C5-
maleimide. Reaction time 2 h. Fluorescent imaging 532 nm. Lane 1: ODN5 reaction with Alexa Fluor 532 C5-
maleimide catalyzed by the 49mer Diels-Alderase ribozyme. Lane 2: ODN5 without Alexa Fluor 532 C5-
maleimide. Lane 3: uncatalyzed background reaction between ODN5 and Alexa Fluor 532 C5-maleimide. 
 
The oligonucleotide synthetically modified with anthracene hexaethylene glycol (AHEG) was 
first tested with Alexa Fluor 532 C5-maleimide and a clear difference between the ribozyme-
catalyzed and uncatalyzed Diels-Alder bioconjugation was detected (figure 31). 
 
 
Figure 31: Labeling reaction of ODN6 (AHEG 15mer (hexaethylene glycol)) with Alexa Fluor 532 C5-
maleimide. Conjugation of ODN6 in trans Diels-Alder assay. Reaction time 30 min. Left: SYBR Gold stained; 
right: fluorescent scan 532 nm. Lane 1: ODN6. Lane 2: ODN6 reaction with Alexa Fluor 532 C5-maleimide 
catalyzed by the 49mer Diels-Alderase ribozyme. Lane 3: ODN6 without Alexa Fluor 532 C5-maleimide. Lane 
4: uncatalyzed background reaction of ODN6 with Alexa Fluor 532 C5-maleimide. 
 
The data show that in the presence of the Diels-Alderase ribozyme the labeling reaction is 
significantly improved. The most important result is that no notable difference was observed 
if the dye was used in a five-fold excess as compared to a 1:1 ratio. The determinator in this 
reaction is the presence of the Diels-Alderase ribozyme. This finding is promising, because 
fluorescent dyes are expensive and the ability of catalyzing the reaction while keeping the 
amount of dye as low as possible is of great interest. 
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Optimization of the labeling efficiency was carried out using Alexa Fluor 532 C5-maleimide. 
An extensive set of different concentrations and different excess ratios of dye over the 
oligonucleotide were tested. A well detectable labeling reaction took place if 7 mol% Diels-
Alderase ribozyme was used. Best results were observed if the labeling took place in a 1:1 
ratio of oligonucleotide and dye in the presence of 14 mol% Diels-Alderase ribozyme as a 
catalyst. Labeled oligonucleotides were observed after 10 min reaction time and a moderate 
yield of fluorescently labeled oligonucleotides was obtained after 30 min. Best results were 
achieved after 2 h reaction time. A prolongation of the reaction time over night did not 
improve the yield significantly. However, the labeling efficiency could not be improved 
above 20% as determined by SYBR Gold staining, followed by analysis with the software 
Image Quant.  
 
4.3.4.1 Direct comparison of C2-maleimide versus C5-maleimide for Diels-Alder 
labeling reaction 
 
Earlier studies have shown that biotin maleimide, the original substrate, the Diels-Alderase 
ribozyme was selected with, and malemidocaproic acid are among the best substrates for the 
Diels-Alderase ribozyme.[41, 96] To investigate the influence not only of the linker length but 
also the heteroatoms in the linker a dye with maleimidocaproic acid hydrazide 34 was 
synthesized (chapter 4.3.3). 
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Scheme 35: DY 649 C5-maleimidocaproic acid hydrazide and DY 649 C2-maleimide. 
 
Fluorescent dyes are rather big molecules and their character and behavior in solubility is very 
much dependent on their structure and charge, thus reactivities of different dyes can not be 
compared directly.  
Having synthesized the DY 649 as C5-maleimidocaproic acid hydrazide a direct comparison 
to the commercially available DY 649 C2-maleimide could be investigated (scheme 35). The 
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reactions were performed in parallel and additionally the influence of the Diels-Alderase 
ribozyme as catalyst was investigated (figure 32). 
The reaction was performed in a 1:1 dye to oligonucleotide ratio, in the concentrations that 
had earlier been determined to be optimal for the labeling reaction catalyzed by the Diels-
Alder ribozyme. The progression of the reaction was investigated after 30 min and after two 
hours and is shown in figure 32. An overview over the labeling yields obtained by analysis 
with Image Quant from figure 32 is given in table 5. 
 
 
Figure 32: Direct comparison of C2- and C5-maleimide. Conjugation of ODN6 (AHEG 15mer) with DY 649 C2-
maleimide and DY 649 C5-maleimidocaproic acid hydrazide. Reaction time 30 min and 2 h. Fluorescent imaging 
at 610 nm. Lane 1: Diels-Alder ribozyme-catalyzed reaction with C2-maleimide. Lane 2: Diels-Alder ribozyme-
catalyzed reaction with C5-maleimide. Lane 3: uncatalyzed reaction with C2-maleimide. Lane 4: uncatalyzed 
reaction with C5-maleimide. Table 5 summarizes the results of gel analysis with ImageQuant. 
 
Table 5: Direct comparison of reaction yields achieved with C2- and C5-maleimide. 
  30 min 2 h
C2-maleimide 1.8% 3.6%
catalyzed 
C5-maleimide 13.2% 24.0%
C2-maleimide 1.7% 2.5%
uncatalyzed 
C5-maleimide 2.1% 4.6%
 
For the C2-maleimide dye only a slight background reaction was observed and even the 
addition of the Diels-Alder ribozyme did not constitute a difference. In contrast, for the C5-
maleimide hydrazide a significant difference between the catalyzed and uncatalyzed reaction 
was observed. Without the addition of the Diels-Alder ribozyme the labeling efficiency does 
not differ much form the labeling efficiency with the C2-maleimide. If the reaction was 
catalyzed with the ribozyme a five-fold increase in labeling efficiency could be observed as 
compared to the uncatalyzed reaction. This experiment demonstrates the catalytic selectivity 
of the Diels-Alder ribozyme. Having demonstrated that the Diels-Alderase ribozyme only 
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catalyzes the labeling reaction with C5-maleimide fluorescent dyes originated in the idea to 
exploit this finding for a novel dual-bioorthogonal labeling strategy and shall be discussed in 
the following. 
 
4.3.5 Dual orthogonal labeling of DNA with maleimides 
 
Inspired by the selectivity observed for labeling of a DNA strand tethered to 
anthracenylmethyl hexaethylene glycol (ODN6) with C5-maleimide fluorescent dyes via a 
ribozyme-catalyzed Diels-Alder reaction, it was conceived that this selectivity could be 
exploited for a novel dual, orthogonal labeling strategy. It was demonstrated that the Diels-
Alderase ribozyme provides a possibility for selective labeling of oligonucleotides with C5-
maleimides but not C2-maleimides. Thiolated biomolecules are typically appropriate for the 
modification with maleimides and since most maleimide dyes are commercially available as 
C2-maleimides this approach was the corollary. 
An oligonucleotide was therefore modified with anthracene hexaethylene glycol at the 5´-end 
and a sulfhydryl moiety at the 3´-end (ODN8), which should then be labeled with two 
maleimide fluorescent dyes with different linker lengths. 
Conception was that the thiol modification could first be labeled with a C2-maleimide, 
whereas the anthracene remains unmodified until a C5-maleimide is added along with the 
Diels-Alder ribozyme as a catalyst (scheme 36). Even in the presence of the Diels-Alderase 
ribozyme no significant Diels-Alder reaction of C2-maleimide dyes with the anthracene was 
observed as shown in the previous chapter. Therefore no removal of the C2-maleimide dye 
should be necessary for the second labeling step, the ribozyme-catalyzed Diels-Alder reaction 
with the C5-maleimide dye. 
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Scheme 36: Proposed dual orthogonal labeling strategy exploiting the selectivity of the Diels-Alderase ribozyme 
for C5-maleimides over C2-maleimides. In a first step the sulfhydryl group is selectively labeled with a C2-
maleimide carrying fluorophore 1 (magenta) and subsequently, without removal of the dye, anthracene is 
selectively labeled with C5-maleimide fluorophore 2 (green) catalyzed by the Diels-Alder ribozyme. 
 
4.3.5.1 Investigations on fluorescent labeling of thiolated oligonucleotides with 
maleimides 
 
For the optimization of the thiol labeling reaction with C2-maleimide fluorescent dyes the 
same 15mer sequence with a thiol-modification was synthesized. For practical reasons (easier 
to synthesize) a thiol modification at the 5´-end, containing a C6 spacer between the last base 
and the sulfur atom, was chosen (ODN7). 
All reactions were carried out with 10 pmol of thiolated oligonucleotide. Standard protocols 
for the labeling of thiol modifications in biomolecules recommend a 20 to 40 fold excess of 
the maleimide dye over the biomolecule to ensure maximal yields for the labeling reaction. 
The influence of different dye excesses were tested. The anthracene modified oligonucleotide 
(ODN6) was always investigated in parallel under the same conditions to determine if a 
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labeling with a C2-maleimide could be accomplished selectively only for the thiol modified 
oligonucleotide ODN7. 
If less than a 10 fold excess of dye was used no significant labeling of the sulfhydryl group 
was observed and with an excesses of 10 and above the Diels-Alder reaction was as fast as the 
thioether bond formation between the maleimide and the thiol (figure 33). Selectivity could 
not be achieved adequately, because the maleimide dye had to be used in excess for thiol 
alkylation with maleimides. Under these conditions, the background reaction between the free 
anthracene-modified oligonucleotide and the C2-maleimide dye in solution was too high. 
Kinetic measurements showed that the Diels-Alder reaction is already too prominent after five 
minutes. Typically modification of thiolated probes is achieved either during 2 h at 25°C or 
over night at 4°C. Performance of the labeling reaction at 4°C could also not decrease the rate 
of the Diels-Alder reaction to achieve a selective labeling reaction on the thiol modification 
without modifying the anthracene as well. 
 
Figure 33: Thiol labeling compared with the reactivity of the anthracene towards maleimides. ODN8 (SH 
15mer) and ODN7 (AHEG 15mer) reactes with Atto 532 C2-maleimide (20 fold excess), reaction time 2 h at 
25°C. a: SYBR Gold stained: the lower bands represent the unreacted product, the upper bands the fluorescently 
labeled oligonucleotides. Labeling efficiency was estimated with ImageQuant to be ~ 10%. B: fluorescent scan 
(532 nm).  
 
A problem that has to be addressed, arises from the preceding disulfide cleavage with TCEP. 
It was observed that TCEP does react with maleimides, and if no excess of maleimide was 
used, the side reaction between maleimide and TCPE had a significant influence on the 
labeling efficiency. This will be discussed in detail in chapter 4.3.10.2. 
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It was concluded that the orthogonal labeling of the thiol modification could not be 
accomplished in the presence of an anthracene. Therefore, a different labeling strategy to 
perform a dual, orthogonal labeling of the bi-functional oligonucleotide had to be developed. 
 
4.3.6 Dual orthogonal functionalization of DNA with two different dyes 
 
As mentioned in the introduction, a less common, but still very efficient method to modify 
thiol-containing biomolecules is the use of α-haloacetamides. Unfortunately the variety of 
iodoacetamides, being the most common α-haloacetamide, commercially available is nowhere 
near the variety of commercial maleimide dyes. Additionally, iodoacetamides are much more 
demanding in synthesis, extremely apolar and less stable than maleimides. Apart from that no 
reactivity towards anthracene was expected and therefore they were chosen to be used in a 
dual, orthogonal labeling of the oligonucleotide ODN8 (scheme 37). 
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Scheme 37: Dual, orthogonal labeling of ODN8. In a first step the sulfhydryl group is selectively labeled with 
fluorophore 1 (purple). Anthracene is labeled with C5-maleimide fluorophore 2 (green) catalyzed by the Diels-
Alder ribozyme. As fluorophore 1 Atto 590 iodoacetamide was employed and fluorophore 2 Alexa Fluor 532.  
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The reactivity of the iodoacetamide dye towards the mono-functionalized oligonucleotides 
ODN7 and ODN6 was again investigated in parallel. Labeling of the thiol-modification of 
ODN7 with Atto 590 iodoacetamide was performed according to standard protocols with a 
20-fold excess of the iodoacetamide dye. Figure 34 shows that the thiolated oligonucleotide 
(ODN7) was fluorescently labeled with iodoacetamide while the anthracene modified 
oligonucleotide (ODN6) stayed entirely unaltered even incubated with a 20-fold excess of 
iodoacetamide dye. 
 
 
Figure 34: Thiol labeling with Atto 590 iodoacetamide, compared with the reactivity of the anthracene. SH 
15mer (ODN8) and AHEG 15mer (ODN7) Atto 590 iodoacetamide (1mM), Reaction time 2 h. SYBR Gold 
stained. 
 
Iodoacetamide dyes are poorly soluble in aqueous buffer. While the Atto 590 dye is known to 
be well soluble in water the iodoacetamide derivative is absolutely insoluble in water. In a 
heterogeneous solution no labeling reaction could be detected. Therefore, 20% ethanol had to 
be added to solubilize of the dye and thereby facilitate the desired labeling reaction. From 
previous studies it is known that the Diels-Alder ribozyme has no significant activity at 
ethanol concentrations above 10%.[95] For that reason the dual orthogonal labeling had to be 
performed in two consecutive steps. After evaporation of the ethanol, removal of excess dye 
and unlabeled oligonucleotide was carried out by gel purification. A purification step in-
between the two labeling steps is also advantageous due to the fact that the disulfide reducing 
agent TCEP is removed and will not compete with the anthracene for the maleimide in the 
second labeling step. 
The dual orthogonal labeling of ODN8 was carried out in two steps. Labeling of the 3´-thiol 
modification was carried out as described above and the Diels-Alderase ribozyme catalyzed 
labeling was performed as described in chapter 4.3.4. Figure 35 shows the PAGE of the dual 
orthogonal labeled oligonucleotide. 
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Figure 35: Dual orthogonal labeling of ODN8. For the Atto 590 dye the best wavelength for imaging is 610 nm 
(red), while the Alexa Fluor dye is imaged at 532 nm (green). The fluorescent scan in the middle shows the 
overlaid images of the scans at 610 nm and 532 nm (left). On the right the SYBR Gold scan of the same PAGE 
is shown. I: ODN8 labeled with Iodoacetamide. II: ODN8 labeled with iodoacetamide and maleimide. III: 
ODN8 unmodified (in the SYBR Gold stain over stained, therefore the band appears white).  
 
4.3.7 Analytical data of post-synthetically modified oligonucleotides 
 
Here analytical data of selected modified oligonucleotides are presented. 
 
Table 6: Selective analytical data of labeled oligonucleotides. MALDI-TOF mass analysis 
ODN Modified ODNs  
[M+H]+ 
calculated 
[M+H]+ 
observed 
ODN9 ODN6 Alexa Fluor 532 C5 maleimide  5956.20 5957.8 
ODN11 ODN7 Atto 590 Iodoacetamide 5560.44 5558.1 
ODN12a ODN8 Atto 590 Iodoacetamide 6088.38 6086.0a 
ODN12 ODN8 Atto 590 Iodoacetamide and Alexa Flour 532 C5 maleimide 6856.28 6857.8 
a calculated for [M+Na]+ 
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4.3.8 Important aspects of the labeling conditions 
 
4.3.8.1 Purification after bioconjugation 
 
For labeling reactions of biomolecules the dye is usually used in a 20 to 40 fold excess. The 
purification of the labeled molecules from the dye excess is in general dependent on the 
nature of the dye. In protein biochemistry and also for larger oligonucleotides size exclusion 
techniques or dialysis provide an efficient way to remove excess dye. For short 
oligonucleotides there are no such standard protocols. Several different approaches to remove 
the excess dye and purify the labeled oligonucleotide were investigated. Phenol extraction or 
chloroform extraction and isopropanol or lithium perchlorate precipitation were not 
satisfactory, because the dye was not removed entirely. Direct injection of the reaction 
mixtures to HPLC was not sufficient. Even low amounts of unreacted dye caused high 
background fluorescence and, depending on the dye and the emission spectra, clear 
interpretation of the labeling was not possible. A similar problem was observed if the reaction 
mixture was directly loaded on a preparative denaturing PAGE, where the free dye masked all 
other signals. 
Another possibility is the use of commercial dye removal kits. These kits are usually used to 
remove excess dye in sequencing reactions and therefore it has to be pointed out that dye 
terminator kits are designed for longer oligonucleotide sequences. The DyeEx 2.0 Spin Kit 
from Qiagen provides separation via gel filtration according to molecular weight. The 
drawback of this kit is that a maximum volume of 20 µL can be loaded and therefore larger 
sample volumes had to be evaporated or lyophilized and adjusted to the required volume. 
With the radioactively labeled 11mer the elution efficiency and the reproducibility of this 
system was investigated. The amount of RNA was determined via Cherenkov counting before 
and after DyeEx application (table 6). Additionally, the samples were analyzed by denaturing 
PAGE and the loss of labeled and unlabeled oligonucleotide visualized by autoradiography 
(as example figure 36 is shown for Alexa Fluor 532 C5-maleimide) and analyzed with 
ImageQuant. 
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Figure 36: Elution efficiency of labeled and unlabeled oligonucleotides by autoradiography.  
 
As shown in figure 36 and the actual loss of short oligonucleotides is rather high. However, 
the fact that the same amount of labeled and unlabeled RNA stays on the gel-filter material 
made DyeEx a valuable tool for the removal of unreacted dye. If handled correctly, the 
reproducibility of dye removal with this particular kit is very high and the elution efficiency is 
~30% for short oligonucleotides. 
Another advantage of DyeEx purification after labeling is that the reducing reagent TCEP is 
also removed from the reaction mixture. If the dye and the excess of TCEP was not removed 
from the reaction solution prior to PAGE analysis, higher background fluorescence was 
observed, along with as well as an abnormal shape of the bands. Abnormal elution behavior 
of TCEP containing probes has been reported previously.[209] For all reaction mixtures except 
the labeling with iodoacetamide DyeEx was used. 
The benefit of the Atto 590 iodoacetamide being entirely insoluble in aqueous solutions is that 
there is no need to remove the excess dye through DyeEx. As the insoluble dye does not 
penetrate the polyacrylamide matrix, it can easily be removed from the loading pockets after 
the PAGE. It can even be recovered by organic extraction, followed by HPLC purification.  
 
4.3.8.2 TCEP as reducing reagent 
 
As introduced earlier, TCEP is marked as the ideal reagent for the reduction of disulfide 
bonds prior to any labeling reaction.[227] The advantages of TCEP over other reducing 
reagents are not only that, in contrast to ME and DTT just a single molecule TCEP is required 
to reduce one disulfide bond, but also that the molecule does not have any thiol functionality 
and therefore does not compete with the thiol group of the oligonucleotide during the labeling 
reaction. Supposedly it has no reactivity toward other molecules. For that reason, common 
knowledge is that there is no need to remove TCEP from the reaction mixture before labeling. 
In contradiction to this belief a few authors observed a competitive reaction between the 
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TCEP and the maleimide. The reactivity of TCEP towards these molecules is usually masked 
by the huge excess of dye over the reducing agent.[228] In protein biochemistry common 
protocols recommend a 10-fold excess of reducing reagent over the thiol and a 20 to 40 fold 
excess of dye over the thiol. 
In this study, the thiolated oligonucleotides could not be detected if they were not reduced 
prior to analytical measurements like HPLC and mass spectroscopy. In gel electrophoretic 
analysis, if not treated with a reducing reagent, the main band was associated with the dimers 
linked via disulfide. Apart from the disulfide linked dimer many bands were visible (figure 
37) if the oligonucleotide was not treated with TCEP. Figure 37 shows that if the dye is used 
in a 1:1 ratio with TCEP no labeling could be observed, while for the reaction mixture 
without TCEP a faint band was observed corresponding to the fluorescently labeled 
oligonucleotide. These findings are in agreement with Getz et al.. Labeling myosine with a 
fluorescent maleimide they found that a labeling reaction took place in the presence of TCEP, 
albeit with a lower efficiency than if no reductant was added at all.[211] For proteins, reducing 
reagents can be removed via dialysis or gel filtration, even though Shafer et al. found that 
TCEP elutes, despite its low molecular weight together with small proteins and can therefore 
not be removed entirely.[209] For short oligonucleotides like the 15mer it is exceptionally 
difficult to remove TCEP before labeling. Gel elution of short oligonucleotides is demanding 
and precipitation is not very efficient. Common protocols for disulfide cleavage of 
oligonucleotides recommend bulk reduction in 1 mg scale. For optimization of the labeling 
reactions only 10 pmol or even smaller amounts of oligonucleotide were used, which made it 
impossible to remove reducing agent prior to the labeling reaction. Da Pieve et al. recently 
reported similar problems for the reduction of thiol modified short aptamers. They observed 
very low conjugation efficiencies in the presence of TCEP.[229] For future labeling reactions of 
thiols with maleimides options like immobilized TCEP should be investigated in order to 
improve the labeling procedure. 
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Figure 37: Reduction of ODN7 with TCEP. SYBR Gold stained. Left: ODN7 without TCEP treatment many 
bands are visible. Middle: No TCEP treatment, but after the addition of Atto 532 maleimide in a 1:1 ratio 
fluorescently labeled ODN7 was observed. Right: ODN7, TCEP and Atto 532 maleimide were used in a 1:1:1 
ratio, no labeling reaction could be observed. 
 
4.3.8.3 Investigation of the reaction between maleimides and TCEP 
 
As discussed in the previous paragraph, there are hardly any reports about the reactivity of 
TCEP with maleimides and common labeling protocols state that TCEP shows no reactivity 
towards maleimides. Hence, no investigation about the mechanism or the undesired products 
has been reported, so far. To confirm that there is indeed a competitive reaction taking place 
between the maleimide dyes and TCEP a set of experiments was designed. Equimolar 
amounts of TCEP and a maleimide derivative were mixed in water and the resulting product 
was analyzed by NMR and mass spectrometry. To keep the reaction conditions as close as 
possible to the actual reaction, N-pentylmaleimide was chosen as maleimide. The 1H-NMR 
spectrum of the reaction product was compared with the spectra of the pure reactants in the 
same solvent. 
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Figure 38: 1H NMR spectrum of N-pentylmaleimide before and after the reaction with TCEP in water. The 
signal for the vinylic protons of N-pentylmaleimide disappears during the reaction. The blue arrow indicates the 
signal generated for the newly incorporated protons. 
 
Before the reaction the vinylic protons of N-pentylmaleimide showed a chemical shift of 6.84 
ppm. After the reaction the signal for the vinylic protons could not be observed any more. 
This experiment shows that double bond had been reduced to a single bond. 
To examine whether the protons come from the solvent water, the same reaction was again 
performed in D2O. The chemical shift of 2.64 ppm (figure 35) indicated with a blue arrow 
could be assigned to the protons of the reduced double bond. If the reaction was performed in 
D2O, this signal was not visible, because deuterium does not give a signal in 1H NMR, 
proving that the protons originate from the solvent water. 
In the phosphorus NMR a shift of the signal was observed. This shows that TCEP (15.8 ppm) 
was bound to the former vinylic bond of the maleimide (39.12 ppm) after the reaction. To 
prove that the shift is not just due to oxidation of the phosphine, the phosphine was oxidized 
with hydrogen peroxide and analyzed (56.64 ppm). 
After the reaction between TCEP and maleimide a stable product was isolated. High 
resolution mass analysis was performed and the proposed reaction products and observed 
masses are illustrated in scheme 38. 
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Scheme 38: Reaction performed in H2O results in product 35, if performed in D2O the mass observed (a HR-ESI 
MS) is exactly associated with one deuterium incorporated at the reduced vinylic bond. 
 
As shown above TCEP does, against common belief, react with maleimides in a 1:1 ratio. For 
the modification of thiolated oligonucleotides with maleimides, TCEP should be removed 
from the reaction before addition of the maleimide or an excess of the dye over TCEP has to 
be applied. 
 
 
4.4 Conclusion 
 
The site-specific covalent labeling of oligonucleotides catalyzed by the Diels-Alderase 
ribozyme was demonstrated successfully in cis and in trans, showing high substrate 
specificity. Only maleimides with a C5-linkage between the maleimide and the fluorescent 
dye were tolerated as substrates, while for fluorescent maleimide dyes with a C2-linkage next 
to the dye no acceleration by the Diels-Alderase ribozyme was observed. Labeling with 
decent efficiencies was observed after 10 min with equimoar amounts of fluorescent dye. The 
synthesis of a C5-maleimidocaproic acid hydrazide dye could be accomplished. With this 
maleimide dye a decent labeling efficiency of 24% could be obtained. 
 
A dual orthogonal labeling strategy exploiting the substrate specificity of the Diels-Alderase 
ribozyme could not be achieved by employing two maleimide dyes with different linker 
lengths between the dye and the maleimide. For the modification of oligonucleotides with 
fluorescent dyes an excess of dye was required and thus the Diels-Alder background reaction 
of the anthracene with the C2-maleimide dye was too prominent. 
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Iodoacetamide showed no reactivity towards anthracene and could therefore be utilized to 
fluorescently label the thiolated functionality. In a second step anthracene could be labeled 
with a maleimide fluorescent dye to provide a bis-fluorescently labeled oligonucleotide. 
 
Notably, the labeling strategy employing the Diels-Alderase ribozyme is truely bioorthogonal. 
The modification of the thiolated oligonucleotide is basically also bioorthogonal, as long as it 
is studied with oligonucleotides. As mentioned earlier in the cell many thiol modifications are 
present. More importantly, in the labeling reaction providing the bis-fluorescently labeled 
oligonucleotide both reactions are orthogonal to each other, meaning that both reactions are 
independent. 
 
Valuable insight into the labeling of thiol modified oligonucleotides was gained investigating 
the reactivity of TCEP with maleimides. It was demonstrated that the reaction between TCEP 
and a maleimide leads to a stable product. This finding is important to improve post-synthetic 
modification of thiolated oligonucleotides as well as for other biomolecules. 
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5 Conclusion and Outlook 
 
The center piece of the presented work is a small ribozyme which catalyzes the Diels-Alder 
reaction between an anthracene and a maleimide with multiple turnover and high 
enantioselectivity.[93] In the course of this work, different approaches have been pursued 
successfully to explore and understand the complex mechanisms of function and action of the 
Diels-Alderase ribozyme. Furthermore, novel approaches for the enzymatic and chemical 
modification of oligonucleotides were developed. 
 
5.1 Synthesis and applications of novel initiator nucleotides 
 
The ability of the DNA-dependent T7 RNA polymerase to selectively incorporate modified 
guanosine monophosphates at the 5´-end can be used for the introduction of organic moieties 
into RNA during transcription. For the in vitro selection of ribozymes this technique is of 
utmost interest. The use of polydisperse polyethylene glycol linkers for the synthesis of 
modified guanosine monophosphates is more demanding than the synthesis of initiator 
nucleotides with monodisperse polyethylene glycol, but creates a library of different 
molecules. This is especially important for applications where the distance is critical.[230] 
In the work presented here, the routes and methods of polydisperse initiator nucleotide 
synthesis were considerably improved. A very clean and short synthetic route was established 
for the synthesis of polydisperse initiator nucleotides that contain an anthracene moiety. The 
synthesis could be achieved in only five steps by starting from the anthracene derivative and 
the TBDMS-protected guanosine monophosphate. Furthermore, the novel synthetic 
procedures established for the aldehyde modified initiator nucleotide present a superior 
synthetic strategy, only requiring three synthetic steps. 
Two key intermediates establish a vast variety of possibilities (scheme 39). One intermediate 
is the TBDMS-protected guanosine phosphoramidite. The other and even more relevant 
intermediate is the mono-tosylated polyethylene glycol, which may be used in a multitude of 
reactions that involve modified initiator nucleotides. It is reasonable to assume that the 
activation of such alcohols with tosyl enables the modification with virtually any organic 
moiety, because it can be reacted with any hard nucleophile in an SN2 reaction. 
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Scheme 39: Synthetic strategy for the preparation of a variety of initiator nucleotides. Tosylated polyethylene 
glycol represents the key intermediate to a vast number of possible organic modifications. 
 
The modification of RNA with an aldehyde is enormously versatile and can be used for 
simple post-synthetic modifications such as the reductive amination with a fluorophore or an 
anchoring group for the immobilization of RNA. Reductive amination can also provide a 
convenient method to introduce small molecules for the selection of aptamers.[231] In the past 
this approach has been utilized with amine modified oligonucleotides, possibly due to the lack 
of direct aldehyde modifications on RNA. The number and stability of small molecules 
bearing amino modifications available, further increases the versatility of the described 
aldehyde modifications. Furthermore, the initiator nucleotide presented here can be used as 
the basis for in vitro selections of many different ribozymes catalyzing diverse chemical 
reactions, for instance an aldol reaction or a Wittig reaction. 
The 5´-end modification of RNA was achieved co-transcriptionally by transcription priming 
using the enzyme T7 RNAP with initiator nucleotides containing a 2,3-dimethylanthracene or 
a benzaldehyde modification. For the transcription of a short DNA template full activity of T7 
Conclusion and Outlook 
 93
RNAP was observed in the presence of the initiator nucleotides. The initiator nucleotide 
bearing a 2,3-dimethylanthracene moiety was incorporated into a 109 nucleotide long RNA 
library that contained a randomized region, at a respectable incorporation rate of 77%, 
although diminished total yields were observed. The aldehyde modified initiator nucleotide 
was incorporated at a rate of 52%. Hydrophilic moieties are known to result in lower 
incorporation efficiencies than hydrophobic moieties,[140] which coincides with the results 
presented here, the anthracene-modification being more hydrophobic than the benzaldeyhde 
modification. 
The reactivity of the modified RNA molecules was subsequently studied in chemical 
reactions. While the anthracene derivative could be reacted in a Diels-Alder reaction, the 
aldehyde was fully converted in the reaction with biotinhydrazide. 
 
 
5.2 Thermal denaturation studies of the Diels-Alderase ribozyme 
 
Due to its complexity, it is necessary to utilize a combination of experimental methods to 
elucidate structure, folding and function of catalytic RNA. Thermal denaturation experiments 
were employed to determine the stability of secondary and tertiary structures. The wild-type 
as well as mutants of the Diels-Alderase ribozyme were investigated in thermal denaturation 
studies to complement other approaches such as X-ray crystallographic studies,[93] lead-
probing,[179] or smFRET.[175] The G-C rich structure of the Diels-Alderase ribozyme 
suggested a high melting temperature and indeed, it was not surprising that even low 
concentrations of divalent metal ions lead to a stabilization of the secondary structure up to 
85°C. 
G2
U17
C10
Mg5
 
Figure 39: Three dimensional structure of the Diels-Alderase ribozyme; the base triple. 
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Further insight into one of the complex interaction characteristic of the Diels-Alderase 
ribozyme was gained by investigating the thermal denaturation behaviour of two mutants 
when compared with the wild-type. The base triple G2–C10–U17 (figure 39) has been shown 
previously to be relevant for catalysis. A mutant 17UiC in which the H-bonding network is 
disrupted, was entirely inactive, while the 17UC mutant, that is still capable of forming the H-
bond, only showed a catalytic activity of 30% as compared to the wild-type.[178] In the thermal 
denaturation experiments, both the wild-type and the mutants were equally stabilized at a 
Mg2+ ion concentration up to 5 mM. At 5 mM ion concentration, a significant increase in 
stabilization of the wild-type was observed, while the mutants were not further stabilized. 
These results are in good agreement with previous studies and indicate that the mutants can 
fold and form the pseudoknotted structure but cannot undergo further compaction. In 
agreement with this, smFRET measurements had also shown that at an Mg2+ ion 
concentration of 5 mM the Diels-Alderase ribozyme molecule had adopted its fully folded 
structure.[175] 
 
 
5.3 Bioorthogonal and orthogonal labeling of oligonucleotides 
 
In the third part of this thesis, a novel application of the Diels-Alderase ribozyme is described 
in which the ribozyme is utilized as a catalyst for fluorescent labeling of oligonucleotides. 
In summary, the site-specific covalent labeling of oligonucleotides catalyzed by the Diels-
Alderase ribozyme was achieved and high substrate specificity was demonstrated. The 
structure of the active site of ribozyme allowed only for maleimides with a C5-linkage 
between the maleimide and the fluorescent dye to be used as substrates. Fluorescent 
maleimide dyes with a C2-linkage next to the dye were not recognized as substrates.  
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Scheme 40: C5-maleimidocaproic acid hydrazide and commercially available C2-maleimide. 
 
A strategy for the synthesis of fluorescent dyes with a C5-maleimidocaproic acid hydrazide 
linkage (scheme 40) was established that provides a route to better substrates than the 
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commercially available C5-maleimide dyes. An acceptable labeling efficiency of 24% could 
be achieved with this maleimide. It is noteworthy that so far only one attempt to utilize an 
anthracene as a diene for the Diels-Alder bioconjugation with fluorescent dyes has been 
reported and no conversion had been observed.[189] Moreover, it was reported that the Diels-
Alder bioconjugation can be very efficient, but is extremely dependent on the type of label 
and fluorescent dyes seemed to be the least efficient labels.[221, 222] 
Weisbrot and Marx recently expressed the need for a catalyst to improve the Diels-Alder 
cycloaddition as a tool for DNA bioconjugation.[200] Having demonstrated that the Diels-
Alderase ribozyme is able to catalyze the reaction between an anthracene tethered 
oligonucleotide and a fluorescent maleimide dye in trans, it would be an interesting task to 
extend this approach and conjugate anthracene-modified oligonucleotides to other labels, as 
well as other biomolecules, such as proteins and peptides. 
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Scheme 41: Illustration of the orthogonal labeling strategy for dual fluorescently labeled probes. 
 
In addition, a new method for labeling one DNA probe with two different fluorescent dyes 
was developed. An anthracene modification and a thiol modification within the same DNA 
strand were selectively labeled with two different fluorescent dyes (scheme 41). 
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It was demonstrated that an anthracene modified oligonucleotide does not react with 
iodoacetamide. However, the thiol group could selectively be modified and labeled with an 
iodoacetamide dye. In a second step the novel method to fluorescently label anthracene in a 
Diels-Alderase catalyzed reaction with fluorescent maleimide dyes was employed to provide a 
unique labeling strategy to dual fluorescent labeled probes. In conclusion, the two reactions 
are orthogonal to each other and provide a strategy for dual labeling of oligonucleotides with 
florescent probes. 
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6 Experimental section 
 
6.1 Molecular biological techniques 
 
6.1.1 General methods 
 
Fine chemicals for molecular biology and spectroscopic experiments were purchased in the 
highest commercially available purity. Water was purified by Mill-Q Synthesis A10 
(Millipore, Billerica, Massachusets, USA). All buffers and solutions were sterilized via 
steriflip® Milipore 22 μm filters. 
 
Gel electrophoretic methods 
 
Separation of nucleic acids via gel electrophoretic methods is based on the different migration 
of molecules with different charges and masses in an electrical field. The migration depends 
on the electric field and the connectivity of the gel matrix. As gel matrix commonly agarose 
and polyacrylamide is used. 
 
Agarose gels 
 
Agarose gel electrophoresis is a standard method for separation, identification and isolation of 
nucleic acids. By varying agarose concentration, gel pore size can be controlled to separate 
nucleic acids in a wide range of sizes. For special applications high resolution agarose, an 
intermediate melting agarose, is available for nucleic acids up to 1000 nt but with a resolution 
in the range of single base pairs. As DNA ladder GeneRuler™ Ultra Low Range and 100 bp 
DNA Ladder (Fermentas, St. Leon-Rot) were used. Nucleic acids have been separated on 2-
3% agarose gels, 1 x TBE buffer, during 25 min, with 120 V. For staining Ethidium bromide 
was added to the agarose gel during preparation, documentation was carried out on a 
AlphaImager (Alpha Innotech Corporation, San Leonardo). 
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Denaturing polyacrylamide gel electrophoresis (PAGE) 
 
PAGE has been used for detection and purification of nucleic acids. The denaturing 
conditions of PAGE analysis are mild and conserve secondary and tertiary structures of 
nucleic acids.  
Oligonucleotides have been separated on 8- 20% polyacrylamide gels. The gel solution has 
been prepared with Rotiphorese® Ready-to-Use Gel Solutions containing sequencing gel 
concentrate, sequencing gel diluent and sequencing gel buffer). After the addition of 
ammonium persulfate (APS (1% (w/v)), as a radical donator and N,N,N',N'-
tetramethylethylenediamine (TEMED (0.1% (v/v)) as catalyst for the formation of free 
radicals in the presence of ammonium persulfate and is thus used as an enhancer for the 
polymerisation. Vertical gels have been produced between two glass plates silanized with 2% 
dichlorodimethylsilane in chloroform. The layer thickness was 0.4 mm for analytical gels and 
1.0 mm for preparative gels. 
The conditions for the separation on PAGE gels varied depending on the percentage of the gel 
and the length of the oligonucleotides to be separated. Loading buffer (1 x TBE-buffer, 90% 
formamide) containing the two dyes xylenecyanol and bromphenol blue help monitoring the 
migration behavior of nucleic acids. Visualization of PAGE analysis was done by phosphor 
imaging (GE Healthcare, Munich), staining with SYBRGold or ethidium bromide and 
imaging with Typhoon (GE Healthcare, Munich) and UV shadowing and imaging by an 
AlphaImager (Alpha Innotech Corporation, San Leandro). 
For the analysis of fluorescent labeled oligonucleotides a loading buffer without xylenecyanol 
was used to reduce the background. Xylenecyanol has UV absorption of λmax 615 nm. 
Bromphenol blue was allowed to run out of the gel or cut off in the scan.  
 
Elution of nucleic acids from electrophoretic gels 
 
Elution of nucleic acids form either PAGE or agarose gels are based on diffusion. The desired 
nucleic acids had been excised from the gel, cut into as small pieces as possible. 500 µL 
ammonium acetate 0.5 M were added, mixed at 20°C and 650 rpm over night on a benchtop 
thermo shaker. The solutions were filtered over 45 µm Spin columns (Nanaosep® MF, PALL® 
Life Science, Darmstadt) to remove small gel pieces and the nucleic acids precipitated as 
described below. Alternatives are elution kits, e.g. MinElute PCR Purification Kit or RNeasy 
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MinElute Cleanup Kit (Qiagen, Hilden). Best elution efficiencies were achieved by elution 
with ammonium acetate. 
 
Precipitation of nucleic acids 
 
The method of choice for precipitation of nucleic acids depends on the size and the desired 
purity of the nucleic acids. 
 
Precipitation with ethanol or isopropanol 
After elution from the gel the nucleic acids in ammonium acetate (0.5 M) have been vortexed 
with a 2 fold excess of ice-cold ethanol or isopropanol and stored at -80°C for at least 30 min, 
or -20°C over night. The cold samples were centrifuged at -5°C, 13 000 rpm for at least 45 
min. E . coli tRNA (10 µg/µl) was used as a precipitation aid for very short oligonucleotides. 
The supernatant was removed and the pellet dried in a centrifugal vacuum concentrator.  
 
Precipitation with lithium perchlorate 
 
For short nucleic acids (10 to 25 nt) best yields have been observed by precipitation with 
lithium perchlorate. 
After elution from the gel the nucleic acids in ammonium acetate (0.5 M) have been vortexed 
with a 10 fold excess of a lithium 2% lithium perchlorate in acetone and centrifuged at r.t., 
10000 rpm for 40 min. The residual acetone was evaporated, the pellet dissolved in 20 µL 
water followed by desalinization on a NAP-5 column and removal of the water in a 
centrifugal vacuum concentrator. 
 
Purification of nucleic acids with organic solvents 
 
Separation of nucleic acids between organic solvents is an easy way to remove proteins from 
the reaction mixture. While nucleic acids remain in the water phase proteins separate into the 
organic phase. Phenol has a denaturing effect on the proteins while chloroform mostly helps 
to separate the organic phase from the aqueous phase. An equivalent volume 
phenol/chloroform (1:1) was added to the reaction mixture and votexed well. Separation of 
the two phases was accelerated by centrifugation at rt, 15000 rpm for 5 min (for Eppendorf 
tubes MIKRO 120, Hettich. Separation in Falcon or Greiner tubes in an Eppendorf centrifuge 
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5804 R at rt, 9000 rpm for 5 min). The organic layer was removed and the procedure repeated 
as described above. The aqueous layer was then transferred to a clean tube and the remaining 
phenol removed by diethyl ether extraction (centrifugation r.t., 15000 rpm for 5 min for 
Eppendorf tubes MIKRO 120, Hettich. Separation in Falcon or Greiner tubes in an Eppendorf 
centrifuge 5804 R at rt, 9000 rpm for 5 min). The organic layer was removed and the nucleic 
acids precipitated from the aqueous solution as described above. 
 
6.1.2 Detection of nucleic acids 
 
Autoradiography 
 
For detection and evaluation of radio labeled nucleic acids phosphor image screens (Imaging 
Screens, GE Healthcare, Munich) were used. The gels were wrapped into plastic foil, 
radioactive paper, used as markers and the imaging screens exposed in a X-ray cassette. 
Exposure time was dependent on the amount of radioactivity of the sample. For read out of 
the screens Typhoon 9400 (GE Healthcare, Munich) was used. The data was edited and 
quantified with ImageQuant 5.2 (GE Healthcare, Munich) and IQ Tools (GE Healthcare, 
Munich). 
 
Fluorescence detection 
 
Fluorescent labelled nucleic acids were analyzed with Typhoon 9400 (GE Healthcare, Munich). 
Typhoon 9400 provides 457/488/532/633 nm excitation, the different lasers are given in table 
7. The wavelength for imaging was tailored to the fluorescence spectra (excitation and 
emission) of the dyes. The data was edited and quantified with ImageQuant 5.2 (GE 
Healthcare, Munich), IQ Tools (GE Healthcare, Munich) or ImageJ 1.42q (National Institutes 
of Health, USA). 
 
Table 7: Lasers in Typhoon 9400.[232] 
Light Laser type Wavelength 
red 10 mW Helium neon laser 632.8 nm 
green 20 mW solid state doubled frequency SYAG laser 532 nm 
blue 30 mW argon ion laser 488 (20 mW), 547 nm (4 mW) 
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Staining 
 
Ethidium bromide staining was mostly used for detection of nucleic acids on agarose gels 
while for PAGE gel analysis SYBRGold staining was the method of choice. 
 
Ethidium bromide 
 
Ethidium bromide is an intercalating fluorescent reagent which changes its emission spectra 
after binding to nucleic acids and can easily be detected with UV light. Ethidium bromide was 
added to the agarose solution before casting the gels, 5 µL bromide solution (1%) per 100 mL 
2% agarose solution. Readout on AlphaImager (Alpha Innotech Corporation, San Leandro). 
 
SYBR®Gold 
 
SYBR®Gold nucleic acid gel stain is an unsymmetrical cyanine dye that exhibits fluorescence 
enhancement upon binding to nucleic acids. PAGE gels were stained by agitating in 1 x TBE 
buffer with 10-20 µL SYBR®Gold stock solution for 30 min. The fact that excitation maxima 
for the dye-nucleic acid complex is around 495 nm and the emission maxima at ~537 nm 
makes the Typhoon 9400 (GE Healthcare, Munich) the perfect readout. Images were recorded 
at 488 nm. 
 
UV-shadowing 
 
UV-shadowing allows the detection of nucleic acids without any treatment; however large 
amounts (> 1.0 nmol) of nucleic acids are necessary as compared to above mentioned 
methods. The gels were covered in plastic and placed on fluorescent TLC plates. Exposed to 
UV light (254 nm) the oligonucleotides quench the fluorescence and are visible as dark 
shadows. Documentation of the readout can be carried out with the AlphaImager (Alpha 
Innotech Corporation, San Leandro). 
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6.1.3 Determining the concentration of nucleic acids 
 
Photometric determination 
 
Concentrations of oligonucleotides were determined by UV measurements on a Nanodrop 
ND-1000 (PeqLab, Erlangen). For nucleic acid quantification, the Beer-Lambert equation is 
modified to use an extinction coefficient with units of ng-cm/ml. Using this extinction 
coefficient gives a manipulated equation:  c = (A * e)/b 
c: (nucleic acid concentration [ng/µL]), A: (absorbance in AU), e (wavelength-dependent 
extinction coefficient in [ng-cm/µL]), b: (path length [cm]).  
The generally accepted extinction coefficients for nucleic acids are: 
dsDNA: 50 ng-cm/ul 
ssDNA: 33 ng-cm/ul 
RNA: 40 ng-cm/ul  
To asses the purity of DNA and RNA the ratio of absorbance at 260 nm (λmax nucleic acids) 
and 280 nm (λmax proteins) is used. A ratio of ~1.8 is generally accepted as “pure” for DNA; a 
ratio of ~2.0 is generally accepted as pure for RNA. If the ratio is appreciably lower in either 
case, it may indicate the presence of protein, phenol or other contaminants that absorb 
strongly at or near 280 nm.[233] 
 
Amount radio labeled nucleic acids 
 
The amount of RNA transcribed via T7 RNAP with [α -32P] could be determined after PAGE 
purification and precipitation. An aliquot typically of 1 µL was taken from the reaction 
mixture and the radioactivity determined by Cerenkov-counting (LS 6500, Beckman Coulter, 
Krefeld). The concentration could be determined by the following equation. 
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6.1.4 Radioactive labeling with 32Phosphor 
 
5´-labeling via kinase reaction 
 
The enzyme T4 Polynucleotide kinase, short T4 PNK, catalyzes the transfer of the γ-
phosphate from ATP to the 5’-OH group of oligonucleotides or nucleoside 3’-
monophosphates.[234] The reaction was incubated on a thermo shaker at 37°C for 30 min. 
PAGE purified, eluted and precipitated as described. 
 
Table 8: 5´-Labeling of oligonucleotides with [γ-32P]-ATP. 
Chemicals Volume [µL] Final
Oligonucleotide  1 0.1 nmol
Buffer A 10x  2 1 x
[γ-32P]-ATP  3
T4 PNK 10 U/µL  1 10 U
H2O 13
Σ 20
 
Radioactive labeling via ligation 
 
The enzyme T4-RNA-ligase catalyzes the esterification of a RNA 3´-hydroxyl group with a 
5´-phosphate group of another molecule (RNA or ribonucleotide) in the presence of ATP.[235] 
The 3´-prime end of RNA was labeled with Cytidin-3´-(5´-32P)-bis-phosphat [32P]-pCp.[236] 
The reaction was incubated in a thermo mixer at 16°C for 20 h, purified on a 20% PAGE as 
described. After elution the labeled RNA was precipitated with 100 µL E. coli tRNA (10 
µg/µl) as a precipitation aid and centrifuged over night (13000 rpm, -5°C). Interestingly DNA 
could also be labeled according to the same protocol. 
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Table 9: 3´-Labeling of RNA with [32P]-pCp. 
Substance Volume [µL] Final
Oligonucleotide 10 µM  2 20 pmol
Ligation buffer for T4 RNA ligase  2 yx
ATP 10 mM  1 0.5 mM
[32P]-pCp 10 100 µCi
T4 RNA ligase 10 U/µL  2 20 U
DMSO  2 10% (v/v)
H2O  1
Σ 20  
 
6.1.5 PCR (Polymerase Chain Reaction) 
 
PCR is an in vitro method for the exponential amplification of DNA sequences. 
GenTherm Taq Polymerase, buffer (10x, without MgCl2), MgCl2 and dNTP solutions (100 
mM) were purchased from Rapidozym (Rapidozym, Berlin, Germany). GenTherm DNA-
Polymerase, is an recombinant 5‘-3‘-DNA-polymerase, originally from Thermus acquaticus, 
expressed in E. coli without 3‘-, 5‘-exonuklease activity. Primer A and primer B were 
synthesized by IBA (Göttingen, Germany). 
 
Table 10: Protocol for analytical PCR. 
Chemicals Volume [µL]  Final  Step Temperature [°C] Time [min:sec]
PCR buffer (10x) 20 1x 1 94 5:00
dsDNA pool (10 µM) 0.4 0.02 µM 2 92 1:00
MgCl2 (50 mM) 16.0 4 mM 3 54 1:00
dNTP Mix (25 mM) 1.6 0.2 mM 4 72 1:30
Primer B (100 µM) 3.0 1.5 µM 5 5 times to step 2   
Pimer A (100 µM) 3.0 1.5 µM 6 72 8:30
Taq polymerase 4 0.1 U/µL 7 End 
H2O 152 -    
Σ 200      
 
Analysis of analytical PCR reaction products was performed on agarose gels, purification 
either with QIAquick PCR Purification Kit (Quiagen, Hilden) or via preparative PAGE. 
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Preparative scale PCR 
 
Table 11: Protocol fro preparative PCR. Volumes for a master mix. 
Chemicals Volume [mL]  Final  Step Temperature [°C] Time [min:sec]
PCR buffer (10x) 1.920 1x 1 92 03:00
ssDNA pool (14.2 µM) 0.261 0.2 µM 2 92 02:00
MgCl2 (50 mM) 1.536 4 mM 3 54 06:00
dNTP Mix (25 mM) 0.150 0.2 mM 4 72 10:00
Primer B (100 µM) 2.88 15 µM 5 5 times to step 2  
Pimer A (100 µM) 1.920 10 µM 6 End 
Taq polymerase 10.159 0.1 U/µL  
H2O 8.0832 -       
Σ 19.200       
 
The master mix for the preparative PCR was prepared in three 50 µL Falcon tubes each 
containing 19.2 mL master mix. All compounds were added, except the Taq polymerase and 
the DNA template, and the master mix was kept on ice. Taq polymerase and the template 
were added right before partitioning the reaction into 200 µL batches in a 96 well plate. The 
master mix was transferred into reservoirs and with a multi channel pipette transferred into a 
96 well plate. Purification of the PCR products from the preparative scale reaction were 
purified by phenol extraction. 
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6.1.6 Primer extension 
 
Primer extension is used to asses how much of an ssDNA pool is amplified to full length 
product. The primer B was labeled with [γ-32P] ATP at its 5' end. The reaction was analyzed 
on a 12% PAGE. 
 
Table 12: Protocol for primer extension. 
Chemicals Volume [µL] Final
PCR buffer 10x 10.0 1x
32P labeled primer B (31 µM) 1.0 0.25 µM
primer B (100 µM) 1.0 0.6 µM
ssDNA template (76.9 µM) 1.0 1 µM
MgCl2 (50 mM) 8.0 4 mM
dNTPs (each 100 mM) 1.0 of each dNTP 10 µM
Taq DNA polymerase (0.1 U/µL) 2.0
H2O 73.0
Σ 100
 
Table 13: Temperature protocol for primer extension in a single PCR cycle. 
Temperature [°C] Time [min] 
94 4:00 
50 60:00 
End  
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6.1.7 In vitro T7 transcription 
 
T7 RNA polymerase utilizes the transcription of dsDNA templates into the complementary 
RNA sequence. The enzyme was isolated from E. coli BL21 (DE3) cells with a cloned gene 
encoding T7 RNA polymerase.[156] 
 
Table 14: Standard protocol T7 transcription. 
Chemicals Volume [µL] Final 
Transcription buffer (10x) 5.0 1x
GTP (25 mM) 0.7 0.35 mM
ATP (100 µM) 2.0 4 mM
CTP (100 µM) 2.0 4 mM
UTP (100 µM) 2.0 4 mM
Template (2 µM) 5.0 0.2 µM  
Initiator nucleotide (17.2 mM) 11.8 4 mM
DTT (100 mM) 5.0 10 mM
BSA (1 mg/ml) 2.0 50 µg/mL 
[α -32P] CTP (10 µCi/µL) 2.0
T7 RNA polymerase 1.25
H2O 11.25
Σ 50
 
After preparing the reaction mixture an aliquot of 1 µL was taken and stored aside to later be 
able to determine the concentration of the transcript. The transcription was incubated at 37°C 
for 2-4 h in a water bath. After 2 h more enzyme was added and incubated for another 2 h at 
37°C. The transcription was stopped by the addition of loading dye (1 x TBE-buffer, 90% 
formamide, xylenecyanol and bromphenol blue) and either directly loaded on a gel or stored 
at -80°C. 
During the optimization of the T7 transcription all substances were varied, except the buffer, 
BSA and DTT. Additionally in some cases a so called booster mix was added after 2 h and 
incubated for other 2 h. 
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Table 15: Booster mix for a T7 transcription of 50 µL. 
Chemicals Volume [µL] 
Transcription buffer (10x) 4.0
GTP (25 mM) 0.35
ATP (100 µM) 1.0
CTP (100 µM) 1.0
UTP (100 µM) 1.0
Initiator nucleotide (17.2 mM) 5.9
T7 RNA polymerase 1.25
 
 
Table 16: MALDI-TOF mass analysis for transcribed RNA with initiator nucleotide. 
 nPEG Calculated [M+H]+ Found 
Transcript = 5’-GG AGC UCA 
GCC UAC GAG CCU GAG CC-3’ 8249 8254 
    
Conjugate  9 8704 8706 
10 8748 8750 
11 8792 8794 
12 8836 8839 
13 8880 8883 
O
O
nPEG
RNA
 14 8924 8931 
 
6.1.8 Diels-Alder reaction of the 2,3 dimethyl anthracene modified RNA 
 
Initiator nucleotide 7b was incorporated during T7 RNAP transcription. The purified 
conjugate (20 pmol) was dissolved in water and PBS buffer and biotin maleimide was added 
in a 10 respectively 1000 fold excess. The reaction was incubated in a thermo shaker over 
night at 25°C and 650 rpm and directly loaded on a 20% PAGE. 
 
6.1.9 Deprotection of the aldehyde modified RNA and reaction with hydrazide 
 
Initiator nucleotide 7c was incorporated during T7 RNAP transcription. The purified 
conjugate (20 pmol) was dissolved in water and the aldehyde functionality deprotected by 
treatment with 2% trifluroacetic acid in water for 10 min at r.t., leaving the RNA entirely 
intact. The reaction was quenched by the addition of 3.6 µL 1 M NaHCO3 solution. 2.67 µL 
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0.4 M sodium acetate buffer were added to adjust the pH to 5.5. Biotin hydrazide was added 
in a 1000 fold excess and the reaction incubated for 4 h at r.t on a thermo shaker at 750 rpm. 
The RNA was precipitated to remove the biotin hydrazide excess by lithium perchlorate 
precipitation and analyzed on a 12% PAGE. 
 
6.1.10 Melting curves 
 
Thermal denaturation experiments of nucleic acids are an important method to observe 
temperature dependent conformational changes. Heating of and molecule leads to a change in 
absorbance and therefore reflects the conformational change. 
Melting experiments are used to determine the hybridization between oligonucleotides or 
different regions within an oligonucleotide and are therefore valuable in primer design. 
Further secondary and even tertiary structure of DNA and RNA molecules and it may also be 
used to study the binding of specific targets to oligonucleotides. 
 
RNA solutions were prepared by mixing the RNA stock solution in buffer and the addition of 
magnesium chloride and/ or sodium chloride solutions respectively EDTA was added. The 
concentration of the RNA was adjusted to an OD of 0.5. In general the OD range should be 
between 0.3 and 0.6. For the Diels-Alderase ribozyme this is equivalent to ~ 10 µg of RNA. 
After addition of all components the solutions were degassed in an ultrasonic bath for 10 
minutes. The samples were transferred into Teflon-stoppered quartz cuvettes and dependent 
on the attempted maximum temperature sealed with additional Teflon tape. All samples were 
overlaid with 2-3 mm silicon oil to prevent evaporation of the buffer. 
As a buffers sodium cacodylate 25 mM (magnesium phosphate 25 mM or MOPS 25 mM) 
adjusted to a pH of 7.0 were used. 
Melting curves were recorded at 260 nm with a Cary 100 Bio-UV7Vis Spectrometer (Varian, 
Darmstadt) and cuvettes (Cary UV MICRO CELL 0.9 mL, Varian, Darmstadt (cuvettes 
produced by Starna) with a path length of 10 mm. UV absorption was recorded as a function 
of the temperature. First the samples were heated with a heating rate of 5°C/min and kept at 
maximum and minimum temperature for 5 minutes to ensure proper folding with the present 
cations. For the analysis the RNA samples were then heated at a rate of 0.5°C/min from 15-
95°C (or 15-65°C) and absorbance readings were collected every 0.1°C. The data for 
denaturation (15-95°C) were collected as well as the data for renaturation (95-15°C). This 
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process was repeated twice. If no degradation of the oligonucleotides takes place the first and 
second recording can exactly be overlaid.  
 
The data was analyzed with MS Excel according to the following procedure 
I. The ordinate scales of the curves were normalized to concentrations of 1 A260 unit 
 at 15°C. 
II. The normalized absorbance data was smoothed using the moving average over 10 data 
 points. 
III. First derivative of the absorbance versus temperature data (dA/dT) were obtained and 
 Tm was determined as the maximum of the first derivative. 
 
During the entire measurement the sample changer was purged with nitrogen gas to avoid 
water condensation in the machine or on the cuvettes. 
Optical density (OD) = log10 (Ii / It) where Ii = Intensity of incident light, It = Intensity of 
transmitted light. One OD unit (ODU) (sometimes also called AU (absorption unit)) is 
defined as the amount of sample that gives an UV absorbance at 260 nm of 1, if the sample is 
dissolved in 1 mL volume and measured in a cuvette with a path length of 1 cm.  
 
6.1.11 Automated solid-phase synthesis of oligonucleotides 
 
Solid phase DNA and RNA synthesis was performed on an Expedite 8909 automated 
synthesizer by Applied Biosystems. The synthesis was performed using standard 
phosphoramidite chemistry.[237, 238] 
 
As a solid support dC CPG (t-butylphenoxyacetyl, TAC controlled pore glass) (40 μmol/g, 
500 Å) and β-cyanoethyl-phosphoramidites containing base-labile TAC-protecting groups 
were purchased from Proligo. For modification at the 5´-end modified polyenglykol-β-
cyanoethylphosphoramidites were prepared (see synthetic procedures).  
The 2’-hydroxyl group was protected as a t-butyldimethylsilylether. Standard reagents 
employed in DNA solid-phase synthesis (deblocking reagent - dichloroacetic acid in DCM, 
activator - dicyanoimidazole, oxidizing reagent - iodine in THF/H2O, and capping reagent t-
butyl-phenoxyacetanhydride in acetonitrile), as well as acetonitrile (water content ≤10 ppm) 
were purchased from Proligo and Sigma Aldrich Fine Chemicals. 
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Solid-phase synthesis of ODNs was performed on 1 μmol scale synthesis, usually leaving the 
terminal 4,4’-dimethoxytrityl (DMT) group on. The phosphoramidites were used prepared as 
0.067 M (DNA monomers), and 0.1 M (RNA monomer) acetonitrile solutions over activated 
molecular sieve. The standard protocols provided by Applied Biosystems were optimized to 
reduce the consumption of the amidites and reduce the time fort he coupling. 
 
The Oligonucleotides were cleaved of the solid support by incubation in ammonia at 55°C 
over night. The solid support was washed with EtOH (3x500 µL), the combined aqueous and 
ethanol containing solution was extracted with chloroform (3x1 mL) and evaporated on the 
lyophilizer. Oligonucleotides were dissolved in 1 mL Millipore water and the modification 
rate was determined by integration of the HPLC spectra. For purification the oligonucleotides 
were filtered through a 0.22 µM membrane filter, purified by preparative HPLC, collected, 
lyophilized and diluted again in water. The integrity of the oligonucleotides was determined 
by analytical HPLC and mass spectrometry. 
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Table 17: Protocol for 1 µmol scale solid-phase DNA/ RNA synthesis (Adenosine (dA/ rA) cycle).[a] 
step Function mode[b] amount [puls] time [s] description 
Deblocking 144 /*Index Fract. Coll NA 1 0 "Event out ON“ 
 0 /*Default WAIT 0 1.5 "Wait“ 
 38 /*Diverted Wsh A PULSE 15 0 "Flush system with Wsh A“ 
 141 /*Trityl Mon. On/Off NA 1 1 "START data collection” 
 16 /*Dblk PULSE 20 0 "Dblk to column” 
 0 /*Default WAIT 0 20 "Default” 
 16 /*Dblk PULSE 40 40 "Deblock” 
 38 /*Diverted Wsh A PULSE 60 0 "Flush system with Wsh A“ 
 141 /*Trityl Mon. On/Off NA 0 1 "STOP data collection” 
 38 /*Diverted Wsh A PULSE 20 0 "Flush system with Wsh A“ 
 144 /*Index Fract. Coll. NA 2 0 "Event out OFF” 
Coupling 1 /*Wsh PULSE 8 0 "Flush system with Wsh A“ 
 2 /*Act PULSE 5 0 " Flush system with Act“ 
 19 /*C + Act PULSE 5 0 "Monomer + Act to column” 
 19 /*C + Act PULSE 3 24 "Couple monomer” 
 2 /*Act PULSE 3 24 "Couple monomer” 
 19 /*C + Act PULSE 2 16 "Couple monomer” 
 2 /*Act PULSE 3 24 "Couple monomer” 
 0 /*Default WAIT 0 20 "Default” 
 1 /*Wsh PULSE 7 56 "Couple monomer” 
 1 /*Wsh PULSE 21 0 "Flush system with Wsh A“ 
Capping 12 /*Wsh A PULSE 20 0 "Flush system with Wsh A“ 
 13 /*Caps PULSE 8 0 "Caps to column” 
 12 /*Wsh A PULSE 9 23 "Cap” 
 12 /*Wsh A PULSE 21 0 "Flush system with Wsh A“ 
Oxidizing 15 /*Ox PULSE 35 0 "Ox to column” 
 0 /*Default WAIT 0 20 "Default” 
 12 /*Wsh A PULSE 60 0 "Flush system with Wsh A“ 
Capping 13 /*Caps PULSE 7 0 "Caps to column” 
 12 /*Wsh A PULSE 45 0 "End of cycle Wash” 
[a] Debloking reagent = dblk, acetonitrile = Wsh, WshA, activator = Act, capping regents = Caps, oxidizer = Ox. 
[b] 1 PULSE = 16 µL. 
 
6.1.12 High-performance liquid chromatography of oligonucleotides 
 
HPLC analyses were performed on an Agilent 1100 Series HPLC system equipped with an 
diode array detector using a Phenomenex® Luna 5 μm C18 column (4.6 × 250 mm) and 
eluting with a gradient of buffer A and buffer B at 1 mL/min flow-rate. Preparative HPLC 
was performed using Phenomenex® Luna 5 μm C18 column (15.0 × 250 mm) and eluting 
with a gradient of buffer A and buffer B at 5 mL/min flow-rate. 
The following gradient was used: 
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Gradient O1:      Gradient O2: 
 
 
 
 
 
 
 
6.1.13 Mass spectrometry of oligonucleotides 
 
Sample preparation 
 
Oligonucleotides were either dissolved in 10 µM water or in 0.1 M TEAA pH 7.0 to a final 
concentration of 10 µM (100 pmol) and desalted using Millipore C18 ZipTips. The C18 resin 
was first wetted by using 50% aqueous acetonitrile solution (2 x 10 μL) and then equilibrated 
with 0.1 M TEAA pH 7.0 (3 x 10 μL). The oligonucleotide was bound to the resin letting the 
entire 10 µL sample solution pass through the resin in the filter tip (10 x). The salts were 
removed by washing the resin first with water (3 x 10 μL) and 0.1 M TEAA pH 7.0 (3 x 10 
μL). A clean vial with 4 µL of 50% acetonitrile/water was used to elute the oligonucleotides 
by aspirating and dispensing the solution (5-10 x). 
 
 
MALDI TOF mass analysis 
 
The samples for analysis were prepared using the dried droplet method with the following 
matrix solutions: 1) 6-aza-2-thiothymine/ diammonium hydrogen citrate in 1:2 v/v water/ 
acetonitrile (detection in negative mode); 2) 3-hydroxy-picolinic acid/ diammonium hydrogen 
citrate in 2:1 v/v water/ acetonitrile (detection in positive mode). 
 
HR-ESI MS analysis 
 
HR-ESI mass spectra were recorded in the negative mode on a Bruker MicroTOF-QII. The 
samples were diluted 1:5 in 25mM piperidine/ imidazole (25% Water / 75% ACN). The 
oligonucleotide solutions were introduced into the ion source with a syringe pump at flow 
rates of 3 to 4 μL/min. For each measurement, up to 128 scans were averaged to improve the 
Time [min] Buffer B [%]  Time [min] Buffer B [%] 
0 10  0 0 
10 10  15 30 
30 30  30 100 
45 100  35 100 
50 100  40 0 
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signal-to-noise ratio. Data processing was performed using the software DataAnalysis 4.0 
SP1. 
 
6.1.14 Fluorescent dyes 
 
All dyes have been purchased from Invitrogen Life Technologies (Carlsbad, California, 
USA), Atto-Tec (Siegen, Germany) or Dyomics (Jena, Germany). DY 649 Hydrazide 
maleimide has been synthesized from the commercially available Dyomics DY 649 NHS 
ester and maleimido caproic acid hydrazide, after HPLC purification a stock solution was 
prepared in EtOH and stored at -20°C. Commercially available dyes have been used without 
further purification. All dyes were diluted in DMSO and the stock solution was always stored 
at -20°C in their original vial but protected from light with aluminium or optically opaque 
boxes. Dilutions were always stored in dark brown reaction vials. For iodoaetamides DMSO 
should be avoided, because iodoacetamides might get oxidized in DMSO. Therefore the Atto 
590 iodoacetamide stock solution was dissolved in anhydrous DMF. 
BODIPY TMR C5-maleimide and Atto 532 maleimide are poorly soluble in water, while Atto 
590 iodoacetamide is absolutely insoluble in water or any type of buffer. Alexa Fluor® 532 
C5-maleimide and all applied Dyomics dyes are extremely well soluble in water respectively 
aqueous buffer systems. 
Absorption and emission maxima were determined in either ethanol or methanol and are 
consistent with the data provided by the supplier. Concentrations were determined by the 
dilution in a defined volume and validated via dilution in ethanol and UV-measurement. The 
concentrations were then calculated via the Lambert-Beer law 
 
A: absorption; c: concentration; d: thickness of the measuring cell; ε: extinction coefficient. 
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Table 18: Data of all flourescent dyes. 
Name Structure λabs 
[nm]
λem 
[nm] 
ε 
[M-1cm-1]
FW 
[g mol-1] 
 
invitrogen 
Alexa Fluor® 
532 C5-
maleimide 
 
 
 
 
528 
 
552 
 
78000 
812.88 
 
found: 
791.18 
 
invitrogen 
BODIPY® TMR 
C5-maleimide 
 
 
 
 
544 
 
570 
 
60000 
 
562.42 
 
Dy-649 hydrazide 
maleimide 
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3 Na
 
 
653 
 
676 
 
250000 
 
1049.20 
 
found 
1049.25 
 
ATTO-TEC 
Atto 532 
maleimide 
 
Exact structure not revealed due to a pending patent. 
 
 
 
532 
 
553 
 
115000 
 
1063 
 
found 
768.14 
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Name Structure λabs 
[nm]
λem 
[nm] 
ε 
[M-1cm-1]
FW 
[g mol-1] 
 
Dyomics 
Dy-547 
maleimide 
 
 
 
 
557 
 
574 
 
150000 
 
761.23 
 
Dyomics 
Dy-649 
maleimide 
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1032.16 
 
ATTO-TEC 
Atto 590 
iodoacetamide 
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O
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594 
 
624 
 
120000 
 
970 
 
found 
857.25 
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6.1.15 Flourescent labeling reactions of oligonucleotides 
 
All labeling reactions were performed in Eppendorf tubes. Before starting the reaction the 
solution was vortexed and started by the addition of the respective dye and incubated on a 
thermo shaker at 650 rpm. The excess of dye was removed with DyeEx™ (Qiagen) according 
to the provided protocol. If the reactions were not directly purified by DyeEx the reaction was 
stopped by the addition of stop-mix. All reactions were analyzed on an 18% PAGE, using a 
loading buffer without xylencyanol to lower the fluorescent background signal. The gels were 
analyzed by scanning for autoradiography and fluorescence at the corresponding wavelength 
and subsequently stained with SYBR Gold and scanned again. Data was processed with 
ImageQuant or ImageJ. 
 
Labeling protocol in the dipartite Diels-Alderase assay 
 
For the Diels-Alder reaction catalyzed in cis the 38mer and the 11mer RNA anthracene-
conjugate were hybridized in a ratio of 1:2. The strands were heated at 65°C in buffer without 
MgCl2 for 2 min, MgCl2 was added and slowly cooled to r.t. to ensure hybridization and 
folding of the two strands. The reaction was incubated at 25°C for 30 min.  
 
Table 19: Protocol for fluorescent labeling of oligonucleotides via the dipartite Diels-Alderase assay. 
Chemicals Volume [µL] Final
Diels-Alder buffer (5 x) 2.0 1 x
38mer (2.5 µM) 0.8 0.2 µM
11mer AHEG (1 µM) 1.0 0.1 µM
11mer AHEG α32-pCp labeled 1.0 doped
Dye (500 µM) 1.0 50 µM
MgCl2 (800 mM) 1.0 80 mM
H2O 3.2
Σ 10
 
Labeling protocol monopartite Diels-Alderase assay 
 
For the catalyzed Diels-Alder reaction in trans the Diels-Alderase ribozyme was heated at 
65°C in buffer without MgCl2 for 2 min, MgCl2 was added and slowly cooled to r.t.. The 
reaction was incubated at 25°C for 30 min up to 2 h. 
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Table 20: Protocol for fluorescent labeling of oligonucleotides via monopartite Diels-Alderase assay. 
Chemicals Volume [µL] Final
Diels-Alder buffer (5 x) 4.0 1 x
ODN (100 µM) 10.0 50 µM
Diels-Alderase (70 µM) 2.0 7 µM
Dye (2 mM) 0.5 50 µM
MgCl2 (800 mM) 2.0 80 mM
H2O 1.5
Σ 20
 
Labeling of thiol modified oligonucleotides with maleimide dyes or iodoacetamide dyes 
 
Thiol modified oligonucleotides have to be treated with a reduction reagent beforehand the 
actual labeling reaction. The reaction mixture was incubated with TCEP for 30 min to 1 h at 
25°C and 650 rpm on a thermo shaker. After addition of the dye the reaction was incubated at 
25°C for 2 h or at 4°C over night. 
Atto 580 iodoacetamide is insoluble in water and therefore 20% EtOH had to be added during 
the reaction. 
 
Table 21: Protocol for fluorescent labeling of thiolated oligonucleotides. 
Chemicals Volume [µL] Final
Tris buffer pH 7.2 (5x) or  
Diels-Alder buffer (5x) 4.0 1 x
ODN (100 µM) 10.0 50 µM
TECP (2 mM) 1.0 100 µM
Dye (20 mM) 1.0 1 mM
H2O 4.0
Σ 20
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Bioorthogonal bi-functionalization of oligonucleotides with two fluorescent dyes 
 
The oligonucleotide was incubated with TCEP for 30 min to 1 h at 25°C and 650 rpm on a 
thermo shaker. After addition of the iodoacetamide dye the reaction was incubated at 25°C for 
2 h or at 4°C over night. Due to the insolubility of the iodoacetamide dye EtOH was added 
but evaporated before Diels-Alderase ribozyme catalyzed labeling with the maleimide dye. 
 
Table 22: Protocol for the bis-functionalization of oligonucleotides with two different fluorescent dyes. 
Chemicals Volume [µL] Final
Tris buffer pH 7.2 (5x) or  
Diels-Alder buffer (5x) 4.0 1 x
ODN (100 µM) 10.0 50 µM
TECP (2 mM) 1.0 100 µM
Iodoacetamide dye (20 mM) 1.0 1 mM
Maleimide dye (2 mM) 0.5 50 µM
Diels-Alderase (140 µM) 1.0 7 µM
MgCl2 (800 mM) 2.0 80 mM
H2O 0.5
Σ 20
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6.2 Synthetic procedures 
 
6.2.1 General 
 
All reagents were purchased from Sigma-Aldrich, Acros, AlfaAesar, ABCR and AppliChem 
and were, unless indicated otherwise, used without further purification. 
Acid free dichloromethane was obtained by storing the solvent on K2CO3 for at least one 
night. Reactions with air-sensitive compounds were performed under argon atmosphere using 
standard Schlenk techniques. 
TLC was carried out on silica gel plates Polygram Sil G/UV254 (40 × 80 mm) from Macherey-
Nagel, Düren. Compounds were made visible by using UV light at 254 nm, or staining 
reagents a) blue shift (0.1 g Ce(SO4), 2.1 g phosphomolybdic acid, 50 mL H2O, 3.1 mL conc. 
H2SO4), b) Potassium Permanganate (1 g KMnO4, 2.5 g K2CO3 in 50 mL H2O), c) DNPH (1 
g 1-(2,4-dinitrophenyl)hydrazine, 25 mL ethanol, 8 mL H2O, 5 mL conc. H2SO4) d) ninhydrin 
(15 g ninhydrin, 0.15 mL acetic acid, 50 mL ethanol), e) vanillin (3 g vanillin, 0.75 mL conc. 
H2SO4, 50 mL ethanol). 
Flash chromatography was carried out on silica gel 40-63 μm from J.T. Baker. Preperative 
reverse phase colum chromatography was carried out on LiChroprep RP – 18 (40–63 µm) 
columns using a mechanical pump. Alternatively an IntelliFlash 310 chromatography system 
from Varian, Darmstadt was used with columns from Varian: SuperFlash C18, 18% carbon, 
end capped on 50 μm particles,  
NMR spectra were recorded on a Varian Mercury Plus 300 MHz spectrometer. 1H and 
13C{1H} NMR spectra were calibrated to TMS on the basis of the relative chemical shift of 
the solvent as an internal standard. 31P{1H} NMR spectra were calibrated to an external 
standard (85% H3PO4). Abbreviations used are as follows: s = singlet, d = doublet, t = triplet, 
m= multiplet. 
Infrared spectroscopy was carried out a Bruker EQUINOX 55, the absorption is measured in 
cm-1 and the intensities indicated as follows: s = strong, m = medium, b = broad. 
FAB and EI mass spectra were recorded on a JEOL JMS-700 sector field mass spectrometer. 
MALDI-TOF mass spectra were recorded on a Bruker BIFLEX III spectrometer. 
HR-ESI mass spectra were recorded on a Bruker MicroTOF-Q II spectrometer. 
Melting points, if determined, were measured on a Reichert Jung Model No. 561C-H1. 
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6.3 Synthetic procedures for compounds of chapter 2 
 
6.3.1 Synthetic procedures of the initiator nucleotides 
 
2,3-Dimethylanthracen (9) 
 
 
 
2,3-Dimethyl-9,10-anthraquinone (502 mg, 2.12 mmol) was suspended in 7 mL H2O and 10 
mL 25% NH3 (aq.) in an 150 mL autoclave. The suspension was cooled down in an ice/water 
bath and granular zinc (4.0 g, 61.2 mmol, 28.9 eq.) was added slowly. The autoclave was 
closed and the reaction was slowly allowed to warm up and later heated at 75°C for 23 h. The 
reaction was followed by TLC, turning from yellow to red and was then diluted with DCM 
(50 mL) and water (50 mL). The organic layer was decanted from the solid zinc. The aqueous 
layer was extracted with DCM (2 x 30 mL) and the combined organic layers were dried over 
MgSO4. The solvent was removed under reduced pressure to yield a yellow solid. The product 
was diluted in isopropanol (20 mL), conc. HCl (2.0 mL) was added and heated at 95°C for 4 
h. The reaction mixture was cooled to r.t. and stored at -20°C to crystallize the crude product. 
The product was purified by column chromatography (Hex : EtOAc 98 : 2, Rf = 0.37) on 
silica and again recrystallized from n-hexane to afford a yellow solid (120.3 mg, 28%). 
 
C16H14 (206.28 g mol-1). 
m.p. 202-210 °C. 
1H NMR (300 MHz, CDCl3, 295 K): δ = 8.28 (s, 2H, Ar-H), 7.96 (dd, 2H, J (H,H) = 3.17 Hz, 
J (H,H)= 3.39 Hz, Ar-H), 7.65 (s, 2H, Ar-H), 7.37 (dd, 2H, J (H,H), 3.29 J (H,H)= 3.20 Hz, 
Ar-H), 2.29 (s, 6H, CH3). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 135.55 (2C, Ar-CH3), 131.33 (2C, Ar-H), 
131.13 (2C, Ar-H), 128.06 (2C, Ar-C), 126.91 (2C, Ar-C), 124.76 (4C, Ar-H), 20.42 (2C, 
CH3). 
IR (KBr): ( = 2932 (s), 1629 (s), 1456 (s), 899 (s). 
MS (FAB) m/z (rel. Int. %): 207 (M+1) (5), 206 (15), 154 (100), 138 (30), 136 (74), 120 (12), 
107 (26), 102 (22), 89 (24), 77 (26). 
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2,3-dimethylanthracene-9-carbaldehyde (10) 
 
 
 
In a Schlenk flask under argon were dissolved 2,3-dimethylanthracen 9 (488.5 mg, 2.7 mmol) 
in 10 mL dry DMF. The solution was cooled to 0ºC with an ice/water bath, and 
phosphorus(V) oxychloride (2.2 mL, 23.4 mmol) added dropwise to give a yellow suspension. 
The reaction mixture was allowed to warm up and heated at 95°C for 20 h. The mixture was 
basified by the addition of NH3 (aq.) and DCM was added (400 mL). The aqueous layer was 
extracted with DCM (2 x 30 mL) and the organic layer was washed with brine (2 x 30 mL) 
and H2O (2 x 50 mL). The organic extracts were combined, dried over MgSO4 and the solvent 
was removed under reduced pressure. The crude product was purified by column 
chromatography (DCM : Hex 9 : 1, Rf = 0.55) over silica gel to afford a yellow solid 513.7 
mg (93%). 
 
C17H14O (234.29 g mol-1). 
m.p. 116-117 °C. 
1H NMR (300 mHz, CDCl3, 295 K): δ = 11.50 (s, 1H, COH), 8.98 (dd, 1H, J (H,H) = 0.9 Hz, 
J (H,H) = 9.0 Hz, Ar-H), 8.79 (s, 1H, Ar-H), 8.57 (s, 1H, Ar-H), 8.03 (dt, 1H, J (H,H) = 0.7 
Hz, J (H,H) = 8.4 Hz, Ar-H), 7.80 (d, 1H, J (H,H) = 0.5 Hz, Ar-H), 7.64 (dt, 1H, J (H,H) = 
1.5 Hz, J (H,H) = 7.8 Hz, Ar-H), 7.51 (dt, 1H, J (H,H) = 1.1 Hz, J (H,H) = 6.6 Hz, Ar-H), 
2.54 (d, 3H, J (H,H) = 0.7 Hz, CH3), 2.49 (d, 3H, J (H,H) = 0.9 Hz, CH3). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 193.01 (1C, CHO), 140.18 (2C, Ar-H), 134.07 
(1C, Ar-C), 131.92 (1C, Ar-CH3), 131.71 (1C, Ar-CH3), 130.68 (1C, Ar-C), 129.21 (1C, Ar-
COH), 128.62 (1C, Ar-C), 128.01 (1C, Ar-H), 125.17 (2C, Ar-H), 123.42 (2C, Ar-H), 
122.51 (1C, Ar-H), 21.25 (1C, CH3), 20.13 (1C, CH3). 
IR (KBr): ( = 2911 (s), 1675 (m), 1552 (s), 1450 (s), 1384 (s), 1257 (s). 
MS (FAB) m/z (rel. Int. %): 235, 1 (M+1) (27), 234 (26), 167 (14), 154 (100), 149 (55), 136 
(71), 107 (25), 89 (24), 71 (26), 57 (42). 
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(2,3-dimethylanthracen-9-yl)methanol (11) 
 
HO
 
 
Sodium borohydride (105 mg, 2.76 mmol, 1.25 eq.) were added to a solution of the 2,3-
dimethylanthracene-9-carbaldehyde 10 (513,7 mg, 2,19 mmol) in 30 mL abs. THF and stirred 
overnight at room temperature. The solution was filtered to remove the excess of sodium 
borohydride and the solvent was removed under reduced pressure. The crude product was 
purified by dissolving it in DCM and recrystallizing the impurities by adding ice cold n-
hexane. The impurities could be removed by filtration to afford a yellow solid 472.8 mg 
(92%). 
 
C17H16O (236.32 g mol-1) 
m.p. 158-159 °C. 
Rf: 0.30 (CH2Cl2). 
1H-NMR (300 mHz, CDCl3, 295 K): δ = 8.36 (dd, 1H, J (H,H) = 0.8 Hz, J (H,H) = 8.70 Hz, 
Ar-H), 8.32 (s, 1H, Ar-H), 8.14 (s, 1H, Ar-H), 7.98 (dt, 1H, J (H,H) = 8.8 Hz, J (H,H) = 0.7 
Hz, Ar-H), 7.76 (s, 1H, Ar-H), 7.52 (dt, 1H, J (H,H) = 1.4 Hz, J (H,H) = 7.6 Hz, Ar-H), 7.44 
(dt, 1H, J (H,H) = 1.2 Hz, J (H,H) = 7.4 Hz, Ar-H), 5.63 (d, 2H, J (H,H) = 5.6 Hz, CH2), 2.52 
(d, 3H, J (H,H) = 3.8 Hz, CH3), 2.48 (d, 3H, J (H,H) = 0.8 Hz, CH3), 1.73 (t, 1H, J (H,H) = 
5.6 Hz, OH). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 136.79 (1C, Ar-CH2), 135.28 (1C, Ar-C), 
131.01 (2C, Ar-CH3), 129.64 (2C, Ar-C), 129.60 (1C, Ar-C), 129.03 (1C, Ar-H), 127.87 
(1C, Ar-H), 126.95 (1C, Ar-H), 125.91 (1C, Ar-H), 124.52 (1C, Ar-H), 123.69 (1C, Ar-H), 
122.75 (1C, Ar-H), 57.45 (1C, CH2), 20.98 (1C, CH3), 20.16 (1C, CH3). 
IR (KBr): ν = 3400 (b), 2912 (s), 1630 (b), 1451 (b), 1039 (s), 985 (s). 
MS (FAB) m/z (rel. Int. %): 237,1 (M+1) (11), 236 (34), 219 (26), 181 (22), 165 (28), 154 
(100), 137 (53), 136 (70), 107 (26), 89 (26), 77 (29), 57 (23). 
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9-(Chloromethyl)-2,3-dimethlanthracen (12b) 
 
 
 
To (2,3-dimethylanthracen-9-yl)methanol 11 (472.8 mg, 2.0 mmol) was added 20 mL abs. 
toluene and to the resulting suspension thionyl chloride (0.19 mL, 2.5 mmol, 1.25 eq.) 
dropwise. The reaction was heated to 90°C for 20 h. The solvent was removed under reduced 
pressure to yield a brown solid 471.0 mg (93%). The product could be used for synthesis 
without further purification. 
 
C17H15Cl (254.75 g mol-1) 
Rf: 0 – 0.7 (CH2Cl2).  
1H-NMR (300 MHz, CDCl3, 295 K): δ = 8.36 (s, 1H, Ar-H), 8.28 (dd, 1H, J (H,H) = 0.9 Hz, 
J (H,H) = 8.9 Hz, Ar-H), 8.04 (s, 1H, Ar-H), 7.99 (d, 1H, J (H,H) = 8.4 Hz, Ar-H), 7.77 (s, 
1H, Ar-H), 7.57 (dt, 1H, J (H,H) = 1.4 Hz, J (H,H) = 7.7 Hz, Ar-H), 7.46 (dt, 1H, J (H,H) = 
1.1 Hz, J (H,H) = 7.5 Hz, Ar-H), 5.60 (s, 2H, CH2), 2.55 (s, 3H, CH3), 2,48 (s, 3H, CH3). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 137.40 (1C, Ar-CH2), 135.45 (1C, Ar-C), 
131.10 (1C, Ar-CH3), 130.93 (1C, Ar-CH3), 129.69 (1C, Ar-C), 129.19 (1C, Ar-C), 129.02 
(1C, Ar-C), 128.04 (1C, Ar-H), 127.86 (1C, Ar-H), 126.36 (1C, Ar-H), 126.24 (1C, Ar-H), 
124.67 (1C, Ar-H), 123.29 (1C, Ar-H), 122.34 (1C, Ar-H), 39.27 (1C, CH2), 21.12 (1C, 
CH3), 20.15 (1C, CH3). 
MS (EI) m/z (rel. Int. %): 254 (M) (30), 219 (100), 202 (13), 189 (7), 178 (4). 
IR (KBr): ν = 2916 (s), 1447 (s), 1244 (s), 1025 (s). 
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(4,4´-Dimethoxytrityl)-polyethylene glycol (13) 
 
O
O
O
H
O
n
 
 
 
PEG 600 (8.93 mL, 16.7 mmol) was dried by coevaporation with toluene (3 x 25 mL) and 
suspended in acid free DCM (stored over K2CO3). TEA (0.86 mL, 6.18 mmol, 0.37 eq.) and 
4-dimethylaminopyridine (DMAP) (20 mg, 0.17 mmol, 0.01 eq.) were added. A solution of 
4,4´-dimethoxytriphenylmethylchloride (454 mg, 1.34 mmol, 0.08 eq.) in 13 mL acid free 
DCM was slowly added by a syringe pump over 5 hours 10 min at r.t.. The solution was than 
diluted with DCM and washed with 5% NaHCO3 (50 mL), water (50 mL), and brine (50 mL), 
dried over Na2SO4 and the solvent removed under reduced pressure. The crude PEG protected 
PEG was purified by column chromatography (EtOAc : EtOH 9 : 1, preconditioned with the 
eluent containing 1% Et3N, Rf = 0-0.2) on silica to afford a yellow oil (893.7 mg, 75%). 
 
1H-NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.51-6.6 (m, 13H, Ar-H), 5.62 (s, 1H, OH), 3.79 
(s, 6H, CH3), 3.76-3.52 (m, CH2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 160.51 (2C, Ar-OCH3), 147.40 (1C, Ar-C), 
138.18 (2C, Ar-C), 131.91 (4C, Ar-H), 130.02 (2C, Ar-H), 129.50 (2C, Ar-H), 128.41 (1C, 
Ar-H), 114.81 (4C, Ar-H), 87.60 (1C, Ar3CO), 74.54 (1C, CH2OH), 65.11 (CH2), 65.11 (3C, 
CH3), 63.00 (3C, CH3). 
MALDI MS: m/z 915 [M+Na]+ (calculated for [C47H72O16+Na]+ 915.47), m/z 931 [M+K]+ 
(calculated for [C47H72O16+K]+ 931.45). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 695.34 695.2 711.31 - C37H52O11 
9 739.37 739.2 755.34 - C39H56O12 
10 783.39 783.3 799.37 799.2 C41H60O13 
11 827.42 827.3 843.39 843.2 C43H64O14 
12 871.45 871.2 887.42 887.2 C45H68O15 
13 915.47 915.3 931.45 931.2 C47H72O16 
14 959.50 959.3 975.47 975.2 C49H76O17 
15 1003.52 1003.3 1019.50 1019.2 C51H80O18 
16 1048.55 1047.3 1063.52 - C53H84O19 
17 1091.58 1091.3 1107.55 - C55H88O20 
18 1135.60 1135.3 1151.58 - C57H92O21 
 
(Anthracen-9-yl-methoxy)-polyethylene glycol-DMT (15a) 
 
DMTO
O n
 
 
General procedure I 
 
The DMT-protected polyethylene glycol 13 (1.3 g, 1.46 mmol) was dried by coevaporation 
with toluene (3x25 mL) and dissolved in 8 mL dry ACN under argon. Sodium hydride (93 mg 
60% in oil, 2.33 mmol, 1.6 equiv.) was added. The reaction mixture was stirred for 5 min at 
r.t. before the addition of 9-(chloromethyl)anthracene (362 mg, 1.6 mmol, 1.1 equiv.) and NaI 
(262 mg, 1.75 mmol, 1.2 equiv.). The reaction mixture was stirred for another 40 min at 40°C. 
The reaction was closely followed by TLC. The reaction mixture was quenched with 9 mL of 
water and extracted with EtOAc (80 mL) and additional water (40 mL). The organic layer was 
then washed with water (2 x 40 mL) and brine (2 x 40 mL), dried over Na2SO4 and the 
solvent removed under reduced pressure. The crude product was purified by column 
chromatography (gradient EtOAc : MeOH 98 : 2 to 8 : 2, column preconditioned with the 
eluent containing 1% Et3N) over silica gel to afford a pale yellow oil (700 mg, 46%). 
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Rf = 0.2 (EtOAc : MeOH 98:2). 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 8.57 (s, 1H, Ar-H), 8.52 (d, J(H,H) = 8.4 Hz, 
2H, Ar-H), 8.09 (d, J(H,H) = 8.4 Hz, 2H, Ar-H), 7.60-7.48 (m, 6H, Ar-H), 7.36 (d, J(H,H) = 
9.0 Hz, 5H, Ar-H), 7.30-7.23 (m, 2H, Ar-H), 6.88 (d, J(H,H) = 8.7 Hz, 4H,Ar-H), 5.56 (s, 
2H, OCH2ArA), 3.86 (t, J(H,H) = 5.1 Hz, 2H, PEG CH2OCH2), 3.77 (s, 6H, DMT-CH3), 
3.70-3.52 (m, PEG CH2), 3.17 (11) (t, J(H,H) = 5.1 Hz, 2H, DMTOCH2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 160.51, 147.40, 138.18, 133.43-126.67, 
114.81, 87.60, 72.24, 56.50. 
MALDI MS: m/z 1105.7 [M+Na]+ (calculated for [C62H84O16+Na]+ 1105.58), m/z 1121.7 
[M+K]+ (calculated for [C62 H84O166+K]+ 1121.69). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 885.43 885.6 901.54 - C52H62O11 
9 929.46 929.6 945.57 - C54H66O12 
10 973.49 973.6 989.60 989.6 C56H70O13 
11 1017.52 1017.7 1033.63 1033.6 C58H74O14 
12 1061.55 1061.7 1077.66 1077.6 C60H80O15 
13 1105.58 1105.7 1121.69 1121.7 C62H84O16 
14 1149.61 1149.7 1165.72 1165.7 C64H88O17 
15 1193.64 1193.7 1209.75 1209.7 C66H92O18 
16 1237.67 1237.8 1253.78 1253.8 C68H96O19 
17 1281.7 1281.8 1297.81 1297.8 C70H100O20 
18 1325.73 1325.9 1341.84 - C72H104O21 
 
2-((2,3-Dimethylanthracen-9-yl)-methoxy)-polyethylene glycol-DMT (15b) 
 
DMTO
O n
 
 
Product 15b was prepared according to general procedure I from DMT-protected 
polyethylene glycol 13 (2.05 g, 2.30 mmol), 9-(chloromethyl)-2,3-dimethlanthracen 12b (645 
mg, 2.53 mmol), sodium hydride (160.4 mg 60% in oil, 2.33 mmol, 1.6 equiv.) and NaI 
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(421.2 mg, 2.81 mmol). The crude product was purified by column chromatography (gradient 
EtOAc : MeOH 98 : 2 to 8 : 2, column preconditioned with the eluent containing 1% Et3N) 
over silica gel to afford a yellow oil (1.83 g, 75%). 
 
Rf = 0.2 (EtOAc : MeOH 98:2). 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 8.57 (s, 1H, Ar-H), 8.52 (d, J(H,H) = 8.4 Hz, 
2H, Ar-H), 8.09 (d, J(H,H) = 8.4 Hz, 2H, Ar-H), 7.60-7.48 (m, 6H, Ar-H), 7.36 (d, J(H,H) = 
9.0 Hz, 5H, Ar-H), 7.30-7.23 (m, 2H, Ar-H), 6.88 (d, J(H,H) = 8.7 Hz, 4H,Ar-H), 5.56 (s, 
2H, OCH2ArA), 3.86 (t, J(H,H) = 5.1 Hz, 2H, PEG CH2OCH2), 3.77 (s, 6H, DMT-CH3), 
3.70-3.52 (m, PEG CH2), 3.17 (11) (t, J(H,H) = 5.1 Hz, 2H, DMTOCH2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 160.51, 147.40, 138.18, 133.43-126.67, 
114.81, 87.60, 72.24, 56.50. 
MALDI MS: m/z 1105.7 [M+Na]+ (calculated for [C62H84O16+Na]+ 1105.58), m/z 1121.7 
[M+K]+ (calculated for [C62H84O166+K]+ 1121.69). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 913.45 913.4 929.42 - C54H66O11 
9 957.47 957.5 973.44 973.5 C56H70O12 
10 1001.49 1001.5 1017.46 1017.5 C58H74O13 
11 1045.51 1045.5 1061.48 1061.5 C60H78O14 
12 1089.53 1089.5 1105.50 1105.5 C62H82O15 
13 1133.55 1133.6 1149.52 1149.6 C64H86O16 
14 1177.57 1177.6 1193.54 1193.6 C66H90O17 
15 1221.59 1221.7 1237.56 1237.6 C68H94O18 
16 1265.61 1265.7 1281.58 1281.6 C70H98O19 
17 1309.63 1309.8 1325.60 1325.6 C72H102O20 
18 1353.65 1354.8 1369.62 - C74H106O21 
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(Anthracen-9-yl-methoxy)-polyethylene glycol (16a) 
 
HO
O n
 
 
General procedure II 
 
1-(4,4´-Dimethoxytrityl) (9-anthracenemethoxy) polyethylene glycol 15a (700 mg, 0.67 
mmol) was dissolved in 16.8 mL solution of a 3% trifluoro acetic acid in dichloroethane at r.t. 
After 5 min stirring, the reaction mixture was quenched by pouring it in 25 mL NaHCO3 and 
extracted with 30 mL of CH2Cl2. The organic layer was washed with 25 mL brine, dried over 
Na2SO4 and the solvent removed under reduced pressure. The crude product was purified by 
column chromatography (2 x 20, EtOAc : EtOH 9 : 1, Rf = 0-0.2) on silica gel to afford a pale 
yellow oil 380 mg (82%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 8.56 (s, 1H, Ar-H), 8.52 (d, J(H,H) = 8.7 Hz, 
2H, Ar-H), 8.09 (d, J(H,H) = 7.8 Hz, 2H, Ar-H), 7.61-7.49 (m, 4H, Ar-H), 5.57 (s, 2H, Ar-
CH2), 3.85 (t, J(H,H) = 4.8 Hz, 2H, PEG CH2OH), 3.69 (t, J(H,H) = 5.1 Hz, 2H, PEG 
CH2OCH2), 3.60-3.52 (m, PEG CH2), 2.81 (s, 1H, OH). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 133.42 (1C, Ar-H), 132.85 (1C, Ar-CH2), 
131.53 (1C, Ar-C), 130.68 (1C, Ar-H), 129.84 (1C, Ar-C), 127.89 (1C, Ar-H), 126.88 (1C, 
Ar-H), 126.67 (1C, Ar-H), 74.52 (Ar-CH2), 72.22 (CH2O PEG CH2), 71.58 (PEG CH2OH), 
66.71 (PEG CH2O CH2). 
MALDI MS: m/z 759.7 [M+Na]+ (calculated for [C39H60O13+Na]+ 759.44), m/z 775.7 
[M+K]+ (calculated for [C39H60O13+K]+ 775.55). 
Experimental section 
 130
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 583.32 583.5 599.43 - C31H44O9 
9 627.35 627.6 643.46 643.6 C33H48O10 
10 671.38 671.6 687.49 687.6 C35H52O11 
11 715.41 715.6 731.52 731.7 C37H56O12 
12 759.44 759.7 775.55 775.7 C39H60O13 
13 803.47 803.8 819.58 819.7 C41H64O14 
14 847.50 847.8 863.61 863.8 C43H68O15 
15 891.53 891.8 907.64 907.8 C45H72O16 
16 935.56 935.8 951.67 - C47H76O17 
 
2-((2,3-Dimethylanthracen-9-yl)-methoxy)-polyethylene glycol (16b) 
 
HO
O n
 
 
Product 16a was prepared according to general procedure II from 2-((2,3-dimethylanthracen-
9-yl)-methoxy)-polyethylene glycol-DMT 15b (1.83 g, 1.12 mmol) and 50 mL solution of a 
3% trifluoro acetic acid in dichloroethane. The crude product was purified by column 
chromatography (gradient EtOAc : MeOH 100 : 0 to 98 : 2 to 8 : 2, preconditioned with the 
eluent containing 1% Et3N) over silica gel to afford a yellow oil (719 mg, 84%). 
 
1H-NMR: (300 MHz, (CD3)2CO, 295 K): δ = 8.45 (d, 1H, J (H,H) = 8.4 Hz, Ar-H), 8.42 (s, 
1H, Ar-H), 8.26 (s, 1H, Ar-H), 8.03 (dd, 1H, J (H,H) = 1.5 Hz, J (H,H) = 9.1 Hz, Ar-H), 7,82 
(s, 1H, Ar-H), 7.55-7.30 (m, 2H, Ar-H), 5.53 (s, 2H, Ar-CH2), 3.50-3.70 (m, PEG CH2), 2.53 
(s, 3H, CH3), 2,47 (s, 3H, CH3). 
MALDI MS: m/z 655 [M+Na]+ (calculated for [C35H52O10+Na]+ 655.35), m/z 671 [M+K]+ 
(calculated [C35H52O10+K]+ 671.32). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 611.33 - 627.30 - C33H48O9 
9 655.35 655.5 671.32 671.5 C35H52O10 
10 699.37 699.5 715.34 715.5 C37H56O11 
11 743.39 743.6 759.36 759.5 C39H60O12 
12 787.41 787.6 803.38 803.6 C41H64O13 
13 831.43 831.6 847.40 847.6 C41H68O14 
14 875.45 875.6 891.42 891.6 C43H72O15 
15 919.47 919.7 935.44 935.6 C45H76O16 
16 963.49 963.7 979.46 979.7 C47H80O17 
17 1007.51 1007.7 1023.48 1023.7 C49H84O18 
18 1051.53 1051.7 1067.50 - C51H88O19 
 
Polyethylene glycol-p- toluenesulfonate PEG 600 (26c)  
 
HO
O
SO2
PEG 600
n
 
 
General procedure III 
 
160 g PEG 600 (266.66 mmol, 10 eq.) was dried by coevaporation with toluene (3 x 25 mL) 
and dissolved in 50 mL dry DCM and DMAP (25.2 mg, 0.21 mmol, 0.05 eq.) and TEA (13.8 
mL, 98.19 mmol, 0.37 eq.) were added. TsCl (5.1 g, 26.69 mmol) was dissolved in 200 mL 
dry DCM and added via a dropping funnel. The reaction was complete after 13.5 h. The 
solution was washed with 5% NaHCO3 (3 x 200 mL), water (6 x 150 mL), and brine (3 x 300 
mL), dried over Na2SO4 and the solvent removed under reduced pressure. The obtained 
yellow oil presented itself as pure product (13.9 g, 74%). 
 
Rf: 0.15 (EtOH : MeOH 9 : 1). 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.82 (d, J(H,H) = 7.2 Hz, 2H, Ar-H), 7.49 (d, 
J(H,H) = 7.5 Hz, 2H, Ar-H), 4.18-3.57 (m, PEG CH2), 2.79 (s,1H, OH), 2.46 (s, 3H, CH3). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 146.74 (1C, Ar-CH3), 135.35 (1C, Ar-SO2), 
131.82 (2C, Ar-H), 129.72 (2C, Ar-H), 74.54-63.00 (PEG CH2), 22.53 1(C, CH3). 
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MALDI MS: m/z 723.4 [M+Na]+ (calculated for [C31H56O15S]+ 723.37), m/z not observed for 
[M+K]+ (calculated [C31H56O15S +Na]+ 739.48). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
8 547.59 547.3 C23H40O11S 
9 591.64 591.3 C25H44O12S 
10 635.69 635.3 C27H48O13S 
11 679.74 679.4 C29H52O14S 
12 723.79 723.5 C31H56O15S 
13 767.84 767.5 C33H60O16S 
14 811.89 811.5 C35H64O17S 
15 855.94 855.6 C37H68O18S 
16 899.99 899.6 C39H72O19S 
17 944.04 943.6 C41H76O20S 
18 988.09 987.7 C43H80O21S 
 
Polyethylene glycol p-toluenesulfonate PEG 1500 (26d)  
 
HO
O
SO2
PEG 1500
n
 
 
Product 26d was prepared according to general procedure III from PEG 1500 (100 g, 66.67 
mmol, 10 eq.) dried by coevaporation (2 x 200 mL) in 95 mL dry DC, DMAP (6.3 mg, 0.052 
mmol) and TEA (3.45 mL, 25 mmol). p-TsOCl (1.27 g, 6.67 mmol) in 18 mL dry DCM were 
added via a syringe pump over 7 h and 10 min and stirred over night. The reaction mixture 
was washed with 5% NaHCO3 (3 x 50 mL), H2O (6 x 250 mL) and brine (3 x 250 mL), dried 
over Na2SO4 and the solvent removed under reduced pressure to afford a white solid. As 
compared to PEG 600 the tosylated product of PEG 1500 was solid (10.5 g, 96%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 8.01 (d, J(H,H) = 8.5 Hz, 2 H, Ar-H), 7.61 (d, 
J(H,H) = 8.0 Hz, 2 H, Ar-H), 3.58 (m, PEG CH2), 2.53 (s, 3 H, CH3). 
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13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 147.94 (1C, Ar-CH3), 141.69 (1C, Ar-SO2), 
130.90 (2C, Ar-H), 129.09 (2C, Ar-H), 72.88 00 (PEG CH2), 70.62 (PEG CH2), 61.23 (PEG 
CH2OH), 21.06 (1C, CH3). 
MALDI MS: m/z 1581.8 [M+1]+ (calculated for [C71H136O35S+1]+ 1581.98), m/z not 
observed for [M+Na]+ (calculated [C33 H60O16S +Na]+ 1605.97). 
 
n 
Calculated 
[M]+ 
Found 
[M]+ 
Formula 
23 1184.71 1185.6 C53H100O26S 
24 1228.74 1229.6 C55H104O27S 
25 1272.77 1273.7 C57H108O28S 
26 1316.8 1317.7 C59H112O29S 
27 1360.83 1361.7 C61H116O30S 
28 1404.86 1405.7 C63H120O31S 
29 1448.89 1449.8 C65H124O32S 
30 1492.92 1493.8 C67H128O33S 
31 1536.95 1537.8 C69H132O34S 
32 1580.98 1581.8 C71H136O35S 
33 1625.01 1625.8 C73H140O36S 
34 1669.04 1669.8 C75H144O37S 
35 1713.07 1713.8 C77H148O38S 
36 1757.10 1757.9 C79H152O39S 
37 1801.13 1801.9 C81H156O40S 
38 1845.16 1845.9 C83H160O41S 
39 1889.19 1889.9 C85H164O42S 
40 1933.22 1933.9 C87H168O43S 
41 1977.25 1978.9 C89H172O44S 
42 2021.28 2021.9 C91H176O45S 
43 2065.31 2066.9 C93H180O46S 
44 2109.34 2109.9 C95H184O47S 
45 2153.37 2154.9 C97H188O48S 
46 2197.40 2198.8 C98H192O49S 
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4-(5,5-diethyl-1,3-dioxan-2-yl)phenol (19) 
 
 
 
4-Hydroxybenzaldehyde (10 g, 81.89 mmol), 2,2-diethyl-1,3-propandiol (12.8 g, 103.90 
mmol, 1.27 eq.) and p-toluenesulfonic acid (0.78 g, 4.10 mmol, 0.05 eq.) as catalyst were 
suspended in 40 mL toluene and heated to reflux at 85°C for 3.5 h. The reaction mixture was 
extracted with diethyl ether (2 x 50 mL) and washed with H2O (3 x 50 mL) and brine (3 x 30 
mL), the combined organic layers were dried over Na2SO4 and the organic solvents removed 
under reduced pressure. The crude product was purified with column chromatography (Hex : 
EA 8 : 2, Rf = 0.15) on silica to afford a white solid (11.7 g, 61%). 
 
C14H20O3 (236.31 g mol-1). 
m.p. 56 °C. 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.28 (d, J(H,H) = 8.3 Hz, 2H, Ar-H), 6.80 (d, 
J(H,H) = 8.7 Hz, 2H, Ar-H), 5.32 (s, 1H, Ar-CH), 3.87 (d, J(H,H) = 11.4 Hz, 2H, OCH2a), 
3.58 (d, J(H,H) = 11.4 Hz, 2H, OCH2b), 1.80 (q, J(H,H) = 7.6 Hz, 2H, CH2 a), 1.14 (q, 
J(H,H) = 7.4 Hz, 2H, CH2b), 0.87 (t, J(H,H) = 7.6 Hz, 4H, CH3a), 0.80 (t, J(H,H) = 7.6 Hz, 
3H, CH3b). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 159.31 (1C, Ar-OH), 132.28 (1C, Ar-CH), 
129.28 (2C, Ar-H), 116.24 (2C, Ar-H), 103.54 (1C, Ar-CH), 75.98 (2C, OCH2), 36.16 (1C, 
CH), 25.79 (1C, CH2a), 24.19 (1C, CH2b), 8.77 (1C, CH3a), 7.85 (1C, CH3b). 
MS (FAB) m/z (rel. Int. %): 237 (M+1) (60), 236 (M) (11), 35 (M-1) (24), 154 (18), 143 (12), 
137 (10), 136 (17), 124 (10), 123 (100), 121 (29), 107 (13), 97 (19), 77 (13), 69 (17), 57 (16), 
43 (18), 41 (23), 39 (12), 29 (11). 
IR (KCl): ν =3339 (s), 2969 (s), 2870 (m), 2360 (w), 1615 (m), 1523 (m), 1456 (w), 1398 (s), 
1270 (m), 1213 (m), 1167 (m), 1097 (s), 1057(m), 1000 (m), 955 (s), 917 (m).  
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2-(4-(5,5-Diethyl-1,3-dioxan-2-yl)phenoxy) polyethylene glycol PEG 600 (25c) 
 
O
O
O
O
Hn
PEG 600  
 
General procedure IV 
 
Under argon the protected aldehyde 4-(5,5-Diethyl-1,3-dioxan-2-yl)phenol 19 (6.97 g, 29.52 
mmol, 1.3 eq.) was dissolved in 35 mL dry ACN, cooled down in an ice /water bath to 0°C 
and NaH (1.29 g, 29.52 mmol 1.3 eq.) was added and stirred for 10 min before allowing the 
reaction mixture to warm up to r.t.. Polyethylene glycol p-toluenesulfonate PEG 600 26c 
(13.9 g, 22.71 mmol) was coevaporated with toluene (3 x 50 mL) and dissolved in 160 mL 
dry acetonitrile was and the reaction mixture was heated to reflux at 95°C for 3 days. TLC 
analysis showed that the reaction was not complete and the reaction mixture was heated to 
95°C for 2 d. The reaction mixture was diluted with 100 mL DCM, washed with 5% NaHCO3 
(3 x 150 mL), H2O (6 x 200 mL), brine (3 x 200 mL), dried over Na2SO4 and the solvent 
removed under reduced pressure. The crude product was purified with column 
chromatography (gradient: EA : Hex 9 : 1, EtOAc : EtOH 1 : 1, Rf = 0.42) on silica to afford a 
colorless yellow oil (8.3 g, 44%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.38 (d, J(H,H) = 8.7 Hz, 2H, Ar-H), 6.92 (d, 
J(H,H) = 8.7 Hz, 2H, Ar-H), 5.36 (s, 1H, Ar-CH), 4.13 (t, J(H,H) = 5.1, 2H, OCH2a), 3.81 (t, 
J(H,H) = 4.8, 2H, OCH2b), 3.67-3.57 (m, PEGCH2), 2.79 (s, 1H, OH), 1.81 (q, J(H,H) = 7.5 
Hz, 2H, CH2a), 1.17 (q, J(H,H) = 7.8 Hz, 2H, CH2b), 0.88 (t, J(H,H) = 7.5 Hz, 3H, CH3a), 
0.81 (t, J(H,H) = 7.5 Hz, 3H, CH3b). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 161.06 (1C, Ar-O), 133.80 (1C, Ar-CH), 
129.38 (2C, Ar-H), 115.70 (2C, Ar-H), 103.45 (1C, Ar-CH), 76.13-69.36 (PEGCH2+CH2O), 
36.35 (1C, CH), 25.94 (1C, CH2CH3a), 24.36 (1C, CH2CH3b), 8.83 (1C, CH3a), 7.90 (1C, 
CH3b). 
MALDI MS: m/z 743.7 [M+Na]+ (calculated for [C36H64O16+Na]+ 743.85). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
7 567.65 567.4 C28H48O12 
8 611.70 611.5 C30H52O13 
9 655.75 655.6 C32H56O14 
10 699.80 699.6 C34H60O15 
11 743.85 743.7 C36H64O16 
12 787.90 787.7 C38H68O15 
13 831.95 831.8 C40H72O16 
14 876.00 875.8 C42H76O17 
15 920.05 919.8 C44H80O18 
16 964.10 963.9 C46H84O19 
17 1008.15 1007.9 C48H88O20 
18 1052.20 1052.0 C50H92O21 
19 1096.25 1096.0 C52H96O22 
20 1140.30 1138.0 C54H100O23 
 
2-(4-(5,5-Diethyl-1,3-dioxan-2-yl)phenoxy)polyethylene glycol PEG 1500 (25d) 
 
O
O
O
O
H
n
PEG 1500  
 
According to general procedure IV 4-(5,5-Diethyl-1,3-dioxan-2-yl)phenol 19 (2.38 g, 10.07 
mmol, 1.1 eq.) was dissolved in 15 mL dry ACN, and deprotonated with NaH (241.77 mg, 
10.07 mmol, 1.1 eq.). Polyethylene glycol p-toluenesulfonate PEG 1500 25d (14.5 g, 9.16 
mmol) in 80 mL dry acetonitrile were added and refluxed for 2 days. The reaction mixture 
was diluted with 150 mL DCM, washed with H2O (3 x 200 mL), 5% NaHCO3 (3 x 150 mL), 
brine (3 x 200 mL). Purification on silica (gradient: DCM : Hex 6 : 4, DCM : Hex 8 : 2, EA : 
Hex 1 : 1, DCM : EtOH 1 : 1) on silica to afford a colorless oil 4 g, 27%). 
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1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.39 (d, J(H,H) = 8.7 Hz, 2H, Ar-H), 6.94 (d, 
J(H,H) = 8.7 Hz, 2H, Ar-H), 5.36 (s, 1H, Ar-CH), 4.14 (t, J(H,H) = 5.1, 2H, OCH2a), 3.82 (t, 
J(H,H) = 4.8, 2H, OCH2b), 3.59 (m, PEGCH2), 3.28 (s, 1H, OH), 1.80 (q, J(H,H) = 7.5 Hz, 
2H, CH2a), 1.17 (q, J(H,H) = 7.8 Hz, 2H, CH2b), 0.88 (t, J(H,H) = 7.5 Hz, 3H, CH3a), 0.81 
(t, J(H,H) = 7.5 Hz, 3H, CH3b). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 159.98 (1C, Ar-O), 134.13 (1C, Ar-CH), 
129.71 (2C, Ar-H), 116.62 (2C, Ar-H), 108.18 (1C, Ar-CH), 67.68 (PEGCH2+CH2O), 31.60 
(1C, CH), 26.57 (1C, CH2CH3), 10.65 (1C, CH3). 
MALDI MS: m/z 1623.9 [M+Na]+ (calculated for [C48H82O20+Na]+ 1624.10), 1639.8 
[M+K]+ (calculated for [C48H 82O20+K]+ 1640.03). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
22 1227.79 1227.5 1243.76 1245.6 C58H108O25 
23 1271.82 1271.6 1287.79 1289.6 C30H50O12 
24 1315.85 1315.6 1331.82 1333.6 C32H54O13 
25 1389.88 1359.6 1375.85 1377.6 C34H58O14 
26 1403.91 1403.7 1419.88 1421.7 C36H62O15 
27 1447.96 1447.7 1463.91 1465.7 C38H66O16 
28 1492.01 1791.8 1507.94 1509.7 C40H70O17 
29 1536.04 1535.8 1551.97 1553.8 C42H 74O 18 
30 1580.07 1579.8 1596.00 1597.8 C44H 78O 19 
31 1624.10 1623.9 1640.03 1639.8 C48H 82O20 
32 1668.13 1667.9 1684.06 1683.9 C50H86O21 
33 1712.16 1711.9 1728.09 1727.9 C52H90O22 
34 1756.19 1756.0 1772.12 1772.0 C54H94O23 
35 1800.22 1800.0 1816.15 1816.0 C28H46O11 
36 1844.25 1844.1 1860.18 1860.0 C30H50O12 
37 1888.28 1888.1 1904.21 1904.0 C32H54O13 
38 1932.31 1932.1 1948.24 1948.0 C34H58O14 
39 1976.34 1976.1 1992.27 1992.1 C36H62O15 
40 2020.37 2020.2 2036.3 2036.1 C38H66O16 
41 2064.4 2064.2 2080.33 2080.2 C40H70O17 
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Initiator nucleotides 
 
Initiator nucleotide (7a) 
 
O
O
n
P
O
OO
NH
N
N
O
NH2N
O
OHHO
HH
HH
Na
 
 
General procedure V 
 
(Anthracen-9-yl-methoxy)-polyethylene glycol 16a (380 mg, 0.55 mmol) was dried by 
coevaporation with toluene (3 × 5 mL). A solution of 8 mL 0.1 M of phosphoramidite 17 (470 
mg, 0.66 mmol, 1.2 eq.) in dry THF were added under argon and 4,5-dicyanoimidazole was 
added as activator (65 mg, 0.55 mmol, 1.0 eq.) and the reaction was stirred at r.t. for 1 h. The 
coupling reaction was then stopped by addition of 0.55 mL t-butyl hydroperoxide (3.3 mmol, 
10 eq.). The reaction mixture was stirred for 30 min at r.t and all volatiles were removed 
under vacuum using Schlenk technique. To remove the TBDMS protection groups of the 
guanosine the residue was taken up in 3.3 mL 1 M TBAF in THF (3.3 mmol, 6 equiv) under 
argon and stirred for 3 h at r.t.. Reaction control was performed on TLC RP-18 plates (ACN : 
H2O 1 : 1). The THF was removed under vacuum and the residue was taken up in water, 
filtered over a 0.22 μM membrane filter, and purified by preparative reverse phase 
chromatography using a chromatography pump (gradient ACN : H2O 2 : 8 to 1 : 1) the 
product was collected and lyophilized. Tetra butylammonium cations were exchanged for 
sodium ions on a DOWEX® 50WX8-200 resin (sodium form) according to standard protocol 
with water as eluent. The aqueous solution could then be directly submitted again to the 
preparative reverse phase as described above. The product was collected and lyophilized to 
afford a yellow solid. 
 
1H-NMR (500 MHz, CD3OH, 295 K): δ = 8.58 (s, 1H), 8.40 (m, 2H), 8.10 (m, 3H), 7.68 (m, 
4H), 5.88 (m, 2H), 4.49 (m, 2H), 3.96-3.88 (m, 3H), 3.74-3.37 (m, nH, PEGCH2). 
31P-NMR (500 MHz, D2O, 295 K): δ = 0.23 (s). 
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MALDI MS: m/z 1038.5 [M]+ (calculated for [C47H67N5O19P]+ 1036.46), m/z 1060.5 
[M+Na]+ (calculated for [C47H67N5O19P +Na]+ 1059.45). 
 
n 
Calculated 
[M]+ 
Found 
[M]+ 
Calculated 
[M+Na]+ 
Found 
[M+Na] 
Formula 
8 904.37 903.5 927.36 - C41H55N5O16P- 
9 948.40 950.5 971.39 972.5 C43H59N5O17P- 
10 992.43 994.5 1015.42 1016.5 C45H63N5O18P- 
11 1036.46 1038.5 1059.45 1060.5 C47H67N5O19P- 
12 1080.49 1082.5 1103.48 1104.5 C49H71N5O20P- 
13 1124.52 1126.5 1147.51 1148.5 C51H75N5O21P- 
14 1168.55 1170.6 1191.54 1192.5 C53H79N5O22P- 
15 1212.56 1214.6 1235.57 1238.6 C55H83N5O23P- 
16 1256.61 1258.6 1279.60 1282.5 C57H87N5O24P- 
17 1300.64 1302.6 1323.63 - C59H91N5O25P- 
 
Initiator nucleotide (7b) 
 
O
O
n
P
O
OO
NH
N
N
O
NH2N
O
OHHO
HH
HH
Na
 
 
Initiator nucleotide 7b was synthesized according to general procedure V from 2-((2,3-
Dimethylanthracen-9-yl)-methoxy)-polyethylene glycol 16b (710.7 mg 0.93 mmol), 14.1 mL 
0.1 M of phosphoramidite 17 (470 mg, 0.66 mmol, 1.2 eq.) in dry THF, 4,5-dicyanoimidazole 
(125 mg, 1.06 mmol, 1.0 eq.). The coupling reaction was stopped with 1.18 mL t-
butylhydroperoxide (9.4 mmol, 10 eq.), after evaporation of the reaction mixture the residue 
was taken up in TBAF in THF (5.7 mL, 5.58 mmol, 6 eq.). Half of the crude product was 
purified by preparative reverse phase chromatography using a chromatography pump 
(gradient: 1) ACN: H2O 2:8 400 mL, 2) ACN: H2O 3:7 200 mL, 3) ACN: H2O 4:6 200 mL, 4) 
ACN: H2O 1:1 600 mL) to yield a yellow solid (125.2 mg, 24%). 
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1H-NMR (500 MHz, D2O, 295 K): δ = 8.09 (d, 1H, J (H,H) = 4.2 Hz), 8.04 (s, 1H), 7.75 (s, 
1H), 7.44 (s, 1H), 7.38 (d, 1H, J (H,H) = 7.8 Hz), 7.33 (d, 1H, J (H,H) = 0.4 Hz), 7.17 (s, 1H), 
6,88 (s, 1H), 5.86 – 5.79 (12 x s, 12 x 2H), 5.07 (s, 2H), 4.75 (m), 4.49 (d, 1H, J (H,H) = 1 
Hz), 4.31 (s, 1H), 4.12 (d, 2H, J (H,H) = 3.5 Hz), 3.93 (dd, 2H, J (H,H) = 1.8 Hz, J (H,H) = 
2.9 Hz), 3.70 – 3.30 (m, nH, PEGCH2), 2.14 (s, 3H), 1.96 (s, 3H).  
31P-NMR (500 MHz, D2O, 295 K): δ = 0,231 (s). 
13C{1H} NMR (75 MHz, D2O, 295 K) δ = 159.74, 138.33, 136.92, 132.26, 132.09, 132.07, 
131.69, 131.68, 131.47, 131.46, 130.08, 128.75, 128.31, 127.27, 127.26, 125.98, 125.98, 
125.96, 125.26, 125.24, 124.09, 124.07, 117.58, 117.57, 114.33, 104.99, 88.47, 85.34, 85.23, 
85.20, 85.18, 85.17, 85.15, 75.02, 75.01, 74.99, 72.01, 71.97, 71.47, 71.46, 71.43, 71.03, 
70.43, 66.02, 65.95, 21.36, 20.50. 
MALDI MS: m/z 1154.5 [M+Na]+ (calculated for [C53H79N5O21P-+Na]+ 1154.47), m/z 
1176.5 [M+K]+ (calculated for [C53H79N5O21P-+K]+ 1176.45). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 934.37 - 956.35 - C43H59N5O16P- 
9 978.39 978.3 1000.37 1000.3 C45H63N5O17P- 
10 1022.41 1022.4 1044.39 1044.4 C47H67N5O18P- 
11 1066.43 1066.4 1088.41 1088.4 C49H71N5O19P- 
12 1110.45 1110.4 1132.43 1132.4 C51H75N5O20P- 
13 1154.47 1154.5 1176.45 1176.5 C53H79N5O21P- 
14 1198.49 1198.5 1220.47 1220.5 C55H83N5O22P- 
15 1242.51 1242.6 1264.49 1264.6 C57H87N5O23P- 
16 1286.53 1286.6 1308.51 1308.7 C59H91N5O24P- 
17 1330.55 1330.7 1352.53 1354.7 C61H95N5O25P- 
18 1374.57 1374.7 1396.55 - C63H99N5O26P- 
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Initiator nucleotide (7c) 
 
NH
N
N
O
NH2N
O
OHOH
HH
HH
O
P
O
OO
O
O
O
n
PEG 600
Na
 
 
Initiator nucleotide 7c was synthesized according to general procedure V from 2-(4-(5,5-
diethyl-1,3-dioxan-2-yl)phenoxy)polyethylene glycol PEG 600 25c (960 mg, 2.61 mmol), 
14.1 mL 0.1 M of phosphoramidite 17 (990 mg, 3.13 mmol, 1.2 eq.) in dry THF, 4,5-
dicyanoimidazole (140 g, 2.61 mmol, 1.0 eq.). The coupling reaction was stopped after 50 
min with 1.17 mL t-butyl hydroperoxide (26.10 mmol, 10 eq.), after evaporation of the 
reaction mixture the residue was taken up in TBAF in THF (5.7 mL, 5.58 mmol, 6 eq.) and 
stirred for 16h at r.t.. 246.46 mg of the crude product was purified with reversed phase 
chromatography system with two pumps, using the following gradient with acetonitrile and 
water. 
 
Time [min] ACN [%] 
0 15 
15 40 
50 60 
65 80 
70 100 
75 50 
80 50 
 
After ion exchange and reverse phase chromatography was carried out as described above 
26.7 mg (20%) clean product could be obtained out of the initially loaded 246.46 mg. 
 
1H NMR (500 MHz, D2O, 295 K): δ = 8.10 (s, 1H), 7.43 (s, 2H), 7.03 (s, 2H), 5.92 (d, J(H,H) 
= 5.5 Hz, 1H), 5.50 (m, 1H), 4.51 (t, J(H,H) = 5 Hz, 1H), 4.32 (s, 1H), 4.13 (t, J(H,H) = 4.5 
Hz, 2H), 3.96 (d, J(H,H) = 11 Hz, 2H), 3.92 (m, 4H), 3.78-3.61 (m, nH, PEGCH2), 1.79 (q, 
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J(H,H) = 7.5 Hz, 2H), 1.17 (q, J(H,H) = 7.5 Hz, 2H), 0.89 (t, J(H,H) = 7.5 Hz, 3H), 0.80 (t, 
J(H,H) = 7.5 Hz, 3H). 
13C{1H} NMR (75 MHz, D2O, 295 K): δ = 163.22, 156.15, 151.78, 147.32, 137.40, 130.39, 
127.71, 114.64, 104.64, 101.66, 86.82, 74.50, 73.38, 70.37, 69.69, 69.50, 68.98, 34.46, 23.41, 
22.10, 6.65, 5.79. 
31P-NMR (121.5 MHz, D2O, 295K): δ = 0.25 (s). 
MS HR-ESI: m/z 1064.47 (calculated for [C46H75O21N5P]+ 1064.51). 
MALDI MS: m/z 1067.3 [M]+ (calculated for [C46H75O21N5P]+ 1064.51), m/z 1089.4 
[M+Na]+ (calculated for [C46H75O21N5P +Na]+ 1087.50). 
 
n 
Calculated 
[M]+ 
Found 
[M]+ 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
7 888.39 891.2 911.38 - C38H59O17N5P- 
8 932.42 935.2 955.41 - C40H63O18N5P- 
9 976.45 979.2 999.44 1001.4 C42H67O19N5P- 
10 1020.48 1023.3 1043.47 1045.4 C44H71O20N5P- 
11 1064.51 1067.3 1087.50 1089.4 C46H75O21N5P- 
12 1108.54 1111.4 1131.53 1133.5 C48H79O22N5P- 
13 1152.57 1155.5 1175.56 1177.5 C50H83O23N5P- 
14 1196.6 1199.6 1219.59 1221.6 C52H87O24N5P- 
15 1240.63 1243.6 1263.62 1265.6 C54H91O25N5P- 
16 1284.66 1287.7 1307.65 1309.6 C56H95O26N5P- 
17 1328.69 1331.8 1351.68 1353.7 C58H99O27N5P- 
18 1372.72 1375.9 1395.71 - C60H103O28N5P- 
19 1416.75 1419.9 1439.74 - C62H107O29N5P- 
 
Initiator nucleotide (7d) 
 
NH
N
N
O
NH2N
O
OHOH
HH
HH
O
P
O
OO
O
O
O
n
PEG 1500
Na
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Initiator nucleotide 7d was synthesized according to general procedure V from 2-(4-(5,5-
diethyl-1,3-dioxan-2-yl)phenoxy)polyethylene glycol PEG 1500 25d (1 g 0.58 mmol), 8 mL 
0.1 M of phosphoramidite 17 (493 mg, 0.69 mmol, 1.2 eq.) in dry THF, 4,5-dicyanoimidazole 
(69 mg, 0.58 mmol, 1.0 eq.). The coupling reaction was stopped with 0.58 mL t-butyl 
hydroperoxide (5.8 mmol, 10 eq.), after evaporation of the reaction mixture the residue was 
taken up in TBAF in THF (3.48 mL, 3.48 mmol, 6 eq.). The solvent was removed under 
reduced pressure and HPLC followed by MALDI MS analysis revealed that only one 
TBDMS protection group had been removed. Another 3.48 mL TBAF was added and stirred 
over night. The product was purified on a reverse phase LC chromatography system 
IntelliFlash gradient with acetonitrile and water. The product was eluted between 14-16 min. 
 
Time [min] ACN [%] 
0 10 
10 20 
25 65 
30 70 
 
After ion exchange and chromatography as described 16 mg clean product could be obtained 
out of the initially loaded 150 mg. 
 
1H NMR (500 MHz, D2O, 295 K): δ = 8.11 (s, 1H), 7.48 (s, 2H), 7.08 (s, 2H), 5.93 (d, J(H,H) 
= 5.5 Hz, 1H), 5.55 (d, J(H,H) = 5.0 Hz, 1H), 4.52 (t, J(H,H) = 4.5 Hz, 1H), 4.25 (s, 1H), 4.11 
(t, J(H,H) = 4.5 Hz, 2H), 3.97 (d, J(H,H) = 11 Hz, 2H), 3.93 (m, 4H), 3.77-3.62 (m, nH, 
PEGCH2), 1.81 (m, 2H), 1.18 (m, 2H), 0.91 (t, J(H,H) = 7.5 Hz, 3H), 0.81 (t, J(H,H) = 7.5 
Hz, 3H). 
13C{1H} NMR (75 MHz, D2O, 295 K): δ = 158.83, 151.83, 146.94, 138.20, 127.78, 114.72, 
109.99, 101.66, 86.79, 83.66, 74.53, 69.71, 69.53, 69.48, 67.17, 34.49, 23.43. 
31P NMR (121.5 MHz, D2O, 295K): δ = 0.25 (s). 
MS HR-ESI: m/z 1856.97 (calculated for [C82H147O39N5P] 1857.05). 
MALDI MS: m/z 1771.6 [M+Na]+ (calculated for [C78H139O37N5P+Na]+ 1768.99). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
17 1328.06 1330.2 C58H89O27N5P 
18 1372.09 1374.2 C60H93O28N5P 
19 1416.12 1418.3 C62H97O29N5P 
20 1460.15 1462.3 C64H111O30N5P 
21 1504.81 1506.4 C66H115O31N5P 
22 1548.84 1550.4 C68H119O32N5P- 
23 1592.87 1594.4 C70H123O33N5P 
24 1636.90 1638.5 C72H127O34N5P 
25 1680.93 1683.5 C74H131O35N5P 
26 1724.96 1727.5 C76H135O36N5P 
27 1768.99 1771.6 C78H139O37N5P 
28 1813.02 1815.9 C80H143O38N5P 
29 1857.05 1859.9 C82H147O39N5P 
30 1901.08 1904.0 C84H151O40N5P 
31 1945.11 1948.1 C86H155O41N5P 
32 1989.14 1992.1 C88H159O42N5P 
33 2033.17 2036.3 C90H163O43N5P 
34 2077.20 2080.4 C92H167O44N5P 
35 2121.23 2124.5 C94H171O45N5P 
36 2165.26 2168.6 C96H175O46N5P 
37 2209.29 2212.7 C98H179O47N5P 
38 2253.32 2256.7 C100H183O48N5P 
39 2297.35 2230.7 C102H187O49N5P 
 
Experimental section 
 145
6.3.2 Analysis of the initiator nucleotides 
 
High-performance liquid chromatography of the initiator nucleotides 
 
The purity of the initiator nucleotides A-D was confirmed by analytical HPLC. For initiator 
nucleotide 7a and b gradient I1 was used, initiator nucleotides 7c and d were analysed using 
gradient I2. 
 
  Gradient I1     Gradient I2 
 
 
 
 
 
 
 
Table 23 : Retention time of the initiator nucleotides 7a-d. 
 
 
 
 
 
 
 
 
 
MALDI TOF Mass spectrometry of the initiator nucleotides 
 
The samples for analysis were prepared using the dried droplet method with dithranol in 1:10 
v/v water/ acetone as matrix solutions; detection in the positive mode. 
Time [min] Buffer B [%]  Time [min] Buffer B [%] 
0 5  0 15 
25 40  15 40 
40 80  50 60 
45 100  55 100 
60 100  60 100 
65 5  65 15 
Initiator nucleotide Gradient Retention time Rt [min]  
a I1 32.7-35.4 
b I1 36.0-37.7 
c I2 26.7-33.4 
d I2 39.6-44.4 
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6.3.3 Alternative procedures towards the synthesis of initiator nucleotides 
 
(4,4´-Dimethoxytrityl)-polyethylene glycol PEG 1500 (13d) 
 
DMTO
O
H
n
PEG 1500  
 
PEG 1500 (50 g, 33 mmol) was dried by coevaporation with toluene (3 x 100 mL) and 
suspended in 25 mL acid free CH2Cl2 (stored over K2CO3). Triethylamine (1.7 mL, 12.33 
mmol, 0.37 eq.) and 4-dimethylaminopyridine (DMAP) (40 mg, 0.33 mmol, 0.01 eq.) were 
added. A solution of 4,4´-dimethoxytriphenylmethylchloride (902 mg, 2.66 mmol, 0.08 eq.) in 
9 mL acid free CH2Cl2 was slowly added by a syringe pump over 3 h 35 min at r.t.. The 
solution was than diluted with 75 mL CH2Cl2 and washed with 5% NaHCO3 (2 x 75 mL), 
water (3 x 75 mL), and brine (2 x 75 mL), dried over Na2SO4 and the solvent removed under 
reduced pressure. The crude PEG protected polyethylene glycol was purified by column 
chromatography (gradient pure EtOH, EtOH : DCM 1 : 1, preconditioned with EtOH 
containing 1% Et3N, Rf = 0.2 (EtOH)) on silica to afford a yellow oil (3.6 g, 75%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.44 (m, 1H, Ar-H), 7.33 (m, 2H, Ar-H), 7.26 
(m, 4H, Ar-H), 7.16 (m, 2H, Ar-H), 6.08 (m, 4H, Ar-H), 3.79 (t, J(H,H) = 4.2 Hz, 6H, CH3), 
3.63 (m, PEG CH2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 158.8 (2C, Ar-O), 139.7 (2C, Ar-H), 136.5 
(2C, Ar-C), 130.4 (2C, Ar-H), 129.1 (2C, Ar-H), 128.3 (1C, Ar-H), 128.0 (2C, Ar-H), 113.4 
(2C, Ar-H), 86.1 (1C, Ar3CO), 70.8 (PEG CH2), 62.0 (PEG CH2), 55.5 (CH3). 
MALDI MS: m/z 1884.8 [M+Na]+ (calculated for [C91 H160O38+Na]+ 1884.18). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
19 1179.7 1180.1 C59H96 O22 
20 1223.73 1224.1 C61H100O23 
21 1267.76 1268.1 C63H104O24 
22 1311.79 1312.2 C65H108O25 
23 1355.82 1356.2 C67H112O26 
24 1399.85 1400.3 C69H116O27 
25 1443.88 1444.3 C71H120O28 
26 1487.91 1488.4 C73H124O29 
27 1531.94 1532.5 C75H128O30 
28 1575.97 1576.5 C77H132O31 
29 1620.00 1620.6 C79H136O32 
30 1664.03 1664.6 C81H140O33 
31 1707.06 1708.7 C83H144O34 
32 1752.09 1752.7 C85H148O35 
33 1796.12 1797.7 C87H152O36 
34 1840.15 1840.8 C89H156O37 
35 1884.18 1884.8 C91H160O38 
36 1928.21 1928.8 C93H164O39 
37 1972.24 1973.9 C95H170O40 
38 2016.27 2017.9 C97H174O41 
39 2060.30 2063.0 C99H178O42 
40 2104.33 2106.0 C101H182O43 
41 2148.36 2150.0 C103H186O44 
 
Experimental section 
 148
DMT and TBDMS protected PEG 600 (20c) 
 
O
SiO
O
O
n
PEG 600  
 
General procedure VI 
 
Mono DMT protected polyethylene glycol PEG 600 13a (7.34 g, 8.23 mmol) was dissolved in 
60 mL dry DMF under argon and TBDMS-Cl (1.5 g, 9.9 mmol, 1.2 eq.) and imidazole (1.68 
g, 24.7 mmol, 3 eq.) were added and stirred over night. The reaction mixture was diluted with 
60 mL DCM and 100 mL H2O. The aqueous solution was extracted with DCM (2 x 50 mL) 
and the combined organic layers were washed with 5% NaHCO3 (50 mL), H2O (4 x 50 mL) 
and brine (60 mL), dried over Na2SO4 and the solvent removed under reduced pressure. The 
crude product was purified by column chromatography (pure EtOH, preconditioned with the 
EtOH containing 1% Et3N, Rf = 0.93 -0.51, (EA : EtOH 7 : 3) on silica to afford a yellow oil 
(6.3 g, 76%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.50 (d, J(H,H) = 7.1 Hz, 2H, Ar-H), 7.36 (d, 
J(H,H) = 9.0 Hz, 4H, Ar-H), 7.30 (d, J(H,H) = 7.8 Hz, 2H, Ar-H), 7.21 (t, J(H,H) = 7.2 Hz, 
1H, Ar-H), 6.88 (d, J(H,H) = 8.9 Hz, 4H, Ar-H), 3.79 (s, 6H, OCH3), 3.57 (m, PEG CH2), 
0.90 (s, 9H, C(CH3)3), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 160.49 (2C, Ar-O), 147.40 (1C, Ar-C), 
138.16 (1C, Ar-C), 131.91 (4C, Ar-H), 130.00 (2C, Ar-H), 129.50 (2C, Ar-H), 128.40 (1C, 
Ar-H), 114.79 (4C, Ar-H), 87.57 (1C, Ar3CO), 72.23 (PEG CH2), 63.08 (2C, OCH3), 27.28 
(3C, C(CH3)3), 19.85 (1C, C(CH3)3), -4.07 (2C, Si(CH3)2). 
MALDI MS: m/z 1030.0 [M+Na]+ (calculated for [C53H86O16Si +Na]+ 1029.56), m/z 1046.0 
[M+K]+ (calculated for [C53H86O16Si +K]+ 1045.67). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
10 897.47 898.0 913.58 914.0 C47H74O13Si 
11 941.50 942.0 957.61 958.0 C49H78O14Si 
12 985.53 986.0 1001.64 1002.1 C51H82O15Si 
13 1029.56 1030.0 1045.67 1046.0 C53H86O16Si 
14 1073.59 1074.1 1089.70 1090.0 C55H90O17Si 
15 1117.62 1118.1 1133.73 1134.1 C57H94O18Si 
16 1161.65 1162.1 1177.76 1178.1 C59H98O19Si 
17 1205.68 1206.2 - - C61H102O20Si 
18 1249.71 1250.3 - - C63H104O21Si 
19 1293.74 1295.1 - - C65H108O22Si 
 
DMT and TBDMS protected PEG 1500 (20d) 
 
 
 
Compound 20dwas synthesized from polyethylene glycol PEG 1500 13d (3.6 g, 2.0 mmol), 
TBDMS-Cl (0.38 g, 2.5 mmol, 1.25 eq.) and imidazole (0.41 g, 6.0 mmol, 3 eq.) in 45 mL dry 
DMF. For workup the reaction mixture was diluted with DCM (200 mL) and washed with 5% 
NaHCO3 (3 x 50 mL), H2O (4 x 75 mL) and brine (3 x 75 mL), dried over Na2SO4 and the 
solvent removed under reduced pressure. The crude product was purified by column 
chromatography (EtOH : DCM 1 : 1, preconditioned with the EtOH containing 1% Et3N, Rf = 
0.8 DCM : EtOH 1 : 1) on silica to afford a yellow oil (2.7 g, 70%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.33 (m, 9 H, Ar-H), 6.87 (d, J(H,H) = 8.9 Hz, 4 
H, Ar-H), 3.62 (m, PEG CH2), 1.1 (t, J(H,H) = 7.0 Hz, 9 H, m, PEG CH2), 0.07 (s, 4 H). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 160.3, 147.2, 137.9, 129.8, 129.4, 128.3, 
114.7, 87.4, 72.1, 64.9, 56.4, 27.4, 19.7. 
MALDI MS: m/z 1664.01 [M+Na]+ (calculated for [C81H142O35Si+K+2H]+ 1665.1). 
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n 
Calculated 
[M+K+2H]+ 
Found 
[M+K+2H]+
Calculated
[M+K+Li]+
Found 
[M+K+Li]+
Formula 
14 1091.62 1097.6 1096.62 1097.6 C55H90 O17Si 
15 1135.65 1335.7 1140.65 1141.7 C57H94 O24Si 
16 1179.68 1185.7 1184.68 1185.7 C59H98 O25Si 
17 1223.71 1223.7 1228.71 1229.7 C61H102O26Si 
18 1267.74 1273.8 1272.74 1273.8 C63H106O26Si 
19 1311.77 1311.8 1316.77 1317.8 C65H110O27Si 
20 1355.80 1361.8 1360.80 1361.8 C67H114O28Si 
21 1399.83 1405.9 1404.83 1405.9 C69H118O29Si 
22 1443.86 1449.9 1448.86 1449.9 C71H122O30Si 
23 1487.89 1494.0 1492.89 1494.0 C73H126O31Si 
24 1531.92 1532.0 1536.92 1538.0 C75H130O32Si 
25 1575.95 1576.0 1580.95 1582.1 C77H134O33Si 
26 1619.98 1620.0 1624.98 1626.1 C79H138O34Si 
27 1664.01 1665.1 1669.01 1670.1 C81H142O35Si 
28 1708.04 1708.1 1713.04 1714.2 C83H146O36Si 
29 1752.07 1752.2 1757.07 1758.2 C85H150O37Si 
30 1796.10 1796.2 1801.10 1803.3 C87H154O38Si 
31 1840.13 1841.2 1845.13 1846.3 C89H158O39Si 
32 1884.16 1884.3 1889.16 1890.3 C91H162O40Si 
33 1928.19 1929.3 1933.19 1935.3 C93H166O41Si 
34 1972.22 1972.3 1977.22 1978.4 C95H170O42Si 
35 2016.25 2017.4 2021.25 2022.4 C97H174O43Si 
36 2060.28 2061.4 2065.28 2067.4 C99H178O44Si 
37 2104.31 2105.4 2109.31 - C101H182O45Si 
38 2148.34 2149.4 2153.34 - C103H186O46Si 
39 2192.37 2193.5 2197.37 - C105H190O47Si 
40 2236.40 2237.5 2241.40 - C107H194O48Si 
41 2280.43 2281.6 2285.43 - C109H198O49Si 
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t-Butyl dimethylsilyl polyethylene glycol PEG 600 (22c) 
 
O
SiHO
n
PEG 600  
 
General procedure VII 
 
DMT and TBDMS protected PEG 600 21c (6.3 g, 6.26 mmol) were dissolved in 143.3 mL 
3% TCA in DCE. The reaction mixture was stirred for 5 min at r.t. before it was quenched by 
200 mL saturated NaHCO3 solution and extracted with 250 mL DCM. The combined organic 
layers were washed with brine (2 x 120 mL), dried over Na2SO4 and the solvent removed 
under reduced pressure. The crude product was purified by column chromatography (gradient 
EtOAc : MeOH 98 : 2, EtOAc : MeOH : CH2Cl2 77 : 15 : 8) on silica to afford a pale yellow 
oil (2.2 g, 50%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 3.58 (m, PEG CH2), 2.82 (s, 1H, OH), 0.90 (s, 
9H, C(CH3)3), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 72.26 (PEG CH2), 64.54 (PEG CH2), 27.30 
(3C, C(CH3)3), 19.87 (1C, C(CH3)3), -4.06 (2C, Si(CH3)2). 
MALDI MS: m/z 683.5 [M+Na]+ (calculated for C30H64O13Si+Na]+ 683.40), m/z 699.5 
[M+K]+ (calculated for [C30H64O13Si+K]+ 699.51). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
8 507.28 507.3 523.39 523.3 C22H46O9Si 
9 551.31 551.3 567.42 567.3 C24H50O10Si 
10 595.34 595.4 611.45 611.4 C26H54O11Si 
11 639.37 639.5 655.48 655.4 C28H60O12Si 
12 683.40 683.5 699.51 699.5 C30H64O13Si 
13 727.43 727.5 743.54 743.5 C32H68O14Si 
14 771.46 771.6 787.57 787.5 C34H72O15Si 
15 815.49 815.6 - - C36H76O16Si 
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t-Butyl dimethylsilyl polyethylene glycol PEG 600 (22d) 
 
 
 
Compound 22d was synthesized by deprotecting DMT and TBDMS protected PEG 600 21d 
(2.6 g, 1.5 mmol) with 34 mL 3% TCA in DCE for 7.5 min and quenched by 45 mL saturated 
NaHCO3 solution and extracted with 55 mL DCM. The combined organic layers were washed 
with brine (45 mL), dried over Na2SO4 and the solvent removed under reduced pressure. The 
crude product was purified by column chromatography (gradient EtOAc : MeOH 98 : 2, 
EtOH : CH2Cl2 1 : 1) on silica to afford a white solid (1.7 g, 78 %). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 3.58 (m, PEG CH2), 2.80 (s, 1H, OH), 0.90 (s, 
9H, C(CH3)3), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 70.6 (PEG CH2), 61.3 (PEG CH2), 25.7 
(3C, C(CH3)3), 20.7 (1C, C(CH3)3), -4.07 (2C, Si(CH3)2). 
MALDI MS: m/z not observed [M+Na]+ (calculated for C70H144O32Si+Na]+ 1547.93), m/z 
1582.3 [M+ K+2H]+ (calculated for [C70H144O32S+ K+2H]+ 1582.03). 
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n 
Calculated 
[M+K+2H]+ 
Found 
[M+K+2H]+ 
Formula 
20 1053.67 1053.8 C46H86 O20Si 
21 1097.7 1097.8 C48H100O21Si 
22 1141.73 1141.9 C50H104O22Si 
23 1185.76 1185.9 C52H108O23Si 
24 1229.79 1229.9 C54H112O24Si 
25 1273.82 1274.0 C56H116O25Si 
26 1317.85 1318.0 C58H120O26Si 
27 1361.88 1362.1 C60H124O27Si 
28 1405.91 1406.1 C62H128O28Si 
29 1449.94 1450.1 C64H132O29Si 
30 1493.97 1494.2 C66H136O30Si 
31 1538.00 1538.2 C68H140O31Si 
32 1582.03 1582.3 C70H144O32Si 
33 1626.06 1626.3 C72H148O33Si 
34 1670.09 1670.3 C74H152O34Si 
35 1714.12 1714.3 C76H156O35Si 
36 1758.15 1758.4 C78H160O36Si 
37 1802.18 1802.4 C80H164O37Si 
38 1846.21 1847.4 C82H170O38Si 
39 1890.24 1891.4 C84H174O39Si 
40 1934.27 1935.4 C86H178O40Si 
41 1978.30 1979.4 C88H182O41Si 
42 2022.33 2023.4 C90H186O42Si 
43 2066.36 2067.5 C92H190O43Si 
44 2110.39 2111.5 C94H194O44Si 
45 2154.42 2154.5 C96H198O45Si 
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t-Butyldimethylsilyl polyethylen glycol p-toluolsulfonat PEG 600 (23c) 
 
O
SiO
n
PEG 600
S
O
O
 
 
General procedure VIII 
 
TBDMS protected PEG 600 22c (1.7 g, 2.41 mmol) was coevaporated with toluene (3 x 50 
mL), dissolved under argon in 15 mL dry DCM. DMAP (14.7 mg, 0.12 mmol, 0.05 eq.) and 
trietylamine (1.2 mL, 7.23 mmol, 3 eq) were added, cooled down to 0°C in an ice/ water bath 
to add TsCl (0.51 g, 2.65 mmol, 1.1 eq.). The reaction mixture was allowed to warm up and 
stirred for 12 h at r.t.. The reaction mixture was diluted with 50 mL EtOAc, washed with 5% 
NaHCO3 (2 x 75 mL), H2O (2 x 50 mL) and brine (2 x 50 mL), dried over Na2SO4 and the 
solvent removed under reduced pressure to yield an pale yellow oil (1.8 g, 87%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.82 (d, J(H,H) = 8.4 Hz, 2H, Ar-H), 7.49 (d, 
J(H,H) = 8.0 Hz, 2H, Ar-H), 3.58 (m, PEG CH2), 2.46 (s, 3H, Ar-CH3), 0.89 (s, 9H, 
C(CH3)3), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 146.75 (1C, Ar-CH3), 135.34 (1C, Ar-SO2), 
131.82 (2C, Ar-H), 129.71 (2C, Ar-H), 72.23 (PEG CH2), 27.28 (3C, C(CH3)3), 22.53 (1C, 
Ar-CH3), 19.85 (1C, C(CH3)3), -4.07 (2C, Si(CH3)2). 
MALDI MS: m/z 837.4 [M+Na]+ (calculated for C37H70O15SSi+Na]+ 837.41), m/z 853.4 
[M+K]+ (calculated for [C37H70O15SSi+K]+ 853.52). 
 
n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculated 
[M+K]+ 
Found 
[M+K]+ 
Formula 
9 705.32 705.3 721.43 721.3 C31H58O12SSi 
10 749.35 749.3 765.46 765.3 C33H62O13SSi 
11 793.38 793.4 809.49 809.3 C35H66O14SSi 
12 837.41 837.4 853.52 853.4 C37H70O15SSi 
13 881.44 881.4 897.55 897.4 C39H74O16SSi 
14 925.47 925.4 941.58 941.4 C41H78O17SSi 
15 969.50 969.4 - - C43H82O18SSi 
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t-Butyl dimethylsilyl polyethylene glycol p-toluenesulfonate PEG 1500 (23d) 
 
O
SiO
n
PEG 1500
Ts
 
 
Compound 23d was synthesized according to general procedure VIII from t-butyl 
dimethylsilyl polyethylene glycol PEG 1500 22d (1.7 g, 1.04 mmol) in 5.5 mL dry DCM, 
DMAP (6.3 mg, 0.052 mmol, 0.05 eq.) and TEA (0.44 mL, 3.12 mmol, 3 eq.). For the work 
up the reaction was diluted with EtOAc (25 mL) and washed with 5% NaHCO3 (2 x 35 mL), 
H2O (2 x 25 mL) and brine (2 x 25 mL) to yield a white solid (1.4 g, 75%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.82 (d, J(H,H) = 8.4 Hz, 2H, Ar-H), 7.49 (d, 
J(H,H) = 8.0 Hz, 2H, Ar-H), 3.59 (m, PEG CH2), 2.47 (s, 3H, Ar-CH3), 0.90 (s, 9H, 
C(CH3)3), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 146.7 (1C, Ar-CH3), 136.2 (1C, Ar-SO2), 
131.82 (2C, Ar-H), 129.71 (2C, Ar-H), 72.3 (PEG CH2), 70.3 (PEG CH2), 22.5 (3C, 
C(CH3)3), 22.50 (1C, Ar-CH3), 15.5 (1C, C(CH3)3), -4.07 (2C, Si(CH3)2). 
MALDI MS: m/z not observed [M+Na]+ (calculated for C77H150O35SSi+Na]+ 1695.06), m/z 
1709.2 [M+K]+ (calculated for [C37H70O15SSi+2 Li]+ 1709.09). 
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n 
Calculated 
[M+2Li]+ 
Found 
[M+2Li]+ 
Formula 
22 1268.79 1268.8 C57H110O25SSi 
23 1312.82 1312.8 C59H114O26SSi 
24 1356.85 1356.8 C61H118O27SSi 
25 1400.88 1400.9 C63H122O28SSi 
26 1444.91 1444.9 C65H126O29SSi 
27 1488.94 1489.0 C67H130O30SSi 
28 1532.97 1533.0 C69H134O31SSi 
29 1577.00 1577.1 C71H138O32SSi 
30 1621.03 1621.1 C73H142O33SSi 
31 1665.06 1665.1 C75H146O34SSi 
32 1709.09 1709.2 C77H150O35SSi 
33 1753.12 1753.2 C79 H154O36SSi 
34 1797.15 1797.3 C81H158O37SSi 
35 1841.18 1841.3 C83H162O38SSi 
36 1885.21 1885.3 C85H166O39SSi 
37 1929.24 1930.4 C87H170O40SSi 
38 1973.27 1973.4 C89H174O41SSi 
39 2017.30 2017.4 C91H178O42SSi 
40 2061.33 2067.3 C93H182O43SSi 
41 2105.36 2105.3 C95H186O44SSi 
42 2149.39 2155.3 C97H190O45SSi 
43 2193.42 2193.4 C99H194O46SSi 
44 2237.45 2243.4 C101H198O47SSi 
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TBDMS protected 2-(4-(5, 5-Diethyl-1, 3-dioxan-2-yl)phenoxy) polyethylene glycol PEG 
600 (24c) 
 
 
SiO
O
O
O
n
PEG 600  
 
General procedure IX 
 
Under argon 4-(5,5-diethyl-1,3-dioxan-2-yl)phenol 19 (0.68 g, 2.88 mmol, 1.8 eq.) were 
dissolved in 25 mL dry ACN and cooled in an ice/ water bath to 0°C. NaH (128 mg 60% in 
oil, 3.2 mmol, 2 eq.) were added and the reaction stirred for  10 min at 0 °C before allowing it 
to warm up to r.t. The reaction mixture was stirred for another 15 min at r.t. before t-butyl 
dimethylsilyl polyethylene glycol p-toluenesulfonate PEG 600 23d (1.4 g, 1.6 mmol), which 
had been coevaporated with toluene (3 x 20 mL) was added dropwise via a dropping funnel in 
50 mL dry ACN. The reaction mixture was stirred for 90 h and diluted with 100 mL DCM, 
washed with H2O (3 x 150 mL), 5% NaHCO3 (3 x 150 mL) and brine (3 x 150 mL), dried 
over Na2SO4 and the solvent removed under reduced pressure. The curd product was purified 
by column chromatography (gradient EtOAc : EtOH 8 : 2, DCM : EtOH 1 : 1, Rf = 0.48 
(Hexan : EtOH 8 : 2)) on silica to afford a pale yellow oil (0.9 g, 61%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.37 (d, J(H,H) = 8.7 Hz, 2H, Ar-H), 6.92 (d, 
J(H,H) = 8.8 Hz, 2H, Ar-H), 5.36 (s, 1H, CH), 3.57 (m, (PEGCH2+CH2O)), 1.80 (q, J(H,H) = 
7.6 Hz, 2H, CH2a), 1.15 (q, J(H,H) = 7.5 Hz, 2H, CH2b), 0.90 (s, 9H, C(CH3)3), 0.88 (t, 
J(H,H) = 7.6 Hz, 3H, CH3a), 0.81 (t, J(H,H) = 7.6 Hz, 3H, CH3b), 0.07 (s, 6H, Si(CH3)2). 
13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 161.08 (1C, Ar-O), 129.73 (1C, Ar-CH), 
129.39 (2C, Ar-H), 115.71 (2C, Ar-H), 103.45 (1C, Ar-CH), 76.14 (PEGCH2), 74.34 (11), 
72.26 (PEGCH2),  36.35 (1C, C), 27.30 (3C, C(CH3)3), 25.94 (2C, CH2O), 24.37 (1C, 
C(CH3)3), 7.91 (2C, CH3) -4.05 (2C, Si(CH3)2). 
MALDI MS: m/z 901.5 [M+Na]+ (calculated for C44H82O15Si+Na]+ 901.53), m/z 917.4 
[M+K]+ (calculated for [C44H82O15Si+K]+ 917.64). 
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n 
Calculated 
[M+Na]+ 
Found 
[M+Na]+ 
Calculate 
[M+K]+ 
Found 
[M+K]+ 
Formula 
9 769.44 769.4 - - C38H70O12Si 
10 813.47 813.4 - - C40H74O13Si 
11 857.50 857.5 873.61 873.4 C42H78O14Si 
12 901.53 901.5 917.64 917.4 C44H82O15Si 
13 945.56 945.5 961.67 961.5 C46H86O16Si 
14 989.59 989.5 - - C48H90O17Si 
15 1033.62 1033.5 - - C50H94O18Si 
 
TBDMS protected 2-(4-(5, 5-Diethyl-1, 3-dioxan-2-yl)phenoxy) polyethylene glycol PEG 
1500 (24d) 
 
TBDMSO
O
O
O
n
PEG 1500  
 
Compound 24d was synthesized according to general procedure IX from 4-(5,5-diethyl-1,3-
dioxan-2-yl)phenol 19 (130 mg, 0.55 mmol, 1.8 eq.) in 25 mL dry ACN, NaH (13 mg 60% in 
oil, 0.55 mmol, 1.1 eq.), t-butyl dimethylsilyl polyethylene glycol p-toluenesulfonate PEG 
1500 23d (1.4 g, 0.50 mmol)) in 12 mL dry ACN. The reaction mixture was stirred for 48 min 
and diluted with 50 mL DCM, washed with H2O (3 x 75 mL), 5% NaHCO3 (3 x 75 mL) and 
brine (3 x 75 mL), dried over Na2SO4 and the solvent removed under reduced pressure. The 
curd product was purified by column chromatography (gradient EtOAc : EtOH 8 : 2, DCM . 
EtOH 1 : 1) on silica to afford a white solid (0.9 g, 99%). 
 
1H NMR (300 MHz, (CD3)2CO, 295 K): δ = 7.28 (d, J(H,H) = 8.5 Hz, 2H, Ar-H), 6.81 (d, 
J(H,H) = 8.5 Hz, 2H, Ar-H), 5.62 (s, 1H, CH), (s, 1H), 3.59 (m, (PEGCH2+CH2O)), 1.80 (q, 
J(H,H) = 7.6 Hz, 2H, CH2a), 1.15 (q, J(H,H) = 7.6 Hz, 2H, CH2b), ), 0.90 (s, 9H, C(CH3)3), 
0.88 (t, J(H,H) = 7.6 Hz, 3 H, CH3a), 0.81 (t, J(H,H) = 7.6 Hz, 3 H CH3b), 0.07 (s, 6H, 
Si(CH3)2). 
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13C{1H} NMR (75 MHz, (CD3)2CO, 295 K): δ = 159.4 (1C, Ar-O), 131.7 (1C, Ar-CH), 
129.3 (2C, Ar-H), 116.3 (2C, Ar-H), 103.5 (1C, Ar-CH), 75.9 (PEGCH2), 72.1 (PEGCH2), 
36.2 (1C, C), 25.8 (3C, C(CH3)3), 24.2 (2C, CH2O), 22.4 (1C, C(CH3)3), 8.7 (2C, CH3) -4.05 
(2C, Si(CH3)2). 
MALDI MS: m/z 1758.1 [M]+ (calculated for C84H162O35Si]+ 1759.18), m/z 1774.4 [M+2Li]+ 
(calculated for [C84H82O15Si+2Li]+ 1773.22), m/z 1780.5 [M+Na]+ (calculated for 
[C44H82O15Si+Na]+ 1782.18). 
 
n 
Calculated 
[M]+ 
Found 
[M]+ 
Calculated
[M+2Li]+ 
Found 
[M+2Li]+ 
Calculated
[M+Na]+ 
Found 
[M+Na]+ 
Formula 
20 1230.82 1229.9 1244.86 - 1253.82 1251.9 C60H114O23Si 
21 1274.85 1273.9 1288.89 - 1297.85 1295.9 C62H118O24Si 
22 1318.88 1317.9 1332.92 - 1341.88 1339.9 C64H122O25Si 
23 1362.91 1362.0 1376.95 - 1385.91 1384.0 C66H126O26Si 
24 1406.94 1406.0 1420.98 - 1429.94 1428.0 C68H130O27Si 
25 1450.97 1450.1 1465.01 - 1473.97 1472.1 C70H134O28Si 
26 1495.00 1494.1 1509.04 1510.1 1518.00 1516.2 C72H138O29Si 
27 1539.03 1538.1 1553.07 1554.1 1562.03 1560.3 C74H142O30Si 
28 1583.06 1582.2 1597.10 1599.2 1606.06 1604.3 C76H146O31Si 
29 1627.09 1626.3 1641.13 1642.3 1650.09 1648.3 C78H150O32Si 
30 1671.12 1670.3 1685.16 1686.3 1694.12 1692.4 C80H154O33Si 
31 1715.15 1714.3 1729.19 1730.4 1738.15 1736.4 C82H158O34Si 
32 1759.18 1758.1 1773.22 1774.4 1782.18 1780.5 C84H162O35Si 
33 1803.21 1802.4 1817.25 1819.4 1826.21 1824.5 C86H166O36Si 
34 1847.24 1846.5 1861.28 1868.5 1870.24 1868.5 C88H170O37Si 
35 1891.27 1890.5 1905.31 1906.6 1914.27 1912.6 C90H174O38Si 
36 1935.30 1934.6 1949.34 1951.6 1958.30 1956.6 C92H178O39Si 
37 1979.33 1978.6 1993.37 1995.6 2002.33 1998.6 C94H182O40Si 
38 2023.36 2022.7 2037.40 2039.7 2046.36 2043.7 C96H186O41Si 
39 2067.39 2066.7 2081.43 2083.7 2090.39 2087.2 C98H190O42Si 
40 2111.42 2107.8 2125.46 2127.7 2134.42 2130.7 C100H194O43Si 
41 2155.45 2151.8 2169.49 2171.7 2178.45 2175.8 C102H198O44Si 
42 2199.48 2195.8 2213.52 2215.7 2222.48 - C104H202O45Si 
43 2243.51 2239.9 2257.55 2259.8 2266.51 - C106H206O46Si 
44 2287.54 2283.9 2301.58 2303.8 2310.54 - C108H210O47Si 
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Deprotection of 2-(4-(5, 5-Diethyl-1, 3-dioxan-2-yl)phenoxy) polyethylene glycol (25c / d) 
 
Procedure A 
 
2-(4-(5, 5-Diethyl-1, 3-dioxan-2-yl)phenoxy) polyethylene glycol 25c/d (0.9g, 0.59 mmol) 
was stirred in 1 M TBAF in THF (1.18 mL, 1.18 mmol, 2 eq.) for 1 h at r.t. and evaporated to 
dryness. The crude product was purified with column chromatography (gradient EtOAc : 
EtOH 8 : 2, DCM : EtOH 1 : 1) on silica followed by ion exchange column to exchange TBA+ 
against Na+ ions, followed by an other column chromatography (gradient EtOAc : Hex : DCM 
7 : 2 : 1, DCM : EtOH 1 : 1). MALDI-TOF analysis revealed that the product had only 
partially been deprotected. 
 
Procedure B 
 
2-(4-(5, 5-Diethyl-1, 3-dioxan-2-yl)phenoxy) polyethylene glycol 25c/d (20 mg, 0.013 mmol) 
was stirred with 3 HF x TEA (32 μL, 0.320 mmol), 0.6 mL THF and 0.1 mL TEA for 24 h. 
The reaction mixture was diluted with 15 mL EtOAc (15 ml) washed with saturated NaHCO3-
solution (3 x 25 mL) dried over Na2SO4 and the solvent removed under reduced pressure. 
MALDI-TOF MS analysis confirmed that the product had only partially been deprotected. 
Experimental section 
 161
6.4 Synthetic procedures for compounds chapter 4 
 
N-Pentylmaleimide (31b) 
 
 
 
General procedure X 
 
N-Pentylamine 30b (6.7 mL, 57.48 mmol) and maleic anhydride 29 (6.2 g, 63.23 mmol 1.1 
eq.) were suspended in 320 mL toluene and stirred at 30°C for 1h. Hexamethyldisilazane 
(HMDS) (10.58 mL, 86.22 mmol, 1.5 eq.) in 35 mL toluene and ZnBr2 (14.24 g, 63.23 mmol, 
1.1eq.) were added and the reaction mixture refluxed for 3 h. The heating source was removed 
and the mixture stirred over night. The reaction mixture was poured into 150 mL 0.5 M HCl. 
The organic layer was separated and the aqueous phase was re-extracted with EtOAc ( 2x 170 
mL). The combined organic layers were washed with saturated NaHCO3 (2 x 170 mL) and 
brine (2 x 170 mL), dried over Na2SO4 and the solvent was removed under reduced pressure. 
The crude product was purified by column chromatography (DCM : MeOH 99 : 1, Rf = 0.68) 
on silica to afford a slightly brown crystalline solid (7.88 g, 82%). 
 
C9H13NO2 (167.09 g mol-1). 
1H NMR (300 MHz, CDCl3, 295 K): δ = 6.67 (s, 2 H, CH), 3.49 (t, J(H,H) = 7.5 Hz, 2H, 
NCH2), 1.58 (quint., J(H,H) = 7.5 Hz, 2H, CH2), 1.28 (m, 4H, CH2), 0.87 (t, J(H,H) = 7.2 Hz, 
2H, CH2). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 170.85 (2C, CO), 134.08 (2C, CH), 37.86 (1C, 
CH2), 28.81 (1C, CH2), 28.17 (1C, CH2), 22.16 (1C, CH2), 13.88 (1C, CH3). 
HR-ESI MS: 168.1019 m/z [M]+ (calculated for [C9H13NO2]+ 167.09). 
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6-Maleimidocaproic acid (31c) 
 
N
O
O
OH
O
 
 
Analogue to general procedure X aminocaproic acid 31a (2.6 g, 20.4 mmol) and maleic 
anhydride 29 (2.2 g, 22.4 mmol 1.1 eq.), suspended in a mixture of 110 mL toluene and 60 
mL ACN were reacted with HMDS (3.75 mL, 30.6 mmol, 1.5 eq.) in 10 mL toluene and 
ZnBr2 (5 g, 22.4 mmol, 1.1eq.). Work up was carried out as described accept the aqueous 
phase was acidified with concentrated HCl before extraction. A white solid was obtained (3.5 
g, 74%). 
 
C10H13NO4 (211.08 g mol-1). 
1H NMR (300 MHz, CDCl3, 295 K): δ = 11.28 (s, 1H, OH), 6.67 (s, 2 H, CH), 3.49 (t, 
J(H,H) = 7.2 Hz, 2H, NCH2), 2.32 (t, J(H,H) = 7.5 Hz, 2H, CH2), 1.61 (m, 4H, CH2), 1.31 
(m, 2H, CH2). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 179.33 (2C, COOH), 170.83 (2C, CO), 134.04 
(2C, CH), 37.56 (1C, CH2), 33.71 (1C, CH2), 28.13 (1C, CH2), 26.08 (1C, CH2), 24.06 (1C, 
CH3). 
HR-ESI MS: 210.0791 m/z [M] (calculated for [C10H13NO4] 211.08). 
 
Boc-protected 6-maleimidocaproic acid (32) 
 
 
 
6-Maleimidocaproic acid 31a (500 mg, 2.39 mmol) was dissolved in 30 mL acetonitrile and 
N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl) (504 mg, 2.63 
mmol, 1.1 eq.) and t-butyl carbazate (379 mg, 2.87 mmol, 1.2 eq.) were added and stirred 
over night. The reaction mixture was separated between EtOAc (25 mL) and 0.5 M HCl (25 
mL). The combined organic layers were washed with H2O (3 x 25 mL) and brine (3 x 25 mL), 
dried over Na2SO4 and the solvent removed under reduced pressure. The crude product was 
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purified by column chromatography (pure EtOAc, Rf = 0.7) on silica to afford a yellow oil 
(310 mg, 61%). 
 
C15H23N3O5 (325.16 g mol-1). 
1H NMR (300 MHz, CDCl3, 295 K): δ = 7.20 (s, 1H, NH), 6.67 (s, 2 H, CH), 6.46 (s, 1H, 
NH), 3.50 (t, J(H,H) = 7.2 Hz, 2H, NCH2), 2.21 (t, J(H,H) = 4.5 Hz, 2H, CH2), 1.79 (m, 2H, 
CH2), 1.60 (m, 2H, CH2), 1.47 (s, 9H, CH3), 1.35 (m, 2H, CH2). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 172.14 (1C, CH2CONH), 170.84 (2C, CO), 
155.40 (1C, COC(CH3)3), 134.04 (2C, CH), 81.83 (1C, C(CH3)3), 37.50 (1C, CH2), 33.77 
(1C, CH2), 28.25 (1C, CH2), 28.14 (3C, CH3)3), 26.14 (1C, CH2), 24.51(1C, CH2). 
MALDI MS: m/z 348.0 [M]+ (calculated for [C15H23N3O5+Na]+ 348.15). 
 
6-Maleimidocaproic acid hydrazide (33) 
 
 
 
Boc-protected 6-maleimidocaproic acid hydrazide 32 (269 mg, 2.39 mmol) was dissolved in 
dichloromethane under semi dry conditions and cooled on an ice bath. TFA was added to a 
10% v/v and the reaction mixture was allowed to warm up to r.t., stirred for 17 h and 
evaporated to yield a yellow solid, the reaction could not be further purified and yielded the 
TFA salt, which has a molecular weight of 339.10 g mol-1 (395 mg, 93%). 
 
C10H15N3O3 (225.11 g mol-1). 
1H NMR (300 MHz, CDCl3, 295 K): δ = 9.18 (s, 1H, NH), 6.69 (s, 2 H, CH), 6.49 (s, 1H, 
NH), 3.51 (m, 2H, NCH2), 2.35 (m, 2H, CH2), 1.74 (m, 4H, CH2), 1.31 (m, 2H, CH2). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 171.04 (1C, CH2CONH), 170.97 (2C, CO), 
134.09 (2C, CH), 37.32 (1C, CH2), 33.63 (1C, CH2), 27.83 (1C, CH2), 25.77 (1C, CH2), 
24.33(1C, CH2). 
MALDI MS: m/z 248.0 [M+Na]+ (calculated for [C15H23N3O5+Na]+ 248.10). 
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DY 649 as maleimidocaproic acid hydrazide (34) 
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A stock solution of 6-maleimidocaproic acid hydrazide was prepared in abs. DMF. 10 µL 6-
maleimidocaproic acid hydrazide (1.984 µmol, 2.0 eq.) of this solution were transferred into a 
solution of the DY 649 NHS ester (0.992 µmol) in 50 µL DMF. 1.38 µL trietylamine (9.92 
µmol, 10 eq.) were added and the reaction vial placed in a thermo shaker at 650 rpm at 25°C 
for 1 h. MALDI-TOF analysis showed that no reaction had taken place. 0.28 µL DIPEA (2.96 
µmol, 3 eq.) were added and the reaction incubated for additional 36 h at 25°C. The progress 
of the reaction was monitored by MALDI-TOF analysis. After 36 h most of the product had 
reacted but starting material could still be observed as well as some hydrolysis product of the 
dye. The reaction was evaporated and purified by semi-preparative HPLC chromatography. 
The integrity of the dye was only determined by HPLC and mass analysis, because the 
reaction was only performed in mg scale. 
 
C45H54N5O16S43- (1049.20 g mol-1). 
MS HR-ESI: m/z 1049.2528 [M]+ (calculated for [C45H54N5O16S43-]+ 1049.20), m/z 
1071.2352 [M+K]+ (calculated for [C45H54N5O16S43-+Na]+ 1072.19). 
HPLC: Phenomenex® Luna 5 μm C18 (4.6 × 250 mm), 1 mL/min, 25 °C, tR = 8 min, λ local 
max 256 nm. 
 
 
 
Time [min] Acetonitrile [%] 
0 5 
25 40 
30 100 
35 100 
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ATEG-(β-cyanoethyl-N, N-diisopropylphosphoramidite) (27a) 
 
O
O
4
P
O
N
NC
 
 
General procedure XI 
 
ATEG
 
(190 mg, 0.40 mmol) was suspended in 3 mL of dichloromethan
 
under argon and ethyl 
diisopropylamine (224 µL, 1.28 mmol, 3 eq.) were added. The mixture was cooled to 0ºC in 
an ice /water bath before addition of 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (93 
µL, 0.42 mmol, 1.04 eq.). The reaction mixture was stirred for 1 h, during which the 
temperature was slowly raised to r.t. and followed closely by TLC. After about 1 h the 
reaction mixture was directly submitted to column chromatography (pure EtOAc, Rf = 0.4) 
afford afforded the clean product as yellow oil (178 mg, 71%). 
 
C32H45N2O6P (584.31 g mol-1). 
1H NMR (500 MHz, CDCl3, 295 K): δ = 8.43 (m, 3H, Ar-H), 8.01 (m, 2H, Ar-H), 7.53 (m, 
2H, Ar-H), 7.47 (m, 2H, Ar-H), 5.55 (s, 2H, CH2Ar), 3.80-6.62 (m, 22H, PEG CH2, CH2 and 
CH), 1.16 (m, 12 H, CH3). 
31P NMR (500 MHz, CDCl3, 295 K): δ = 148.48 (s). 
MALDI MS: m/z 623.3 [M+K]+ (calculated for [C32H45N2O6P +K]+ 623.47). 
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AHEG-(β-cyanoethyl-N, N-diisopropylphosphoramidite)  
 
O
O
6
P
O
N
NC
 
Compound 27b was synthesize according to general procedure XI AHEG
 
(260 mg, 0.55 
mmol), ethyl diisopropylamine (290 µL, 1.65 mmol, 3 eq.) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (150 µL, 0.66 mmol, 1.2 eq.) to yield a clean product after 
column chromatography (pure EtOAc, Rf = 0.7) as yellow oil (309 mg, 84%). 
 
C36H53N2O8P (672.47 g mol-1). 
1H NMR (500 MHz, CDCl3, 295 K): δ = 8.43 (t, J(H,H) = 6.6 Hz, 3H, Ar-H), 8.00 (d, J(H,H) 
= 5.6 Hz, 2H, Ar-H), 7.54 (m, 2H, Ar-H), 7.47 (m, 2H, Ar-H), 5.55 (s, 2H, CH2Ar), 3.80-
6.61 (m, 22H, PEG CH2, CH2 and CH), 1.17 (m, 12 H, CH3). 
13C{1H} NMR (75 MHz, CDCl3, 295 K): δ = 172.14 (1C, CH2CONH), 170.84 (2C, CO), 
155.40 (1C, COC(CH3)3), 134.04 (2C, CH), 81.83 (1C, C(CH3)3), 37.50 (1C, CH2), 33.77 
(1C, CH2), 28.25 (1C, CH2), 28.14 (3C, CH3)3), 26.14 (1C, CH2), 24.51(1C, CH2). 
31P NMR (500 MHz, CDCl3, 295 K): δ = 148.48 (s). 
MALDI MS: m/z 673.4 [M+1]+ (calculated for [C36H53N2O8P+1]+ 673.41), m/z 695.4 
[M+Na]+ (calculated for [C36H53N2O8P+Na]+ 695.41). 
 
Addition-product tris(2-carboxyethyl)phosphine  and N-pentylmaleimide (35a/b) 
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Tris(2-carboxyethyl)phosphine hydrochloride (17.15 mg, 59.85 µmol) was dissolved in 1 mL 
water, respectively deuterium oxide and N-pentylmaleimide (10 mg, 59.85 µmol) was added, 
vortexed well and placed in a thermo shaker for 1 h at 25°C and 650 rpm, to best mimic the 
reaction conditions in the labeling reaction. The reaction in water was lyophilized and 
dissolved in deuterium oxide for NMR analysis, while from the reaction in D2O 700 µL were 
directly submitted to NMR analysis. The remaining reaction mixture was lyophilized and 
submitted to mass analysis.  
 
35a: 
C18H29NO8P (418.16 g mol-1). 
1H NMR (500 MHz, D2O, 295 K): δ = 3.55 (t, J(H,H) = 7.0 Hz, 3H, CH2N), 3.37 (m, 1H, 
CHP), 2.89 (m, 14H, CH2), 1.57 (quint., J(H,H) = 7.5 Hz, 2H, CH2), 1.29 (m, 4 H, CH2), 0.87 
(t, J(H,H) = 7.5 Hz, 3H, CH3). 
13C{1H} NMR (75 MHz, D2O, 295 K): δ = 176.17 (1C, COOH), 174.23 (1C, CO), 173.14 
(1C, CO), 39.96 (1C, CH2), 29.31 (1C, CH), 26.18 (1C, CH2), 25.93 (1C, CH2), 25.90 (1C, 
CH2), 21.44 (1C, CH2), 14.62 (1C, CH2), 14.22 (1C, CH2), 13.07 (1C, CH3). 
31P NMR (500 MHz, D2O, 295 K): δ = 39.12 (s). 
HR-ESI MS: 418.1550 m/z [M] (calculated for [C18H29NO8P] 418.1625). 
 
35b: 
C18H28DNO8P (419.17 g mol-1). 
1H NMR (500 MHz, D2O, 295 K): δ = 3.55 (t, J(H,H) = 7.0 Hz, 3H, CH2N), 3.37 (m, 1H, 
CHP), 2.87 (m, 14H, CH2), 1.57 (quint., J(H,H) = 7.5 Hz, 2H, CH2), 1.29 (m, 4 H, CH2), 0.87 
(t, J(H,H) = 7.5 Hz, 3H, CH3), 
13C{1H} NMR (75 MHz, D2O, 295 K): δ = 176.17 (1C, COOH), 174.21 (1C, CO), 173.15 
(1C, CO), 39.96 (1C, CH2), 28.25 (1C, CH), 26.19 (1C, CH2), 25.91 (1C, CH2), 25.88 (1C, 
CH2), 21.44 (1C, CH2), 14.61 (1C, CH2), 14.21 (1C, CH2), 13.07 (1C, CH3). 
31P NMR (500 MHz, D2O, 295 K): δ = 39.12 (s). 
HR-ESI MS: 419.1611 m/z [M] (calculated for [C18H28DNO8P] 419.1688). 
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6.5 Oligonucleotides, buffers and material 
 
Oligonucleotides 
 
Oligonucleotides were either synthesized by automated solid-phase synthesis on an Expedite 
8909 automated synthesizer by Applied Biosystems or ordered from IBA (Goettingen, 
Germany), NOXXON (Berlin, Germany), Eurofins MWG Operon (Ebersberg, Germany) or 
CSS – Chemical Synthesis Services (East Lothian, Scottland). 
Purchased oligonucleotides were HPLC purified and in case of the 49mer Diels-Alderase 
ribozyme desalted. 
 
49 nt Ribozyme: 
wt 
5’- GGA GCU CGC UUC GGC GAG GCC GUG CCA GCU CUU CGG AGC AAU ACU CGG C -3’ 
Mutants 
5’- GGA GCU CGC UUC GGC GAG GCC GUG CCA GCU CUU CGG AGC AAC ACU CGG C -3’ 
5’- GGA GCU CGC UUC GGC GAG GCC GUG CCA GCU CUU CGG AGC AAiC ACU CGG C -3’ 
 
49 nt Ribozym as bipartite system: 
38 nt: 5’- GGG CGA GGC CGU GCC AGC UCUUCGGAGCAAUACUCGGC -3’ 
11 nt: 5’- GGA GCU CGC CC -3’ 
11 nt modified: 
5’- AHEG-GGA GCU CGC CC -3’ 
 
Primers: 
Primer A 
5'-TCT AAT ACG ACT CAC TAT AGG AGC TCA GCC TTC ACT GC -3’ 
Primer B 
5'-GTG GAT CCG ACC GTG GTG CC -3’ 
 
109 nt ssDNA pool with randomized 70 nt region 
5'-GGA GCT CAG CCT TCA CTG C- N70-GGC ACC ACG GTC GGA TCC AC-3' 
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128 nt dsDNA pool with randomized 70 nt region and promoter region 
5'- TCT AAT ACG ACT CAC TAT AGG GGA GCT CAG CCT TCA CTG C- N70-GGC ACC ACG GTC 
GGA TCC AC-3' 
 
25 nt sense 
5’- TCT AAT ACG ACT CAC TAT AGG AGC TCA GCC TAC GAG CCT GAG CC-3’ 
25 nt antisense 
5’- GGC TCA GGC TCG TAG GCT GAG CTC CTA TAG TGA GTC GTA TTA GA-3’ 
Transcript 
5’-GG AGC UCA GCC UAC GAG CCU GAG CC-3’ 
 
19 nt sense 
5´ - GGA GCT CAG CCT TCA CTG C -3’ 
19 nt antisense 
5´ -GCA GTG AAG GCT GAG CTC C -3’ 
Modified 19 nt 
5´ AHEG-GGA GCT CAG CCT TCA CTG C-3’ 
5´ SH C6- GGA GCT CAG CCT TCA CTG C -3’ 
 
15 nt sense 
5´ -GTA CAG TCT GAA GTG-3’ 
15 nt antisense 
5´ -CAC TTC AGA CTG TAC-3’ 
Modified 15 nt 
5´ AHEG-GTA CAG TCT GAA GTG-3’ 
5´ ATEG-GTA CAG TCT GAA GTG-3’ 
5´ SH C6 -GTA CAG TCT GAA GTG-3’ 
5´ AHEG-GTA CAG TCT GAA GTG- SH C3 3’ 
Experimental section 
 170
Standard buffers 
 
Diels-Alderase buffer 30 mM Tris HCl pH 7.4 
 300 mM NaCl 
 80 mM MgCl2 
  
Transcription buffer 40 mM Tris HCl pH 8.1 
 22 mM MgCl2 
 1 mM Spermidine 
  0.01 % Triton X-100 
  
Buffer A 0.1 M TEAA pH 7.0 
  
Buffer B 0.1 M TEAA pH 7.0 
 80% ACN 
  
Caccodylate buffer 50 mM Sodium Cacodylate pH 7.5 
  
Loading buffer denaturating standard 90% Formamide 
 9.8% TBE 
 0.1% Xylencyanol 
 0.1% Bromphenol blue 
  
Stopmix standard 100 mM β-Mercaptoethanol 
 20 mM EDTA 
 80% Formamide 
 
 
Enzymes 
 
T7 RNA polymerase  In-house 
T4 Polynucleotide Kinase (T4 PNK) Fermentas, St. Leon-Rot 
T4 RNA Ligase Fermentas, St. Leon-Rot 
BioTherm DNA-Polymeras, 5 u / µl Rapidozym, Berlin 
dNTPs Rapidozym, Berlin 
radioactive nucleotides Hartmann Analytic, Braunschweig 
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Standard reagents 
 
UltraPure™ Agarose Invitrogen, Karlsruhe 
High resolution Agarose Invitrogen, Karlsruhe 
Ethidium bromide solution  Carl-Roth, Karlsruhe 
SYBR®Gold  Molecular Probes®, Invitorgen,  
GeneRuler™ 100 bp DNA Ladder Fermentas, St. Leon-Rot 
GeneRuler™ Ultra Low Range DNA Ladder Fermentas, St. Leon-Rot 
Rotiphorese® Ready-to-Use Gel Solutions  Carl Roth, Karlsruhe 
 
 
Kits and devices 
 
DyeEx 2.0 Spin Kit 250  Qiagen, Hilden 
Eppendorf tubes siliconized Carl Roth, Karlsruhe 
Filtertips  Sarstedt, Nümbrecht 
Greiner tubes  Greiner Bio-One, Frickenhausen 
Nanaosep® MF Centrifugal Devices PALL® Life Science 
NAP columns Sephadex G-25 GE Healthcare 
PCR tubes  Thermo Scientific, Schwerte 
PCR wells Thermo Scientific, Schwerte 
QIAquick PCR Purification Kit  Qiagen, Hilden 
RNeasy MinElute Cleanup Kit Qiagen, Hilden 
TranscriptAid™ T7 High Yield Transcription Kit Fermentas, St. Leon-Rot 
ZipTip Millipore, Schwalbach 
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Instruments 
 
Analytical balance  AX 204 and B3001-S Mettler Toledo 
Centrifuges  Eppendorf 5804 R and Mikro 120 Hettich 
Electrophoresis chamber  GIBCO BRL Sequencing System  
Freeze dryer  BenchTop K Series,VirTis Ismatec 
Gel Documentation equipment  AlphaImagerTM 2200 Alpha Innotech 
Flourescence spectrometer Jasco 
HPLC  Agilent 1100 Series 
HPLC Columns Luna C18, 5 μm, 4.6 250 mm and 15.0×250 mm 
IntelliFlash 310 Varian 
Mass Spectrometer MALDI-TOF Bruker BIFLEX III 
 FAB and EI JEOL JMS-700 
 Bruker MicroTOF-QII 
 LIFDI JEOL JMS-700 magnectic sector 
Minicentrifuges Kiesker 
NMR Spectrometer  Mercury Plus 300, Varian VNMR S 500 
pH-Meter  MP 220 Mettler Toledo 
Phosphorimager  Typhoon 9400 Amersham Biosciences 
Pipettes Abimed  P2, P20, P200, P1000 
Scintillation counter  Beckman LS 6500 
Speed vac Univapo 100 ECH 
Syntheziser  Applied Biosystems ExpediteTM 8909 
Syringe filters PTFE 13 mm, 0.2 μm, Carl Roth 
Thermomixer  Eppendorf, Thermomixer 5436 
Ultrapure Water Purification System Milli-Q, Millipore 
UV Cuvettes Quarzglas  HELLMA 
UV-Lamp 254 nm  Benda NU-8 KL 
UV-Transilluminator  254 nm, 300 × 200 mm Carl Roth 
UV/VIS Spectrophotometer Ultrospac 2100 pro Amersham 
 NanoDrop ND-1000 Peqlab Biotechnologie 
 Cary 100 Bio Varian 
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6.6 List of Abbreviations 
 
A  Adenosine; Peak area 
Å  Ångström 
A260  Absorbance at 260 nm 
Ac  Acetyl 
ACN   Acetonitrile 
AHEG  9-anthracenylmethyl hexaethylene glycol 
APS  Ammonium persulfate 
ATEG  9-anthracenylmethyl tetraethylene glycol 
ATP   Adenosine-5'-triphosphate 
Boc  tert-butyloxycarbonyl 
br  Broad (IR) 
BSA  Bovine serum albumin 
Bu  Butyl 
c  Concentration 
C   Cytidine 
cDNA   Complementary DNA 
CEP-Cl   2-Cyanoethyl diisopropylphosphoramidochloridite 
Ci   Curie; 1Ci = 37 MBq 
CPG   Controlled pore glass 
cpm  Counts per minute (radioactive decay) 
CTP  Cytidine-5'-triphosphate 
Cy3/5  Cyanine 3/5 
d   Doublet (NMR) 
DAD  Diode array detector 
DCI  4,5-Dicyanoimidazole 
DCM   Dichloromethane 
DEA   Diethylamine 
DIPA  Diisopropylamine 
DMAP   4-(Dimethylamino)pyridine 
DMF   N,N’-Dimethylformamide 
DMSO   Dimethyl sulfoxide 
DMT   4,4’-Dimethoxytrytil 
DNA   Deoxyribonucleic acid 
dNTP  Deoxynucleoside 5'-triphosphate 
ds  Double stranded 
DTT  dithiothreitol 
EA   Ethyl acetate 
EDC-HCl  N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
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EDTA   Ethylenediaminetetraacetic acid 
EI   Electron impact 
EPR  Electron paramagnetic resonance 
equiv   Equivalent 
ESI   Electro spray ionization 
EtBr  Ethidium bromide 
EtOH   Ethanol 
FAB   Fast atomic bombardment 
FAD  Fluorescence array detector 
FRET  Förster resonance energy transfer 
FT-ICR   Fourier-transform ion cyclotron resonance 
FW  Formula weight (Molecular weight) 
g   Gram 
G   Guanosine 
GMP  Guanosine-5'-monophosphate 
GTP  Guanosine-5'-triphosphate 
h  Hour 
HEPES  4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
Hex   Hexane 
HOMO  Highest-energy occupied molecular orbital 
HPLC   High Performance Liquid Chromatography 
Hz  Hertz 
i  iso 
I   Light intensity 
I   Spin quantum number 
IR  Infrared 
J   Coupling constant 
K  Reaction rate constant 
l   Length of the light path 
L   Liter 
LIFDI  liquid injection field desorption ionization  
LUMO  lowest-energy unoccupied molecular orbital 
m  Multiplet (NMR), medium (IR), meter 
M   Mol/L; Molar 
m.p.  melting point 
M+   molecular ion (MS) 
mA  Milli Ampere 
MALDI-TOF  Matrix assisted laser desorption ionization time-of-flight 
MBq  Mega Becquerel 
Me   Methyl 
MHz  Megahertz 
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min   Minute 
mol  Mol 
MOPS  3-morpholinopropane-1-sulfonic acid (buffer) 
MS   Mass spectrometry 
n  Polyethylene glycol units 
n  stretching vibration 
NHS   N-hydroxysuccinimide, N-hydroxysuccinimidyl 
nm   Nanometer 
NMR   Nuclear magnetic resonance 
nt  Nucleotide 
NTP  Nucleoside 5'-triphosphate 
OD  Optical density 
ORN   Oligoribonucleotide 
ODN   Oligodeoxynucleotide 
PAGE   Polyacrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
PCR   Polymerase chain reaction 
pCp  Cytidine 3',5'-bisphosphate 
PEG  polyethylene glycole 
PNA  Peptide nucleic acid 
PNK  Polynucleotide kinase 
ppm   Parts per million 
q  Quartet (NMR) 
quint.  Quintet (NMR) 
rel int  Relative intensity 
Rf   Retention factor (TLC) 
RNA   Ribonucleic acid 
RNAP  RNA polymerase 
rpm   Rotations per minute 
RT   Reverse transcription 
rt   Room temperature 
s  Singlet (NMR); strong (IR) 
SDS   Sodiumdodecyl sulfate 
sec   Second 
SELEX   Systematic evolution of ligands by exponential enrichment 
ss  Single stranded 
t, t  Triplet, tert 
T   Thymidine; Temperature 
TBAF  Tetra-n-butylammonium fluoride 
TAMRA  Tetramethyl-6-Carboxyrhodamine 
TBDMS-Cl   tert-butyldimethylsilyl chloride 
Experimental section 
 176
TBE   Tris-borate-EDTA buffer 
TCA   Trichloroacetic acid 
TCEP  Tris(2-carboxyethyl)phosphine  
TEA   Triethylamine 
TEAA   Triethylammonium acetate 
TEMED  Tetramethylethylenediamine 
TFA   Trifluoroacetic acid 
THF   Tetrahydrofuran 
TLC   Thin layer chromatography 
Tm   Melting temperature (nucleic acids) 
TOCSY   Total correlated spectroscopy (NMR) 
tR   Retention time (HPLC) 
Tris   Trishydroxymethylaminomethane; 2-amino-2-hydroxymethyl-1,3-propanediol 
U   Uridine; Unit 
UTP  Uridine 5′-triphosphate 
UV   Ultraviolet 
V  Volt 
W  Watt 
w  Weak (IR) 
wt  Wild type 
δ  Chemical shift (NMR), bending vibration (IR) 
ε   Molar extinction coefficient 
λ   Wavelength 
λabs  Absorption maximum 
λem  Emission maximum 
λmax  Maximum absorption 
   
   
f  femto 
p  pico 
n  nano 
µ  micro 
m  milli 
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6.7 Appendix 
 
Thermal denaturation studies of the Diels-Alderase ribozyme 
 
 
Figure 40: Absorption of the wild-type at different MgCl2 concentrations respectively with EDTA. 
 
 
Figure 41: First derivative absorbance at 260 nm of the wild-type at different MgCl2 concentrations respectively 
with EDTA. 
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Figure 42: Absorption of the mutant U17C at different MgCl2 concentrations respectively with EDTA. 
 
 
Figure 43: First derivative absorbance at 260 nm of the mutant U17C at different MgCl2 concentrations 
respectively with EDTA. 
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Figure 44: Absorption of the mutant U17iC at different MgCl2 concentrations respectively with EDTA. 
 
 
Figure 45: First derivative absorbance at 260 nm of the mutant U17iC at different MgCl2 concentrations 
respectively with EDTA. 
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Bioorthogonal and orthogonal labeling of oligonucleotides 
 
 
Figure: Determination of the melting temperature of the modified 15mer oligonucleotides. Tm was measured in 
25 mM sodium cacodylate buffer pH 7.5 with 7.5 mM MgCl2. 
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